<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Metodi di meta-analisi: dalla domanda alla conclusione</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:ital,wght@0,400;0,600;0,700;1,400;1,600&amp;family=Source+Sans+Pro:wght@300;400;600;700&amp;display=swap" rel="stylesheet"/>
 Plot per grafici interattivi 
<script src="https://cdn.plot.ly/plotly-2.27.0.min.js"></script>
<script>
if (typeof Plotly === 'undefined') {
  document.addEventListener('DOMContentLoaded', function() {
    document.querySelectorAll('[id*="plot"], [id*="chart"], .plotly-graph-div, .js-plotly-plot').forEach(function(el) {
      el.innerHTML = '<div style="padding:2rem;text-align:center;background:#2a2a4a;border:1px dashed #D4AF37;border-radius:8px;color:#FAF8F5;margin:1rem 0;"><p style="font-size:1.1rem;margin-bottom:0.5rem;">Interactive chart unavailable offline</p><p style="font-size:0.85rem;opacity:0.7;">Connect to the internet to load interactive Plotly.js visualizations</p></div>';
    });
  });
}
</script>
<style>
    :root {
      --navy: #1E2761;
      --deep-navy: #141B3D;
      --gold: #D4AF37;
      --cream: #FAF8F5;
      --light-cream: #FFFFFF;
      --text: #2D3748;
      --light-text: #718096;
      --red: #C53030;
      --green: #22c55e;
      --teal: #0f5b6a;
      --transition: 0.5s cubic-bezier(0.4, 0, 0.2, 1);
    }

    * { margin: 0; padding: 0; box-sizing: border-box; }

    html, body {
      height: 100%;
      font-family: 'Source Sans Pro', sans-serif;
      background: var(--deep-navy);
      color: var(--cream);
    }

    /* ====== COURSE SHELL ====== */
    .course-container {
      display: flex;
      height: 100vh;
      overflow: hidden;
    }

    /* ====== SIDEBAR NAV ====== */
    .sidebar {
      width: 300px;
      background: linear-gradient(180deg, var(--deep-navy) 0%, #0a0f1a 100%);
      border-right: 1px solid rgba(212,175,55,0.2);
      display: flex;
      flex-direction: column;
      flex-shrink: 0;
    }

    .sidebar-header {
      padding: 1.5rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }

    .sidebar-header h1 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.4rem;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 0.25rem;
    }

    .sidebar-header p {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
    }

    .module-list {
      flex: 1;
      overflow-y: auto;
      padding: 1rem 0;
    }

    .module-item {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.65rem 1.25rem;
      cursor: pointer;
      transition: all 0.2s;
      border-left: 3px solid transparent;
    }

    .module-item:hover {
      background: rgba(212,175,55,0.1);
    }

    .module-item.active {
      background: rgba(212,175,55,0.15);
      border-left-color: var(--gold);
    }

    .module-item.completed .module-number {
      background: var(--green);
      color: white;
    }

    .module-number {
      width: 26px;
      height: 26px;
      border-radius: 50%;
      background: rgba(255,255,255,0.1);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.75rem;
      font-weight: 600;
      flex-shrink: 0;
    }

    .module-info {
      flex: 1;
      min-width: 0;
    }

    .module-title {
      font-size: 0.85rem;
      font-weight: 600;
      white-space: nowrap;
      overflow: hidden;
      text-overflow: ellipsis;
    }

    .module-subtitle {
      font-size: 0.7rem;
      color: rgba(255,255,255,0.5);
    }

    /* ====== SIDEBAR FOOTER ====== */
    .sidebar-footer {
      padding: 1rem;
      border-top: 1px solid rgba(212,175,55,0.2);
    }

    .progress-dashboard-btn {
      width: 100%;
      padding: 0.75rem;
      background: rgba(212,175,55,0.15);
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 8px;
      color: var(--gold);
      font-weight: 600;
      cursor: pointer;
      display: flex;
      align-items: center;
      justify-content: space-between;
      margin-bottom: 0.5rem;
    }

    .daily-review-btn {
      width: 100%;
      padding: 0.6rem;
      background: rgba(239,68,68,0.15);
      border: 1px solid rgba(239,68,68,0.3);
      border-radius: 8px;
      color: #f87171;
      font-weight: 600;
      cursor: pointer;
      display: flex;
      align-items: center;
      justify-content: center;
      gap: 0.5rem;
      font-size: 0.85rem;
    }

    .progress-bar-container {
      margin-top: 0.75rem;
    }

    .progress-label {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
      margin-bottom: 0.25rem;
    }

    .progress-bar {
      height: 6px;
      background: rgba(255,255,255,0.1);
      border-radius: 3px;
      overflow: hidden;
    }

    .progress-fill {
      height: 100%;
      background: linear-gradient(90deg, var(--gold), #f0c040);
      border-radius: 3px;
      transition: width 0.3s;
    }

    /* ====== MAIN CONTENT ====== */
    .main-content {
      flex: 1;
      display: flex;
      flex-direction: column;
      overflow: hidden;
    }

    .top-bar {
      display: flex;
      justify-content: space-between;
      align-items: center;
      padding: 1rem 2rem;
      background: rgba(0,0,0,0.2);
      border-bottom: 1px solid rgba(212,175,55,0.15);
    }

    .module-indicator {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.7);
    }

    .top-bar-actions {
      display: flex;
      gap: 0.75rem;
    }

    .top-bar-btn {
      padding: 0.5rem 1rem;
      background: rgba(255,255,255,0.1);
      border: 1px solid rgba(255,255,255,0.2);
      border-radius: 6px;
      color: var(--cream);
      font-size: 0.85rem;
      cursor: pointer;
      transition: all 0.2s;
    }

    .top-bar-btn:hover {
      background: rgba(255,255,255,0.15);
    }

    .top-bar-btn.primary {
      background: var(--teal);
      border-color: var(--teal);
    }

    /* ====== SLIDE AREA ====== */
    .slide-container {
      flex: 1;
      overflow-y: auto;
      padding: 2rem;
    }

    .slide {
      display: none;
      max-width: 1000px;
      margin: 0 auto;
    }

    .slide.active {
      display: block;
    }

    /* ====== SLIDE STYLES ====== */
    .principle-display {
      text-align: center;
      margin-bottom: 2rem;
    }

    .principle-text {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2rem;
      font-style: italic;
      color: var(--gold);
      line-height: 1.4;
    }

    .slide-title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2.2rem;
      color: var(--gold);
      margin-bottom: 1.5rem;
      text-align: center;
    }

    .slide-content {
      background: rgba(255,255,255,0.03);
      border: 1px solid rgba(212,175,55,0.15);
      border-radius: 12px;
      padding: 2rem;
    }

    .story-box {
      background: linear-gradient(135deg, rgba(191,45,45,0.1), rgba(30,39,97,0.15));
      border-left: 4px solid var(--red);
      border-radius: 0 12px 12px 0;
      padding: 1.5rem;
      margin-bottom: 1.5rem;
    }

    .story-label {
      font-size: 0.75rem;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: var(--red);
      margin-bottom: 0.5rem;
    }

    .story-text {
      font-size: 1.1rem;
      line-height: 1.7;
      color: var(--cream);
    }

    .story-hook {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.3rem;
      font-style: italic;
      color: var(--gold);
      margin-top: 1rem;
      padding-top: 1rem;
      border-top: 1px solid rgba(255,255,255,0.1);
    }

    .method-box {
      background: linear-gradient(135deg, rgba(15,91,106,0.15), rgba(30,39,97,0.1));
      border-left: 4px solid var(--teal);
      border-radius: 0 12px 12px 0;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .method-label {
      font-size: 0.75rem;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: var(--teal);
      margin-bottom: 0.5rem;
    }

    .method-content h3 {
      color: var(--cream);
      margin-bottom: 1rem;
      font-size: 1.2rem;
    }

    .method-content ul {
      margin-left: 1.5rem;
      color: rgba(255,255,255,0.85);
    }

    .method-content li {
      margin-bottom: 0.5rem;
      line-height: 1.5;
    }

    /* ====== TOOL PANEL ====== */
    .tool-panel {
      background: var(--light-cream);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
      color: var(--text);
    }

    .tool-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
      padding-bottom: 0.75rem;
      border-bottom: 2px solid var(--teal);
    }

    .tool-icon {
      font-size: 1.5rem;
    }

    .tool-title {
      font-weight: 700;
      font-size: 1.1rem;
      color: var(--navy);
    }

    .tool-input-group {
      margin-bottom: 1rem;
    }

    .tool-input-group label {
      display: block;
      font-weight: 600;
      font-size: 0.85rem;
      margin-bottom: 0.25rem;
      color: var(--navy);
    }

    .tool-input-group input,
    .tool-input-group textarea,
    .tool-input-group select {
      width: 100%;
      padding: 0.6rem;
      border: 1px solid #e2e8f0;
      border-radius: 6px;
      font-family: inherit;
      font-size: 0.9rem;
    }

    .tool-input-group textarea {
      min-height: 80px;
      resize: vertical;
    }

    .tool-btn {
      padding: 0.6rem 1.25rem;
      background: var(--teal);
      color: white;
      border: none;
      border-radius: 6px;
      font-weight: 600;
      cursor: pointer;
      transition: background 0.2s;
    }

    .tool-btn:hover {
      background: #0a4a57;
    }

    .tool-output {
      margin-top: 1rem;
      padding: 1rem;
      background: #f7fafc;
      border-radius: 8px;
      font-family: 'Monaco', 'Consolas', monospace;
      font-size: 0.85rem;
      white-space: pre-wrap;
    }

    /* ====== SCENARIO PANEL ====== */
    .scenario-panel {
      background: linear-gradient(135deg, rgba(124,58,237,0.1), rgba(30,39,97,0.2));
      border: 2px solid rgba(124,58,237,0.4);
      border-radius: 16px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .scenario-header {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      margin-bottom: 1rem;
    }

    .scenario-icon {
      font-size: 1.5rem;
    }

    .scenario-title {
      font-weight: 700;
      font-size: 1.1rem;
      color: var(--cream);
    }

    .scenario-situation {
      background: rgba(0,0,0,0.2);
      padding: 1rem;
      border-radius: 8px;
      margin-bottom: 1rem;
      line-height: 1.6;
    }

    .scenario-question {
      font-weight: 600;
      color: var(--gold);
      margin-bottom: 1rem;
    }

    .scenario-choices {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }

    .scenario-choice {
      display: flex;
      align-items: flex-start;
      gap: 0.75rem;
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 2px solid rgba(255,255,255,0.15);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
    }

    .scenario-choice:hover {
      background: rgba(255,255,255,0.1);
      border-color: rgba(124,58,237,0.5);
    }

    .scenario-choice.correct {
      background: rgba(34,197,94,0.15);
      border-color: var(--green);
    }

    .scenario-choice.incorrect {
      background: rgba(239,68,68,0.1);
      border-color: var(--red);
    }

    .choice-letter {
      width: 24px;
      height: 24px;
      border-radius: 50%;
      background: rgba(124,58,237,0.3);
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: 700;
      font-size: 0.8rem;
      flex-shrink: 0;
    }

    .scenario-consequence {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }

    .scenario-consequence.visible {
      display: block;
    }

    .scenario-consequence.good {
      background: rgba(34,197,94,0.15);
      border: 1px solid rgba(34,197,94,0.3);
    }

    .scenario-consequence.bad {
      background: rgba(239,68,68,0.1);
      border: 1px solid rgba(239,68,68,0.3);
    }

    /* ====== QUIZ ====== */
    .quiz-container {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(212,175,55,0.2);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .quiz-question {
      font-size: 1.1rem;
      margin-bottom: 1rem;
      line-height: 1.5;
    }

    .quiz-options {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }

    .quiz-option {
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.2);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
      color: var(--cream);
      font-family: inherit;
      font-size: inherit;
      text-align: left;
      width: 100%;
      display: flex;
      align-items: flex-start;
      gap: 0.5rem;
    }

    .quiz-option:hover {
      background: rgba(255,255,255,0.1);
    }

    .quiz-option:disabled {
      cursor: not-allowed;
      opacity: 0.8;
    }

    .option-letter {
      font-weight: 600;
      color: var(--gold);
      flex-shrink: 0;
    }

    .quiz-option.selected {
      border-color: var(--gold);
      background: rgba(212,175,55,0.1);
    }

    .quiz-option.correct {
      border-color: var(--green);
      background: rgba(34,197,94,0.15);
    }

    .quiz-option.incorrect {
      border-color: var(--red);
      background: rgba(239,68,68,0.1);
    }

    /* ====== NAVIGATION ====== */
    .slide-nav {
      display: flex;
      justify-content: space-between;
      align-items: center;
      padding: 1rem 2rem;
      background: rgba(0,0,0,0.2);
      border-top: 1px solid rgba(212,175,55,0.15);
    }

    .nav-btn {
      padding: 0.75rem 1.5rem;
      background: rgba(255,255,255,0.1);
      border: 1px solid rgba(255,255,255,0.2);
      border-radius: 8px;
      color: var(--cream);
      font-weight: 600;
      cursor: pointer;
      transition: all 0.2s;
    }

    .nav-btn:hover {
      background: rgba(255,255,255,0.15);
    }

    .nav-btn.primary {
      background: var(--gold);
      border-color: var(--gold);
      color: var(--navy);
    }

    .nav-btn:disabled {
      opacity: 0.5;
      cursor: not-allowed;
    }

    .slide-counter {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.6);
    }

    .slide-dots {
      display: flex;
      gap: 6px;
    }

    .slide-dot {
      width: 8px;
      height: 8px;
      border-radius: 50%;
      background: rgba(255,255,255,0.2);
    }

    .slide-dot.active {
      background: var(--gold);
    }

    .slide-dot.completed {
      background: var(--green);
    }

    /* ====== PROGRESS DASHBOARD ====== */
    .dashboard-overlay {
      position: fixed;
      inset: 0;
      background: rgba(0,0,0,0.8);
      display: none;
      align-items: center;
      justify-content: center;
      z-index: 1000;
    }

    .dashboard-overlay.open {
      display: flex;
    }

    .dashboard-panel {
      background: var(--light-cream);
      border-radius: 16px;
      width: 90%;
      max-width: 600px;
      max-height: 80vh;
      overflow-y: auto;
      color: var(--text);
    }

    .dashboard-header {
      padding: 1.5rem;
      background: linear-gradient(135deg, var(--navy), var(--teal));
      color: white;
      border-radius: 16px 16px 0 0;
    }

    .dashboard-header h2 {
      font-family: 'Cormorant Garamond', Georgia, serif;
      margin-bottom: 0.5rem;
    }

    .dashboard-content {
      padding: 1.5rem;
    }

    .stat-grid {
      display: grid;
      grid-template-columns: repeat(3, 1fr);
      gap: 1rem;
      margin-bottom: 1.5rem;
    }

    .stat-card {
      text-align: center;
      padding: 1rem;
      background: #f7fafc;
      border-radius: 8px;
    }

    .stat-value {
      font-size: 1.8rem;
      font-weight: 700;
      color: var(--navy);
    }

    .stat-label {
      font-size: 0.75rem;
      color: var(--light-text);
      text-transform: uppercase;
    }

    .badge-grid {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
    }

    .badge {
      padding: 0.4rem 0.8rem;
      background: #e2e8f0;
      border-radius: 999px;
      font-size: 0.8rem;
      color: var(--light-text);
    }

    .badge.earned {
      background: linear-gradient(135deg, var(--gold), #f0c040);
      color: var(--navy);
      font-weight: 600;
    }

    .close-btn {
      position: absolute;
      top: 1rem;
      right: 1rem;
      width: 32px;
      height: 32px;
      border-radius: 50%;
      background: rgba(255,255,255,0.2);
      border: none;
      color: white;
      font-size: 1.2rem;
      cursor: pointer;
    }

    /* ====== DECISION TREE ====== */
    .decision-tree {
      background: linear-gradient(135deg, rgba(30,39,97,0.1), rgba(20,27,61,0.15));
      border: 2px solid rgba(212,175,55,0.3);
      border-radius: 16px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .decision-node {
      background: rgba(255,255,255,0.08);
      border: 2px solid rgba(255,255,255,0.2);
      border-radius: 12px;
      padding: 1.25rem;
      margin-bottom: 1rem;
      transition: all 0.3s ease;
    }

    .decision-node.active {
      border-color: var(--gold);
      background: rgba(212,175,55,0.15);
    }

    .decision-node.completed {
      border-color: var(--green);
      background: rgba(34,197,94,0.1);
    }

    .decision-node.wrong {
      border-color: var(--red);
      background: rgba(197,48,48,0.1);
    }

    .decision-question {
      font-size: 1.1rem;
      font-weight: 600;
      color: var(--cream);
      margin-bottom: 1rem;
    }

    .decision-branches {
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }

    .decision-branch {
      display: flex;
      align-items: center;
      gap: 0.75rem;
      padding: 0.75rem 1rem;
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.15);
      border-radius: 8px;
      cursor: pointer;
      transition: all 0.2s;
    }

    .decision-branch:hover {
      background: rgba(255,255,255,0.1);
      border-color: var(--gold);
    }

    .decision-branch.selected {
      background: rgba(212,175,55,0.2);
      border-color: var(--gold);
    }

    .decision-branch.correct {
      background: rgba(34,197,94,0.2);
      border-color: var(--green);
    }

    .decision-branch.incorrect {
      background: rgba(197,48,48,0.15);
      border-color: var(--red);
    }

    .branch-arrow {
      width: 24px;
      height: 24px;
      border-radius: 50%;
      background: rgba(212,175,55,0.3);
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.8rem;
      flex-shrink: 0;
    }

    .decision-outcome {
      margin-top: 1rem;
      padding: 1rem;
      border-radius: 8px;
      display: none;
    }

    .decision-outcome.visible {
      display: block;
      animation: fadeIn 0.3s ease;
    }

    .decision-outcome.good {
      background: rgba(34,197,94,0.15);
      border-left: 4px solid var(--green);
    }

    .decision-outcome.bad {
      background: rgba(197,48,48,0.15);
      border-left: 4px solid var(--red);
    }

    .decision-outcome.neutral {
      background: rgba(245,158,11,0.15);
      border-left: 4px solid #f59e0b;
    }

    /* ====== INTERACTIVE PLOTS ====== */
    .plot-container {
      background: var(--light-cream);
      border-radius: 12px;
      padding: 1rem;
      margin: 1rem 0;
    }

    .plot-area {
      width: 100%;
      min-height: 350px;
      background: white;
      border-radius: 8px;
    }

    .plot-controls {
      display: flex;
      flex-wrap: wrap;
      gap: 0.75rem;
      margin-bottom: 1rem;
      padding: 0.75rem;
      background: rgba(0,0,0,0.03);
      border-radius: 8px;
    }

    .plot-control-group {
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .plot-control-group label {
      font-size: 0.8rem;
      font-weight: 600;
      color: var(--navy);
    }

    .plot-control-group select,
    .plot-control-group input[type="number"] {
      padding: 0.4rem 0.6rem;
      border: 1px solid #ddd;
      border-radius: 4px;
      font-size: 0.85rem;
    }

    .plot-control-group input[type="range"] {
      width: 100px;
    }

    /* ====== DATA TABLE EDITOR ====== */
    .data-editor {
      background: var(--light-cream);
      border-radius: 12px;
      padding: 1.25rem;
      margin: 1rem 0;
      color: var(--text);
    }

    .data-table {
      width: 100%;
      border-collapse: collapse;
      font-size: 0.85rem;
      margin-bottom: 1rem;
    }

    .data-table th {
      background: var(--navy);
      color: white;
      padding: 0.6rem;
      text-align: left;
      font-weight: 600;
    }

    .data-table td {
      padding: 0.5rem;
      border-bottom: 1px solid #eee;
    }

    .data-table input {
      width: 100%;
      padding: 0.35rem;
      border: 1px solid #ddd;
      border-radius: 4px;
      font-size: 0.85rem;
    }

    .data-table input:focus {
      border-color: var(--teal);
      outline: none;
    }

    .data-table .row-actions {
      text-align: center;
    }

    .data-table .delete-row {
      background: transparent;
      border: 1px solid #ddd;
      padding: 0.2rem 0.5rem;
      border-radius: 4px;
      cursor: pointer;
      color: var(--red);
    }

    .add-row-btn {
      display: inline-flex;
      align-items: center;
      gap: 0.5rem;
      padding: 0.5rem 1rem;
      background: var(--teal);
      color: white;
      border: none;
      border-radius: 6px;
      cursor: pointer;
      font-size: 0.85rem;
    }

    /* ====== REAL-TIME STATS PANEL ====== */
    .stats-panel {
      background: linear-gradient(135deg, var(--navy), var(--teal));
      border-radius: 12px;
      padding: 1.25rem;
      color: white;
      margin: 1rem 0;
    }

    .stats-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(120px, 1fr));
      gap: 1rem;
    }

    .stat-item {
      text-align: center;
      padding: 0.75rem;
      background: rgba(255,255,255,0.1);
      border-radius: 8px;
    }

    .stat-value {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
    }

    .stat-label {
      font-size: 0.75rem;
      opacity: 0.8;
      margin-top: 0.25rem;
    }

    .stat-interpretation {
      margin-top: 1rem;
      padding: 0.75rem;
      background: rgba(255,255,255,0.1);
      border-radius: 8px;
      font-size: 0.9rem;
      line-height: 1.5;
    }

    /* ====== STORY DEEP DIVE ====== */
    .story-deep {
      background: linear-gradient(135deg, rgba(191,45,45,0.08), rgba(30,39,97,0.12));
      border-left: 4px solid var(--red);
      border-radius: 0 16px 16px 0;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .story-timeline {
      position: relative;
      padding-left: 2rem;
      margin: 1rem 0;
    }

    .story-timeline::before {
      content: '';
      position: absolute;
      left: 8px;
      top: 0;
      bottom: 0;
      width: 2px;
      background: rgba(255,255,255,0.2);
    }

    .timeline-event {
      position: relative;
      margin-bottom: 1.25rem;
      padding-left: 1rem;
    }

    .timeline-event::before {
      content: '';
      position: absolute;
      left: -1.5rem;
      top: 0.35rem;
      width: 12px;
      height: 12px;
      border-radius: 50%;
      background: var(--gold);
      border: 2px solid rgba(255,255,255,0.3);
    }

    .timeline-event.crisis::before {
      background: var(--red);
    }

    .timeline-event.revelation::before {
      background: var(--green);
    }

    .timeline-year {
      font-weight: 700;
      color: var(--gold);
      font-size: 0.85rem;
    }

    .timeline-text {
      color: rgba(255,255,255,0.9);
      line-height: 1.5;
      margin-top: 0.25rem;
    }

    /* ====== REAL DATA CARD ====== */
    .real-data-card {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(212,175,55,0.3);
      border-radius: 12px;
      padding: 1.25rem;
      margin: 1rem 0;
    }

    .real-data-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1rem;
      padding-bottom: 0.75rem;
      border-bottom: 1px solid rgba(255,255,255,0.1);
    }

    .real-data-source {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
    }

    .real-data-stat {
      display: flex;
      align-items: baseline;
      gap: 0.5rem;
      margin-bottom: 0.5rem;
    }

    .real-data-stat .value {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--gold);
    }

    .real-data-stat .label {
      font-size: 0.9rem;
      color: rgba(255,255,255,0.8);
    }

    /* ====== ANIMATIONS ====== */
    @keyframes fadeIn {
      from { opacity: 0; transform: translateY(10px); }
      to { opacity: 1; transform: translateY(0); }
    }

    @keyframes pulse {
      0%, 100% { transform: scale(1); }
      50% { transform: scale(1.05); }
    }

    .animate-in {
      animation: fadeIn 0.4s ease;
    }

    .pulse {
      animation: pulse 2s infinite;
    }

    /* ====== ACCESSIBILITY ====== */
    /* Focus states for all interactive elements */
    button:focus, .module-item:focus, .quiz-option:focus,
    .decision-branch:focus, input:focus, select:focus, a:focus {
      outline: 3px solid var(--gold);
      outline-offset: 2px;
    }

    /* High contrast mode support */
    @media (prefers-contrast: high) {
      :root {
        --gold: #FFD700;
        --cream: #FFFFFF;
      }
    }

    /* Focus-visible styles for keyboard navigation */
    :focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
    }

    :focus:not(:focus-visible) {
      outline: none;
    }

    button:focus-visible,
    a:focus-visible,
    [role="button"]:focus-visible,
    input:focus-visible,
    select:focus-visible,
    textarea:focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }

    /* Reduced motion support */
    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
      }
    }

    /* Screen reader only class */
    .sr-only {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    /* ====== HAMBURGER MENU ====== */
    .hamburger {
      display: none;
      position: fixed;
      top: 1rem;
      left: 1rem;
      z-index: 1001;
      width: 44px;
      height: 44px;
      background: var(--navy);
      border: 2px solid var(--gold);
      border-radius: 8px;
      cursor: pointer;
      flex-direction: column;
      align-items: center;
      justify-content: center;
      gap: 5px;
    }

    .hamburger span {
      display: block;
      width: 22px;
      height: 2px;
      background: var(--gold);
      transition: all 0.3s;
    }

    .hamburger.active span:nth-child(1) {
      transform: rotate(45deg) translate(5px, 5px);
    }

    .hamburger.active span:nth-child(2) {
      opacity: 0;
    }

    .hamburger.active span:nth-child(3) {
      transform: rotate(-45deg) translate(5px, -5px);
    }

    .sidebar-overlay {
      display: none;
      position: fixed;
      inset: 0;
      background: rgba(0,0,0,0.6);
      z-index: 999;
    }

    .sidebar-overlay.active {
      display: block;
    }

    /* ====== RESPONSIVE BREAKPOINTS ====== */

    /* Tablet: 768px */
    @media (max-width: 768px) {
      .hamburger {
        display: flex;
      }

      .sidebar {
        position: fixed;
        left: -320px;
        top: 0;
        height: 100vh;
        z-index: 1000;
        transition: left 0.3s ease;
        width: 280px;
      }

      .sidebar.open {
        left: 0;
      }

      .main-content {
        margin-left: 0;
        width: 100%;
      }

      .top-bar {
        padding-left: 60px;
      }

      .slide-container {
        padding: 1rem;
      }

      .plot-controls {
        flex-direction: column;
      }

      .stats-grid {
        grid-template-columns: repeat(2, 1fr);
      }

      .decision-branches {
        gap: 0.75rem;
      }

      .decision-branch {
        padding: 1rem;
        min-height: 48px;
      }

      .quiz-option {
        padding: 1rem;
        min-height: 48px;
      }

      .tool-grid {
        grid-template-columns: 1fr;
      }

      .progress-modal-content {
        width: 95%;
        max-width: none;
        margin: 1rem;
      }
    }

    /* Mobile: 480px */
    @media (max-width: 480px) {
      .sidebar {
        width: 100%;
        left: -100%;
      }

      .top-bar {
        flex-wrap: wrap;
        gap: 0.5rem;
        padding: 0.75rem;
        padding-left: 55px;
      }

      .top-bar-actions {
        order: 3;
        width: 100%;
        justify-content: space-around;
      }

      .top-bar-btn {
        padding: 0.5rem 0.75rem;
        font-size: 0.75rem;
      }

      .slide-container {
        padding: 0.75rem;
      }

      .story-deep, .real-data-card {
        padding: 1rem;
      }

      .story-timeline {
        padding-left: 1rem;
      }

      .timeline-event {
        padding: 0.75rem;
      }

      .stats-grid {
        grid-template-columns: 1fr;
        gap: 0.5rem;
      }

      .stat-item {
        padding: 0.75rem;
      }

      .stat-value {
        font-size: 1.4rem;
      }

      .principle-number {
        font-size: 3rem;
      }

      .principle-text {
        font-size: 1.3rem;
      }

      .decision-tree {
        padding: 1rem;
      }

      .decision-node {
        padding: 1rem;
      }

      h2 {
        font-size: 1.4rem;
      }

      h3 {
        font-size: 1.1rem;
      }

      .nav-controls {
        flex-wrap: wrap;
        gap: 0.5rem;
      }

      .nav-btn {
        flex: 1;
        min-width: 80px;
        padding: 0.75rem;
      }
    }

    /* ====== CERTIFICATE MODAL ====== */
    .certificate-modal {
      display: none;
      position: fixed;
      inset: 0;
      background: rgba(0,0,0,0.85);
      z-index: 2000;
      align-items: center;
      justify-content: center;
      padding: 1rem;
    }

    .certificate-modal.active {
      display: flex;
    }

    .certificate {
      background: linear-gradient(135deg, #FAF8F5, #F5F0E8);
      border: 8px solid var(--gold);
      border-radius: 8px;
      padding: 3rem;
      max-width: 700px;
      width: 100%;
      text-align: center;
      position: relative;
      box-shadow: 0 20px 60px rgba(0,0,0,0.3);
    }

    .certificate::before {
      content: '';
      position: absolute;
      inset: 8px;
      border: 2px solid var(--gold);
      border-radius: 4px;
      pointer-events: none;
    }

    .certificate-title {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2.5rem;
      color: var(--navy);
      margin-bottom: 0.5rem;
    }

    .certificate-subtitle {
      font-size: 1rem;
      color: var(--light-text);
      margin-bottom: 2rem;
    }

    .certificate-name {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 2rem;
      color: var(--navy);
      margin: 1.5rem 0;
      padding: 0.5rem;
      border-bottom: 2px solid var(--gold);
      display: inline-block;
    }

    .certificate-body {
      font-size: 1rem;
      color: var(--text);
      line-height: 1.6;
      margin-bottom: 2rem;
    }

    .certificate-date {
      font-size: 0.9rem;
      color: var(--light-text);
      margin-top: 2rem;
    }

    .certificate-actions {
      display: flex;
      gap: 1rem;
      justify-content: center;
      margin-top: 2rem;
    }

    .certificate-btn {
      padding: 0.75rem 1.5rem;
      border-radius: 8px;
      font-weight: 600;
      cursor: pointer;
      border: none;
    }

    .certificate-btn.primary {
      background: var(--navy);
      color: white;
    }

    .certificate-btn.secondary {
      background: transparent;
      color: var(--navy);
      border: 2px solid var(--navy);
    }

    /* ====== TOOL LIBRARY MODAL ====== */
    .tool-library-modal {
      display: none;
      position: fixed;
      inset: 0;
      background: rgba(0,0,0,0.85);
      z-index: 1500;
      overflow-y: auto;
      padding: 2rem;
    }

    .tool-library-modal.active {
      display: block;
    }

    .tool-library-content {
      max-width: 900px;
      margin: 0 auto;
      background: var(--deep-navy);
      border-radius: 16px;
      border: 1px solid rgba(212,175,55,0.3);
      padding: 2rem;
    }

    .tool-library-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      margin-bottom: 1.5rem;
      padding-bottom: 1rem;
      border-bottom: 1px solid rgba(212,175,55,0.2);
    }

    .tool-library-grid {
      display: grid;
      grid-template-columns: repeat(auto-fill, minmax(250px, 1fr));
      gap: 1rem;
    }

    .tool-library-item {
      background: rgba(255,255,255,0.05);
      border: 1px solid rgba(255,255,255,0.1);
      border-radius: 12px;
      padding: 1.25rem;
      cursor: pointer;
      transition: all 0.2s;
    }

    .tool-library-item:hover {
      background: rgba(212,175,55,0.1);
      border-color: var(--gold);
    }

    .tool-library-item h4 {
      color: var(--gold);
      margin-bottom: 0.5rem;
    }

    .tool-library-item p {
      font-size: 0.85rem;
      color: rgba(255,255,255,0.7);
    }

    /* ====== DECISION TREE PATH HISTORY ====== */
    .path-history {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
      margin-bottom: 1rem;
      padding: 0.75rem;
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
    }

    .path-step {
      display: flex;
      align-items: center;
      gap: 0.25rem;
      font-size: 0.8rem;
      color: rgba(255,255,255,0.7);
    }

    .path-step::after {
      content: '‚Üí';
      margin-left: 0.5rem;
      color: var(--gold);
    }

    .path-step:last-child::after {
      display: none;
    }

    .undo-btn, .restart-btn {
      padding: 0.5rem 1rem;
      background: rgba(212,175,55,0.2);
      border: 1px solid var(--gold);
      border-radius: 6px;
      color: var(--gold);
      font-size: 0.85rem;
      cursor: pointer;
      transition: all 0.2s;
    }

    .undo-btn:hover, .restart-btn:hover {
      background: rgba(212,175,55,0.3);
    }

    .tree-controls {
      display: flex;
      gap: 0.5rem;
      margin-top: 1rem;
    }

    /* ====== TOAST NOTIFICATIONS ====== */
    .toast-container {
      position: fixed;
      top: 1rem;
      right: 1rem;
      z-index: 10000;
      display: flex;
      flex-direction: column;
      gap: 0.5rem;
    }

    .toast {
      padding: 0.75rem 1.25rem;
      background: linear-gradient(135deg, var(--gold), #f0c040);
      color: var(--navy);
      border-radius: 8px;
      font-weight: 600;
      font-size: 0.9rem;
      box-shadow: 0 4px 15px rgba(0,0,0,0.3);
      animation: toastSlideIn 0.3s ease, toastFadeOut 0.3s ease 2.7s forwards;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .toast.badge-toast {
      background: linear-gradient(135deg, #4ade80, #22c55e);
    }

    .toast.level-toast {
      background: linear-gradient(135deg, #8b5cf6, #7c3aed);
      color: white;
    }

    @keyframes toastSlideIn {
      from { transform: translateX(100%); opacity: 0; }
      to { transform: translateX(0); opacity: 1; }
    }

    @keyframes toastFadeOut {
      from { opacity: 1; }
      to { opacity: 0; }
    }

    /* ====== SKIP LINK ====== */
    .skip-link {
      position: absolute;
      top: -100px;
      left: 0;
      background: var(--gold);
      color: var(--navy);
      padding: 0.75rem 1.5rem;
      z-index: 10001;
      font-weight: 600;
      text-decoration: none;
      border-radius: 0 0 8px 0;
    }

    .skip-link:focus {
      top: 0;
    }

    /* ====== NOTIFICATION MODAL ====== */
    .notification-modal {
      position: fixed;
      inset: 0;
      background: rgba(0,0,0,0.7);
      display: flex;
      align-items: center;
      justify-content: center;
      z-index: 9999;
      opacity: 0;
      visibility: hidden;
      transition: all 0.3s;
    }

    .notification-modal.active {
      opacity: 1;
      visibility: visible;
    }

    .notification-content {
      background: var(--deep-navy);
      border: 1px solid var(--gold);
      border-radius: 12px;
      padding: 2rem;
      max-width: 400px;
      text-align: center;
    }

    .notification-content h3 {
      color: var(--gold);
      margin-bottom: 1rem;
    }

    .notification-content p {
      color: rgba(255,255,255,0.8);
      margin-bottom: 1.5rem;
    }

    .notification-btn {
      padding: 0.75rem 2rem;
      background: var(--gold);
      color: var(--navy);
      border: none;
      border-radius: 6px;
      font-weight: 600;
      cursor: pointer;
    }

    /* ====== PRINT STYLES ====== */
    @media print {
      body {
        background: white !important;
        color: black !important;
      }

      .sidebar, .hamburger, .sidebar-overlay, .top-bar,
      .slide-nav, .dashboard-overlay, .tool-library-modal,
      .toast-container, .nav-btn, .progress-dashboard-btn,
      .daily-review-btn, .tree-controls, .skip-link {
        display: none !important;
      }

      .course-container {
        display: block !important;
      }

      .main-content {
        width: 100% !important;
        padding: 0 !important;
      }

      .slide-container {
        height: auto !important;
        overflow: visible !important;
      }

      .slide {
        display: block !important;
        opacity: 1 !important;
        page-break-after: always;
        padding: 1rem !important;
        background: white !important;
        color: black !important;
      }

      .slide-title, .method-box h3, .method-box h4 {
        color: #1E2761 !important;
      }

      .tool-panel, .quiz-container, .scenario-panel, .decision-tree {
        border: 1px solid #ccc !important;
        background: #f9f9f9 !important;
        color: black !important;
        padding: 1rem !important;
        margin: 1rem 0 !important;
      }

      .tool-btn, .quiz-option, .scenario-choice {
        border: 1px solid #666 !important;
        background: white !important;
        color: black !important;
      }

      .certificate {
        box-shadow: none !important;
        border: 2px solid var(--gold) !important;
      }
    }

    /* ====== REAL-WORLD STORY STYLES ====== */
    .real-world-story {
      background: linear-gradient(135deg, rgba(30,39,97,0.15), rgba(20,27,61,0.2));
      border: 2px solid rgba(212,175,55,0.3);
      border-radius: 16px;
      padding: 2rem;
      margin: 1rem 0;
    }

    .story-rhetorical-question {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.6rem;
      font-style: italic;
      color: var(--gold);
      text-align: center;
      margin-bottom: 2rem;
      padding: 1.5rem;
      background: rgba(212,175,55,0.08);
      border-radius: 12px;
      line-height: 1.5;
    }

    .story-stats-box {
      background: rgba(0,0,0,0.3);
      border: 1px solid rgba(212,175,55,0.4);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .story-stats-header {
      font-weight: 700;
      font-size: 1rem;
      color: var(--gold);
      margin-bottom: 1rem;
      padding-bottom: 0.5rem;
      border-bottom: 1px solid rgba(212,175,55,0.3);
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .story-stats-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
      gap: 1rem;
    }

    .story-stat-item {
      text-align: center;
      padding: 0.75rem;
      background: rgba(255,255,255,0.05);
      border-radius: 8px;
    }

    .story-stat-value {
      font-size: 1.3rem;
      font-weight: 700;
      color: var(--cream);
      display: block;
    }

    .story-stat-value.danger {
      color: var(--red);
    }

    .story-stat-value.success {
      color: var(--green);
    }

    .story-stat-label {
      font-size: 0.75rem;
      color: rgba(255,255,255,0.6);
      text-transform: uppercase;
      letter-spacing: 0.05em;
      margin-top: 0.25rem;
    }

    .story-decision-tree {
      background: rgba(255,255,255,0.03);
      border: 1px solid rgba(255,255,255,0.15);
      border-radius: 12px;
      padding: 1.5rem;
      margin: 1.5rem 0;
    }

    .story-decision-header {
      font-weight: 700;
      color: var(--cream);
      margin-bottom: 1rem;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .story-decision-scenario {
      color: rgba(255,255,255,0.85);
      line-height: 1.6;
      margin-bottom: 1.5rem;
      padding: 1rem;
      background: rgba(0,0,0,0.2);
      border-radius: 8px;
    }

    .story-path {
      padding: 1rem;
      border-radius: 8px;
      margin-bottom: 1rem;
      border-left: 4px solid;
    }

    .story-path.path-wrong {
      background: rgba(197,48,48,0.1);
      border-left-color: var(--red);
    }

    .story-path.path-right {
      background: rgba(34,197,94,0.1);
      border-left-color: var(--green);
    }

    .story-path-label {
      font-weight: 700;
      font-size: 0.9rem;
      margin-bottom: 0.5rem;
    }

    .story-path.path-wrong .story-path-label {
      color: var(--red);
    }

    .story-path.path-right .story-path-label {
      color: var(--green);
    }

    .story-path-content {
      color: rgba(255,255,255,0.85);
      line-height: 1.6;
    }

    .story-path-arrow {
      display: flex;
      align-items: center;
      gap: 0.5rem;
      margin: 0.5rem 0;
      color: rgba(255,255,255,0.6);
      font-size: 0.9rem;
    }

    .story-revelation {
      background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(212,175,55,0.05));
      border: 2px solid var(--gold);
      border-radius: 12px;
      padding: 1.5rem;
      margin-top: 1.5rem;
    }

    .story-revelation-header {
      font-family: 'Cormorant Garamond', Georgia, serif;
      font-size: 1.2rem;
      font-weight: 700;
      color: var(--gold);
      margin-bottom: 0.75rem;
      display: flex;
      align-items: center;
      gap: 0.5rem;
    }

    .story-revelation-text {
      color: var(--cream);
      line-height: 1.7;
      font-size: 1.05rem;
    }

    .story-source {
      font-size: 0.8rem;
      color: rgba(255,255,255,0.5);
      margin-top: 1rem;
      padding-top: 0.75rem;
      border-top: 1px solid rgba(255,255,255,0.1);
    }

    .story-connection {
      margin-top: 1rem;
      padding: 0.75rem 1rem;
      background: rgba(15,91,106,0.2);
      border-left: 3px solid var(--teal);
      border-radius: 0 8px 8px 0;
      font-size: 0.95rem;
      color: rgba(255,255,255,0.9);
    }
  </style>
</head>
<body>
<!-- Toast Notification Container -->
<div aria-atomic="true" aria-live="polite" class="toast-container" id="toastContainer"></div>
 Modale di notifica (per revisione quotidiana ecc.) 
<div aria-modal="true" class="notification-modal" id="notificationModal" role="dialog">
<div class="notification-content">
<h3 id="notificationTitle">Notice</h3>
<p id="notificationMessage">Message here</p>
<button class="notification-btn" onclick="closeNotification()">OK</button>
</div>
</div>
 Salta collegamento per accessibilit√† 
<a class="skip-link" href="#main-content">Skip to main content</a>
<!-- Hamburger Menu Button (Mobile) -->
<button aria-expanded="false" aria-label="Toggle navigation menu" class="hamburger" onclick="toggleSidebar()">
<span></span>
<span></span>
<span></span>
</button>
<!-- Sidebar Overlay (Mobile) -->
<div class="sidebar-overlay" onclick="toggleSidebar()"></div>
 Libreria degli strumenti Modal 
<div aria-labelledby="toolLibraryTitle" aria-modal="true" class="tool-library-modal" id="toolLibraryModal" role="dialog">
<div class="tool-library-content">
<div class="tool-library-header">
<h2 id="toolLibraryTitle">üì¶ Tool Library</h2>
<button aria-label="Chiudi libreria strumenti" class="close-btn" onclick="closeToolLibrary()">√ó</button>
</div>
<div class="tool-library-grid" id="toolLibraryGrid">
<!-- Tools populated by JS -->
</div>
</div>
</div>
<!-- Certificate Modal -->
<div aria-labelledby="certificateTitle" aria-modal="true" class="certificate-modal" id="certificateModal" role="dialog">
<div class="certificate">
<h1 class="certificate-title" id="certificateTitle">Certificate of Completion</h1>
<p class="certificate-subtitle">Corso sui metodi di meta-analisi</p>
<p class="certificate-body">Questo certifica che</p>
<div class="certificate-name" id="certificateName">Your Name</div>
<p class="certificate-body">
        ha completato con successo il corso completo<br/>
<strong>"Dalla domanda alla conclusione: un corso sui metodi di meta-analisi"</strong><br/><br/>
        demonstrating proficiency in systematic review methodology, risk of bias assessment,<br/>
        calcolo della dimensione dell'effetto, analisi dell'eterogeneit√† e certezza delle prove valutazione.
      </p>
<p class="certificate-date" id="certificateDate"></p>
<div class="certificate-actions">
<button class="certificate-btn primary" onclick="downloadCertificate()">üì• Download PDF</button>
<button class="certificate-btn secondary" onclick="closeCertificate()">Close</button>
</div>
</div>
</div>
<div class="course-container">
<!-- SIDEBAR -->
<nav aria-label="Moduli del corso" class="sidebar" id="sidebar">
<div class="sidebar-header">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;">‚Üê Course Library</a>
<h1>Meta-Analysis Methods</h1>
<p>Dalla domanda alla conclusione</p>
</div>
<div class="module-list" id="moduleList">
<!-- Modules will be populated by JS -->
</div>
<div class="sidebar-footer">
<button class="progress-dashboard-btn" onclick="openDashboard()">
<span>üìä Progress Dashboard</span>
<span id="sidebarPoints">0 pts</span>
</button>
<button class="daily-review-btn" onclick="startDailyReview()">
<span>üîÑ</span> Daily Review
        </button>
<div class="progress-bar-container">
<div class="progress-label">Progress: <span id="progressPercent">0%</span></div>
<div class="progress-bar">
<div class="progress-fill" id="progressFill" style="width: 0%"></div>
</div>
</div>
</div>
</nav>
<!-- MAIN CONTENT -->
<main class="main-content" id="main-content">
<div class="top-bar">
<div class="module-indicator" id="moduleIndicator">Modulo 0: L'apertura</div>
<div class="top-bar-actions">
<button aria-label="Apri libreria strumenti" class="top-bar-btn" onclick="openToolLibrary()">üîß Tools</button>
<button aria-label="Open glossary" class="top-bar-btn" onclick="openGlossary()">üìñ Glossary</button>
<button class="top-bar-btn primary" onclick="goToNextModule()">Next Module ‚Üí</button>
</div>
</div>
<div class="slide-container" id="slideContainer">
<!-- Slides will be populated by JS -->
</div>
<div class="slide-nav">
<button class="nav-btn" id="prevBtn" onclick="prevSlide()">‚Üê Previous</button>
<div class="slide-counter">
<span id="slideCounter">1 / 10</span>
<div class="slide-dots" id="slideDots"></div>
</div>
<button class="nav-btn primary" id="nextBtn" onclick="nextSlide()">Next ‚Üí</button>
</div>
</main>
</div>
<!-- PROGRESS DASHBOARD -->
<div aria-labelledby="dashboardTitle" aria-modal="true" class="dashboard-overlay" id="progressDashboard" role="dialog">
<div class="dashboard-panel">
<div class="dashboard-header" style="position: relative;">
<button aria-label="Chiudi cruscotto" class="close-btn" onclick="closeDashboard()">√ó</button>
<h2 id="dashboardTitle">Your Progress</h2>
<p id="levelBadge">Level 1: Novice</p>
</div>
<div class="dashboard-content">
<div class="stat-grid">
<div class="stat-card">
<div class="stat-value" id="totalPoints">0</div>
<div class="stat-label">Points</div>
</div>
<div class="stat-card">
<div class="stat-value" id="modulesCompleted">0/15</div>
<div class="stat-label">Modules</div>
</div>
<div class="stat-card">
<div class="stat-value" id="toolsUsed">0</div>
<div class="stat-label">Tools Used</div>
</div>
</div>
<h3 style="margin-bottom: 0.75rem;">Badges</h3>
<div class="badge-grid" id="badgeGrid">
<!-- Badges populated by JS -->
</div>
</div>
</div>
</div>
<script>
// ============================================================
// COURSE DATA
// ============================================================

const STORAGE_KEY = 'metaAnalysisMethodsCourse';

const sevenPrinciples = [
  { num: 1, text: "La domanda d√† forma alla risposta", short: "Question" },
  { num: 2, text: "Pre-specification is protection", short: "Protocol" },
  { num: 3, text: "Ci√≤ che non cerchi, non troverai", short: "Search" },
  { num: 4, text: "Every number needs a source", short: "Extract" },
  { num: 5, text: "Bias hides in plain sight", short: "Assess" },
  { num: 6, text: "La media pu√≤ mentire", short: "Synthesize" },
  { num: 7, text: "Certainty must be justified", short: "Certainty" }
];

// ============================================================
// BADGES SYSTEM
// ============================================================

const badges = [
  // Module completion badges
  { id: 'first_steps', name: 'First Steps', icon: 'üë£', description: 'Modulo completo 0: L\'apertura', condition: () => gameState.modulesCompleted.includes(0) },
  { id: 'question_master', name: 'Question Master', icon: '‚ùì', description: 'Modulo completo 1: L\'apertura Domanda', condition: () => gameState.modulesCompleted.includes(1) },
  { id: 'protocol_pro', name: 'Protocol Pro', icon: 'üìã', description: 'Completa il modulo 2: Il protocollo', condition: () => gameState.modulesCompleted.includes(2) },
  { id: 'search_sage', name: 'Search Sage', icon: 'üîç', description: 'Completa il modulo 3: La ricerca', condition: () => gameState.modulesCompleted.includes(3) },
  { id: 'screener', name: 'Study Screener', icon: 'üìä', description: 'Completa il modulo 4: La selezione', condition: () => gameState.modulesCompleted.includes(4) },
  { id: 'data_detective', name: 'Data Detective', icon: 'üîé', description: 'Completa il modulo 5: La Estrazione', condition: () => gameState.modulesCompleted.includes(5) },
  { id: 'bias_hunter', name: 'Bias Hunter', icon: '‚öñÔ∏è', description: 'Completa il modulo 6: Rischio di bias', condition: () => gameState.modulesCompleted.includes(6) },
  { id: 'effect_expert', name: 'Effect Expert', icon: 'üìê', description: 'Completa il modulo 7: Dimensioni degli effetti', condition: () => gameState.modulesCompleted.includes(7) },
  { id: 'forest_ranger', name: 'Forest Ranger', icon: 'üå≤', description: 'Completa il modulo 8: Il diagramma della foresta', condition: () => gameState.modulesCompleted.includes(8) },
  { id: 'heterogeneity_hero', name: 'Heterogeneity Hero', icon: 'üìà', description: 'Completa il modulo 9: Eterogeneit√†', condition: () => gameState.modulesCompleted.includes(9) },
  { id: 'pub_bias_pro', name: 'Publication Bias Pro', icon: 'üîª', description: 'Modulo completo 10: Bias di pubblicazione', condition: () => gameState.modulesCompleted.includes(10) },
  { id: 'grade_guru', name: 'GRADE Guru', icon: '‚≠ê', description: 'Modulo completo 11: GRADE', condition: () => gameState.modulesCompleted.includes(11) },
  { id: 'reporter', name: 'Expert Reporter', icon: 'üìù', description: 'Modulo completo 12: Reporting', condition: () => gameState.modulesCompleted.includes(12) },
  { id: 'advanced_analyst', name: 'Advanced Analyst', icon: 'üß™', description: 'Modulo completo 13: Avanzato Metodi', condition: () => gameState.modulesCompleted.includes(13) },
  { id: 'course_graduate', name: 'Course Graduate', icon: 'üéì', description: 'Completa tutti i moduli', condition: () => gameState.modulesCompleted.length >= 14 },

  // Tool usage badges
  { id: 'tool_novice', name: 'Tool Novice', icon: 'üîß', description: 'Utilizza il tuo primo strumento', condition: () => gameState.toolsUsed.length >= 1 },
  { id: 'tool_adept', name: 'Tool Adept', icon: 'üõ†Ô∏è', description: 'Utilizza 5 strumenti diversi', condition: () => gameState.toolsUsed.length >= 5 },
  { id: 'tool_master', name: 'Tool Master', icon: '‚öôÔ∏è', description: 'Utilizza tutti gli 11 strumenti', condition: () => gameState.toolsUsed.length >= 11 },

  // Quiz badges
  { id: 'quiz_starter', name: 'Quiz Starter', icon: '‚úèÔ∏è', description: 'Rispondi al tuo primo quiz', condition: () => Object.keys(gameState.quizAnswers).length >= 1 },
  { id: 'quiz_whiz', name: 'Quiz Whiz', icon: 'üß†', description: 'Rispondi correttamente a 5 quiz', condition: () => Object.values(gameState.quizAnswers).filter(a => a.correct).length >= 5 },
  { id: 'perfect_score', name: 'Perfect Score', icon: 'üíØ', description: 'Rispondi correttamente a 10 quiz', condition: () => Object.values(gameState.quizAnswers).filter(a => a.correct).length >= 10 },

  // Points badges
  { id: 'points_100', name: 'Century Club', icon: 'üí∞', description: 'Earn 100 points', condition: () => gameState.points >= 100 },
  { id: 'points_500', name: 'High Scorer', icon: 'üèÜ', description: 'Earn 500 points', condition: () => gameState.points >= 500 },
  { id: 'points_1000', name: 'Point Champion', icon: 'üëë', description: 'Earn 1000 points', condition: () => gameState.points >= 1000 },

  // Decision tree badges
  { id: 'decision_maker', name: 'Decision Maker', icon: 'üå≥', description: 'Completa il tuo primo albero decisionale', condition: () => Object.keys(gameState.decisionTrees).length >= 1 },
  { id: 'path_finder', name: 'Path Finder', icon: 'üó∫Ô∏è', description: 'Completa 5 alberi decisionali', condition: () => Object.keys(gameState.decisionTrees).filter(k => gameState.decisionTrees[k].currentNode !== 'start').length >= 5 }
];

// Level thresholds
const levels = [
  { name: 'Novice', minPoints: 0 },
  { name: 'Apprentice', minPoints: 100 },
  { name: 'Practitioner', minPoints: 300 },
  { name: 'Expert', minPoints: 600 },
  { name: 'Master', minPoints: 1000 },
  { name: 'Grand Master', minPoints: 1500 }
];

const modules = [
  {
    id: 0,
    title: "The Opening",
    subtitle: "Perch√© Metodi Matter",
    principle: null,
    slides: [
      {
        type: 'title',
        content: {
          title: "Dalla domanda alla conclusione",
          subtitle: "Un corso sui metodi di meta-analisi",
          text: "Impara a condurre meta-analisi rigorose attraverso le storie di chi ha sbagliato."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LE ORIGINI: DALLA THALIDOMIDE ALLE PROVE SINTESI",
          source: "Lancet 1962 (Thalidomide) | BMJ 1972 (Cochrane) | CAST 1989",
          timeline: [
            { year: "1957-61", text: "Talidomide commercializzata come sedativo ‚Äúcompletamente sicuro‚Äù per le donne incinte. Basato su studi sugli animali e affermazioni del produttore. Non √® richiesta alcuna prova umana sistematica.", type: "normal" },
            { year: "1961", text: "Oltre 10.000 bambini nati con gravi difetti alla nascita. Malformazioni agli arti, danni agli organi, morte. Il farmaco non √® mai stato adeguatamente testato sugli esseri umani.", type: "crisis" },
            { year: "1972", text: "Archie Cochrane pubblica 'Efficacia ed efficienza': '√à sicuramente una grande critica alla nostra professione il fatto di non aver organizzato un riassunto critico... di tutti gli studi randomizzati e controllati.'", type: "revelation" },
            { year: "1980s", text: "Small trials show antiarrhythmic drugs suppress PVCs after heart attacks. Meta-analyses combine them. Logic seems perfect: suppress arrhythmias ‚Üí prevent death.", type: "normal" },
            { year: "1989", text: "CAST trial stopped: antiarrhythmics TRIPLE mortality (RR 3.6, 95% CI 1.7-8.5). An estimated 50,000 Americans killed by drugs that 'worked' on a surrogate.", type: "crisis" },
            { year: "1993", text: "Fondata la Cochrane Collaboration. La sintesi sistematica delle prove diventa una scienza. L'obiettivo: non permettere mai pi√π che talidomide o CAST si ripetano.", type: "revelation" }
          ],
          realData: {
            endpoint: "La nascita della medicina basata sull'evidenza",
            drug: "Thalidomide: 10,000+ birth defects",
            placebo: "CAST: ~50,000 excess deaths",
            rr: "Due catastrofi dovute a prove non sistematiche",
            ci: "Cochrane founded to prevent the third",
            nnh: "Il costo di non sapere come sapere"
          },
          hook: "THE HOOK: Questo corso esiste perch√© i bambini erano nati senza arti e pazienti cardiaci morti a causa di trattamenti \"efficaci\". La sintesi delle prove non √® accademica. √à il confine tra guarigione e danno."
        }
      },
      {
        type: 'content',
        content: {
          title: "Cosa ti insegner√† questo corso",
          sections: [
            {
              heading: "The Seven Principles of Sound Meta-Analysis",
              items: [
                "1. La domanda d√† forma alla risposta: formulazione PICO",
                "2. Pre-specification is protection ‚Äî Protocol registration",
                "3. Ci√≤ che non cerchi, non troverai ‚Äî Ricerca completa",
                "4. Every number needs a source ‚Äî Data integrity",
                "5. Bias hides in plain sight ‚Äî Risk of bias assessment",
                "6. The average can lie ‚Äî Heterogeneity exploration",
                "7. Certainty must be justified ‚Äî GRADE framework"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Come funziona questo corso",
          sections: [
            {
              heading: "Each Module Contains:",
              items: [
                "üìñ UNA STORIA ‚Äî Cosa √® andato storto e perch√© √® importante",
                "üîß IL METODO ‚Äî Come farlo correttamente",
                "‚öôÔ∏è LO STRUMENTO ‚Äî Pratica interattiva",
                "üîÄ LO SCENARIO ‚Äî Applica il tuo giudizio",
                "‚úÖ IL QUIZ ‚Äî Metti alla prova la tua comprensione"
              ]
            }
          ]
        }
      },
      {
        type: 'principle',
        content: {
          text: "I sette principi ricorreranno ovunque. Alla fine, non solo li conoscerai, ma capirai perch√© ognuno di essi √® importante."
        }
      }
    ]
  },
  {
    id: 1,
    title: "The Question",
    subtitle: "PICO Framework",
    principle: 0,
    story: "CAST",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La domanda d√† forma alla risposta"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE REVERSAL: CAST TRIAL (1989)",
          source: "NEJM 1989; 321:406-412 | PubMed: 2473403",
          timeline: [
            { year: "1970s", text: "Studi osservazionali collegano le PVC dopo infarto miocardico alla morte cardiaca improvvisa. La catena meccanicistica sembra ovvia.", type: "normal" },
            { year: "1980s", text: "Class I antiarrhythmic drugs shown to suppress PVCs by 80%+. Logic: suppress PVCs ‚Üí prevent death.", type: "normal" },
            { year: "1987", text: "CAST trial begins. 1,727 patients randomized to encainide, flecainide, or placebo.", type: "normal" },
            { year: "Apr 1989", text: "DSMB stops trial early. Arrhythmic death: 4.5% vs 1.2%. RR = 3.6 (95% CI: 1.7-8.5).", type: "crisis" },
            { year: "1989-91", text: "Si stima che oltre 50.000 americani siano morti a causa di questi farmaci \"efficaci\". L'endpoint surrogato ha ingannato tutti.", type: "crisis" },
            { year: "Legacy", text: "CAST transformed cardiology. FDA now requires mortality outcomes for cardiac drugs.", type: "revelation" }
          ],
          realData: {
            endpoint: "Arrhythmic death or cardiac arrest",
            drug: "56/730 (7.7%)",
            placebo: "22/725 (3.0%)",
            rr: "2.5",
            ci: "1.6-4.0",
            nnh: "22"
          },
          hook: "They asked: 'Does it suppress arrhythmias?' (Yes, beautifully.) They should have asked: 'Does it help patients live?' (No. It killed them.)"
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY TAKEAWAY: CAST killed 50,000 people because researchers measured the wrong outcome. A surrogate endpoint (arrhythmia suppression) moved in the right direction while patients moved toward death. Before you analyze anything, ask: Does my outcome actually matter to patients?"
        }
      },
      {
        type: 'content',
        content: {
          title: "La domanda sbagliata contro la domanda giusta",
          sections: [
            {
              heading: "What They Asked:",
              items: [
                "Population: Post-MI patients with PVCs",
                "Intervention: Encainide/Flecainide",
                "Comparator: Placebo",
                "Outcome: PVC suppression ‚Üê SURROGATE"
              ]
            },
            {
              heading: "What They Should Have Asked:",
              items: [
                "Population: Post-MI patients with PVCs",
                "Intervention: Encainide/Flecainide",
                "Comparator: Placebo",
                "Outcome: All-cause mortality ‚Üê PATIENT-IMPORTANT"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: PICO FRAMEWORK",
          title: "Formulare la domanda giusta",
          sections: [
            {
              heading: "P ‚Äî Population",
              text: "Chi stai studiando esattamente? Sii specifico riguardo ai criteri di inclusione, alla gravit√† della malattia, al contesto."
            },
            {
              heading: "I ‚Äî Intervention",
              text: "What treatment, exposure, or test? Include dose, duration, delivery method."
            },
            {
              heading: "C ‚Äî Comparator",
              text: "Compared to what? Placebo, active control, usual care, no intervention?"
            },
            {
              heading: "O ‚Äî Outcome",
              text: "What matters to patients? Prioritize: mortality > morbidity > symptoms > surrogates"
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'pico-builder',
          title: "PICO Builder",
          description: "Esercitati a formulare la domanda di ricerca"
        }
      },
      {
        type: 'content',
        content: {
          title: "THE GRAVEYARD: When Surrogates Killed",
          sections: [
            {
              heading: "CAST (1989) ‚Äî Cardiac Arrhythmias",
              items: [
                "Surrogate: PVC suppression (drugs reduced arrhythmias by 80%+)",
                "Reality: Mortality TRIPLED (RR 3.6, 95% CI: 1.7-8.5)",
                "Estimated 50,000 Americans killed by 'effective' drugs",
                "THE LESSON: Arrhythmias predict death, but suppressing them doesn't prevent it"
              ]
            },
            {
              heading: "ATBC (1994) ‚Äî Beta-Carotene in Smokers",
              items: [
                "Surrogate: Antioxidant blood levels (increased as expected)",
                "Reality: Lung cancer INCREASED by 16% (RR 1.16, 95% CI: 1.02-1.33)",
                "29,133 Finnish male smokers harmed by a vitamin",
                "Source: JNCI 1996; PubMed 8901854"
              ]
            },
            {
              heading: "CARET (1996) ‚Äî Beta-Carotene + Vitamin A",
              items: [
                "Surrogate: Same antioxidant rationale as ATBC",
                "Reality: Lung cancer INCREASED by 28% (RR 1.28, 95% CI: 1.04-1.57)",
                "Studio interrotto in anticipo per DANNO: gli integratori stavano uccidendo i partecipanti",
                "Source: NEJM 1996; DOI 10.1056/NEJM199605023341802"
              ]
            },
            {
              heading: "THE PATTERN: Mechanistic Logic Fails",
              items: [
                "Arrhythmias ‚Üí death, but anti-arrhythmics don't help",
                "Oxidative stress ‚Üí cancer, but antioxidants don't help (and may harm)",
                "Cholesterol ‚Üí heart disease, but some cholesterol drugs kill",
                "LA DOMANDA da porre sempre: migliorare il surrogato aiuta effettivamente pazienti?"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'pico_decision_tree',
          title: "La decisione sui farmaci per il diabete",
          situation: "Sei il metodologo principale di una meta-analisi. Il nuovo farmaco per il diabete di un'azienda farmaceutica mostra un'impressionante riduzione dell'HbA1c in 8 studi clinici. Vogliono l'approvazione della FDA.",
          nodes: [
            {
              id: 'start',
              question: "L'azienda ti chiede di utilizzare la riduzione dell'HbA1c come risultato principale. Cosa fai?",
              branches: [
                { id: 'a', text: "Accept ‚Äî HbA1c is the standard diabetes endpoint", nextNode: 'surrogate_trap' },
                { id: 'b', text: "Insist on cardiovascular outcomes", nextNode: 'cv_outcome' },
                { id: 'c', text: "Chiedi quali risultati hanno dati per", nextNode: 'investigate' }
              ]
            },
            {
              id: 'surrogate_trap',
              type: 'outcome',
              consequence: 'bad',
              title: "La ripetizione del rosiglitazone",
              text: "Your meta-analysis shows impressive HbA1c reduction: -1.2% (95% CI: -1.4 to -1.0). FDA approves. Three years later, an independent meta-analysis of CV outcomes finds OR 1.43 (95% CI: 1.03-1.98) for MI. The drug is withdrawn. You asked the wrong question.",
              realCase: "Questo scenario esatto si √® verificato con rosiglitazone (Avandia). Nissen & Wolski, NEJM 2007."
            },
            {
              id: 'cv_outcome',
              type: 'outcome',
              consequence: 'good',
              title: "La domanda giusta",
              text: "Your meta-analysis of CV outcomes reveals: MACE HR 0.86 (95% CI: 0.74-0.99). Not only does the drug lower HbA1c, it actually prevents heart attacks. You've distinguished it from harmful drugs in the same class.",
              realCase: "Questo √® ci√≤ che hanno dimostrato empagliflozin (EMPA-REG) e liraglutide (LEADER), ma solo perch√© hanno posto la domanda giusta."
            },
            {
              id: 'investigate',
              question: "Buona idea. Scopri che hanno dati sui risultati del CV ma non erano stati pre-specificati come primari. Dicono: \"Possiamo eseguire anche queste analisi\". E adesso?",
              branches: [
                { id: 'd', text: "Aggiungi i risultati CV come analisi esplorativa", nextNode: 'exploratory' },
                { id: 'e', text: "Make CV outcomes the pre-specified primary outcome in a new protocol", nextNode: 'cv_outcome' },
                { id: 'f', text: "Procedi con HbA1c: i dati CV sono comunque post-hoc", nextNode: 'surrogate_trap' }
              ]
            },
            {
              id: 'exploratory',
              type: 'outcome',
              consequence: 'neutral',
              title: "Partial Credit",
              text: "La tua meta-analisi viene pubblicata con HbA1c primaria e CV secondaria/esplorativa. I revisori prendono nota dei risultati del CV ma non possono trarre conclusioni definitive perch√© non era stato specificato in anticipo. Il segnale c'√®, ma le prove sono pi√π deboli di quanto potrebbero essere.",
              realCase: "Molte delle prime meta-analisi sul diabete presentavano questo problema: preziosi dati CV sepolti come analisi esplorative."
            }
          ]
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "Hai considerato cosa succede quando la domanda stessa √® sbagliata?",
          context: "In the 1980s, researchers observed that premature ventricular contractions (PVCs) after heart attacks predicted sudden death. The logic seemed airtight: suppress PVCs, prevent death. They designed a trial to answer: 'Do antiarrhythmics that suppress PVCs reduce sudden death?' The drugs worked beautifully on the surrogate. But they asked the wrong question.",
          stats: [
            { value: "80%+", label: "PVC Suppression", type: "" },
            { value: "3.6x", label: "Mortality Increase", type: "danger" },
            { value: "~50,000", label: "Americans Killed", type: "danger" },
            { value: "1989", label: "Trial Stopped", type: "" }
          ],
          source: "CAST Trial - NEJM 1989; 321:406-412",
          decisionScenario: "Stai progettando uno studio per una nuova aritmia droga. Il farmaco sopprime magnificamente i PVC negli studi di Fase II. Devi scegliere il tuo endpoint primario.",
          pathA: {
            title: "Use surrogate endpoint (PVC suppression)",
            steps: [
              "Trial shows 80% PVC suppression",
              "Drug appears highly effective",
              "FDA approves based on surrogate",
              "Millions of patients prescribed the drug",
              "Post-marketing: Mortality TRIPLES",
              "An estimated 50,000 Americans die from 'effective' treatment"
            ]
          },
          pathB: {
            title: "Insist on hard endpoint (mortality)",
            steps: [
              "Trial takes longer and costs more",
              "Requires larger sample size",
              "DSMB stops trial early for harm",
              "Drug never reaches market",
              "50,000 lives saved",
              "La verit√† viene rivelata prima, non dopo, il danno"
            ]
          },
          revelation: "Il PICO determina cosa puoi imparare. Una domanda sbagliata con una buona risposta √® peggio di nessuna risposta. Il CAST ha chiesto \"Sopprime le aritmie?\" (S√¨.) Avrebbero dovuto chiedere \"Aiuta i pazienti a vivere?\" (No, li ha uccisi.) La domanda d√† forma alla risposta, e la domanda sbagliata ha causato 50.000 morti.",
          moduleConnection: "Ecco perch√© PICO √® importante. La scelta del risultato non √® tecnica: √® etica. Ogni meta-analisi eredita i difetti delle domande poste dagli studi che la compongono."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Una meta-analisi chiede: \"Il farmaco X riduce la pressione sanguigna?\" vs \"Il farmaco X riduce gli ictus e gli attacchi cardiaci?\" Quale inquadratura ha maggiori probabilit√† di produrre risultati clinicamente utili?",
          options: [
            { id: 'a', text: "Blood pressure ‚Äî it's easier to measure", correct: false },
            { id: 'b', text: "Strokes and heart attacks ‚Äî they're what matter to patients", correct: true },
            { id: 'c', text: "Entrambi sono ugualmente utili", correct: false },
            { id: 'd', text: "Neither ‚Äî we need all-cause mortality", correct: false }
          ],
          explanation: "Mentre la mortalit√† per tutte le cause √® ideale, gli eventi cardiovascolari sono esiti importanti per il paziente che la pressione arteriosa (un surrogato) pu√≤ o meno prevedere. SPRINT ha mostrato che il controllo intensivo della pressione arteriosa ha ridotto gli eventi cardiovascolari, ma ACCORD-BP no: non si pu√≤ sapere dalla sola pressione arteriosa."
        }
      }
    ]
  },
  {
    id: 2,
    title: "The Protocol",
    subtitle: "Pre-registration",
    principle: 1,
    story: "HRT",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Pre-specification is protection"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "L'INVERSIONE: HRT: IL PI√ô GRANDE CAPOVOLGIMENTO IN MEDICINA",
          source: "JAMA 2002; 288:321-333 | WHI Writing Group | PubMed: 12117397",
          timeline: [
            { year: "1960s-80s", text: "Studi osservazionali mostrano costantemente che la TOS riduce la malattia coronarica del 40-50%. Il razionale biologico √® convincente: gli estrogeni migliorano i profili lipidici.", type: "normal" },
            { year: "1991", text: "NHS (Nurses' Health Study) pubblica: RR 0,56 (95% CI 0,40-0,80) per CHD. Milioni di donne iniziano la terapia ormonale sostitutiva per la ‚Äúprotezione del cuore‚Äù.", type: "normal" },
            { year: "1998", text: "Lo studio HERS sconvolge il campo: nessun beneficio nelle donne con CHD esistente. FC 0,99 (0,81-1,22). Ma √® stato respinto: \"popolazione sbagliata\".", type: "crisis" },
            { year: "Jul 2002", text: "WHI si √® fermato presto per HARM. Frequenza cardiaca coronarica 1,29 (1,02-1,63). Gli oltre 30 studi osservazionali erano SBAGLIATI.", type: "crisis" },
            { year: "The Truth", text: "Healthy user bias: Women who chose HRT were healthier, exercised more, had better diets. The 'benefit' was confounding, not causation.", type: "revelation" }
          ],
          realData: {
            endpoint: "Coronary heart disease (CHD)",
            drug: "164/8506 (1.93%)",
            placebo: "122/8102 (1.51%)",
            rr: "1.29",
            ci: "1.02-1.63",
            nnh: "238"
          },
          hook: "30 studi osservazionali. Oltre 40 meta-analisi. Tutti mostrano benefici. Quindi lo studio randomizzato ha mostrato danni. Confondimento, effetti salutari per l'utente e analisi/report selettivi possono fuorviare quando i metodi non sono bloccati e completamente trasparenti."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY TAKEAWAY: HRT was the biggest reversal in modern medicine. Millions of women took hormones believing they prevented heart disease ‚Äî but the 'evidence' came from researchers who could change their analyses after seeing results. Pre-registration locks your decisions BEFORE you see the data, making bias visible and accountability possible."
        }
      },
      {
        type: 'content',
        content: {
          title: "Why Pre-Registration Matters",
          sections: [
            {
              heading: "Without Pre-Registration:",
              items: [
                "Outcome switching ‚Äî change endpoints after seeing data",
                "Subgroup fishing ‚Äî test many subgroups, report 'significant' ones",
                "Analysis flexibility ‚Äî try different models until one 'works'",
                "Selective reporting ‚Äî publish positive, hide negative"
              ]
            },
            {
              heading: "With Pre-Registration:",
              items: [
                "Risultato primario bloccato prima dell'analisi dei dati",
                "Sottogruppi pre-specificati con motivazione",
                "Piano di analisi documentato",
                "Tutti i risultati devono essere riportati"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: REGISTRAZIONE PROSPERO",
          title: "Creating a Protocol",
          sections: [
            {
              heading: "Essential Elements:",
              text: "1. Domanda PICO 2. Criteri di ammissibilit√† 3. Strategia di ricerca 4. Piano di estrazione dei dati 5. Strumento di rischio di bias 6. Metodo di sintesi 7. Analisi di sottogruppi (pre-specificate) 8. Analisi di sensibilit√†"
            },
            {
              heading: "Where to Register:",
              text: "PROSPERO (prospero.york.ac.uk) ‚Äî registro gratuito, internazionale e consultabile per revisioni sistematiche. La registrazione crea un timestamp che dimostra che il tuo piano ha preceduto la tua analisi."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'protocol_decision_tree',
          title: "La tentazione di HARKing",
          situation: "Stai conducendo una meta-analisi di un nuovo farmaco antipertensivo. Il vostro protocollo specificava gli \"eventi cardiovascolari\" come risultato primario. Dopo aver estratto i dati, noti che il farmaco sembra aiutare particolarmente i pazienti diabetici, un sottogruppo non pianificato.",
          nodes: [
            {
              id: 'start',
              question: "Il tuo coautore desidera evidenziare i risultati del sottogruppo diabetico nell'abstract. Cosa fai?",
              branches: [
                { id: 'a', text: "Add it as a key finding ‚Äî the signal is strong", nextNode: 'harking_trap' },
                { id: 'b', text: "Report as exploratory, clearly labeled post-hoc", nextNode: 'proper_reporting' },
                { id: 'c', text: "Run more subgroups to see if the pattern holds", nextNode: 'fishing_expedition' }
              ]
            },
            {
              id: 'harking_trap',
              type: 'outcome',
              consequence: 'bad',
              title: "La trappola dell'Harking",
              text: "Hai commesso l'Harking: ipotizzando dopo che i risultati sono noti. La tua \"scoperta\" ha un tasso di falsi positivi pari a circa il 40% a causa di test multipli. Quando uno studio di replica non riesce a confermarlo, la tua credibilit√† ne risente.",
              realCase: "ISIS-2 ha notoriamente dimostrato che l'aspirina funzionava solo per Gemelli e Bilancia: un ovvio falso positivo che illustra perch√© i sottogruppi post-hoc sono inaffidabili."
            },
            {
              id: 'proper_reporting',
              question: "Buona scelta. Ma l'editore della rivista respinge: 'La scoperta del diabete √® la parte pi√π interessante. Puoi renderlo pi√π evidente?' E adesso?",
              branches: [
                { id: 'd', text: "Agree to emphasize it in the title/abstract", nextNode: 'editor_pressure' },
                { id: 'e', text: "Spiegare le preoccupazioni statistiche e tenere duro", nextNode: 'integrity_win' },
                { id: 'f', text: "Withdraw and try a different journal", nextNode: 'withdraw' }
              ]
            },
            {
              id: 'fishing_expedition',
              type: 'outcome',
              consequence: 'bad',
              title: "La spedizione di pesca",
              text: "You run 15 subgroup analyses. Three show 'significant' results (p < 0.05). But with 15 tests, you'd expect ~1 false positive by chance alone. You've found noise, not signal. Your meta-analysis becomes unreliable.",
              realCase: "Lo studio ACCORD ha condotto pi√π sottogruppi, riscontrando \"benefici\" in alcuni e \"danni\" in altri. La maggior parte erano artefatti statistici."
            },
            {
              id: 'editor_pressure',
              type: 'outcome',
              consequence: 'neutral',
              title: "The Compromise",
              text: "L'articolo √® pubblicato con il sottogruppo diabetico in primo piano. I medici iniziano a prescrivere preferenzialmente ai diabetici. Anni dopo, uno studio dedicato sui diabetici non ha mostrato alcun beneficio particolare. La tua meta-analisi ha contribuito a una pratica clinica fuorviante.",
              realCase: "Many drugs showed 'subgroup benefits' in meta-analyses that vanished in dedicated trials."
            },
            {
              id: 'integrity_win',
              type: 'outcome',
              consequence: 'good',
              title: "Scientific Integrity Wins",
              text: "Spiega che i risultati esplorativi richiedono conferma. Il documento viene pubblicato con le opportune avvertenze. Uno studio successivo verifica specificamente l‚Äôipotesi del diabete e conferma i risultati, ora con un‚Äôadeguata pre-specificazione. Ti viene riconosciuto il merito di aver identificato un'ipotesi che vale la pena verificare.",
              realCase: "This is how science should work: exploratory findings generate hypotheses; confirmatory trials test them."
            },
            {
              id: 'withdraw',
              type: 'outcome',
              consequence: 'neutral',
              title: "La ritirata dei principi",
              text: "Un'altra rivista accetta l'articolo con un'appropriata etichettatura esplorativa. Ci vuole pi√π tempo ma mantiene il rigore scientifico. Il risultato viene infine testato in una prova dedicata.",
              realCase: "A volte la scelta giusta significa accettare una pubblicazione pi√π lenta per una scienza migliore."
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Qual ‚Äã‚Äã√® lo scopo principale della registrazione di un protocollo di revisione sistematica su PROSPERO prima di iniziare l'estrazione dei dati?",
          options: [
            { id: 'a', text: "To claim priority over other researchers", correct: false },
            { id: 'b', text: "To prevent outcome switching and selective reporting", correct: true },
            { id: 'c', text: "To get ethical approval", correct: false },
            { id: 'd', text: "To ensure adequate sample size", correct: false }
          ],
          explanation: "La registrazione del protocollo crea un timestamp che dimostra che i risultati, i sottogruppi e le analisi sono stati specificati prima di vedere i dati. Ci√≤ impedisce l'HARKing e il p-hacking, che gonfiano i tassi di falsi positivi."
        }
      }
    ]
  },
  {
    id: 3,
    title: "The Search",
    subtitle: "Trovare tutte le prove",
    principle: 2,
    story: "Rosiglitazone",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Ci√≤ che non cerchi, non troverai"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE REVERSAL: ROSIGLITAZONE ‚Äî HIDING IN PLAIN SIGHT",
          source: "NEJM 2007; 356:2457-2471 | Nissen & Wolski | PubMed: 17517853",
          timeline: [
            { year: "1999", text: "FDA approves rosiglitazone (Avandia) for diabetes based on HbA1c reduction. It becomes a blockbuster ‚Äî $3 billion/year in sales.", type: "normal" },
            { year: "2000-06", text: "GSK conduce 42 prove. Molti mostrano riguardanti i segnali CV. La maggior parte non viene mai pubblicata. I dati si trovano nei file FDA e in ClinicalTrials.gov.", type: "normal" },
            { year: "May 2007", text: "Nissen cerca i documenti della FDA, ClinicalTrials.gov, e chiede a GSK dati non pubblicati. Trova ci√≤ che gli altri hanno mancato.", type: "revelation" },
            { year: "May 2007", text: "Meta-analisi pubblicata: OR 1.43 (1.03-1.98) per MI. Il danno cardiaco era visibile in dati non pubblicati per ANNI.", type: "crisis" },
            { year: "2010-11", text: "FDA restricts use. European regulators suspend marketing. Estimated 47,000 excess heart attacks caused.", type: "crisis" }
          ],
          realData: {
            endpoint: "Myocardial infarction",
            drug: "86/15,560 (0.55%)",
            placebo: "72/12,283 (0.59%)",
            rr: "1.43",
            ci: "1.03-1.98",
            nnh: "52"
          },
          hook: "Il segnale era l√¨ nel 2000. Ci sono voluti 7 anni e un ricercatore disposto a cercare oltre PubMed per trovarlo. Quanti sono morti nell'attesa?"
        }
      },
      {
        type: 'content',
        content: {
          title: "Dove si nascondono le prove",
          sections: [
            {
              heading: "Published Literature (What Most Searches Find):",
              items: [
                "PubMed/MEDLINE ‚Äî biomedical journals",
                "EMBASE ‚Äî European/drug focus",
                "CENTRAL ‚Äî Cochrane's trial registry"
              ]
            },
            {
              heading: "Grey Literature (What Most Searches Miss):",
              items: [
                "ClinicalTrials.gov ‚Äî registered trials, many unpublished",
                "Contributi FDA/EMA: dati normativi non presenti nelle riviste",
                "WHO ICTRP ‚Äî international trial registry",
                "Abstract della conferenza: dati preliminari",
                "Theses/dissertations ‚Äî negative results often here",
                "Manufacturer data ‚Äî FOIA requests may be needed"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: COMPLETO SEARCHING",
          title: "Building a Search Strategy",
          sections: [
            {
              heading: "Step 1: Identify Concepts",
              text: "Dividi il tuo PICO in concetti ricercabili. Per rosiglitazone + cardiovascolare: (rosiglitazone OR Avandia) AND (infarto miocardico OR attacco cardiaco OR cardiovascolare)"
            },
            {
              heading: "Passaggio 2: espandere con i sinonimi",
              text: "Use MeSH terms, brand names, generic names, spelling variants. Miss one synonym, miss studies."
            },
            {
              heading: "Step 3: Search Multiple Sources",
              text: "Minimum: MEDLINE + EMBASE + CENTRAL + trial registries + reference checking. Better: add grey literature, contact experts."
            },
            {
              heading: "Step 4: Document Everything",
              text: "Record exact search strings, dates, results. Reproducibility requires transparency."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'search-builder',
          title: "Search Strategy Builder",
          description: "Crea stringhe di ricerca specifiche per il database dal tuo PICO"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'search_decision_tree',
          title: "La caccia agli oggetti nascosti Dati",
          situation: "Stai meta-analizzando un farmaco per il diabete (simile al rosiglitazone). PubMed ti offre 15 studi che mostrano benefici. Ma ClinicalTrials.gov mostra 23 studi registrati. Otto studi completati non hanno pubblicazioni.",
          nodes: [
            {
              id: 'start',
              question: "Hai trovato 8 studi mancanti. La scadenza √® stretta. Qual √® la tua prima mossa?",
              branches: [
                { id: 'a', text: "Proceed with 15 published trials ‚Äî they're peer-reviewed", nextNode: 'proceed_published' },
                { id: 'b', text: "Contatta il produttore per dati non pubblicati", nextNode: 'contact_manufacturer' },
                { id: 'c', text: "Search FDA approval documents and advisory committee briefings", nextNode: 'search_fda' }
              ]
            },
            {
              id: 'proceed_published',
              type: 'outcome',
              consequence: 'bad',
              title: "La ripetizione del rosiglitazone",
              text: "La tua meta-analisi mostra benefici (RR 0,85, CI 0,78-0,93). √à pubblicato su una rivista prestigiosa. Tre anni dopo, qualcuno ritrova gli studi mancanti negli archivi della FDA. Hanno mostrato DANNO. La tua meta-analisi ha ingannato migliaia di medici.",
              realCase: "Questo √® esattamente ci√≤ che √® accaduto con il rosiglitazone. La letteratura pubblicata ha mostrato un beneficio del glucosio. I dati nascosti hanno mostrato danni cardiaci."
            },
            {
              id: 'contact_manufacturer',
              question: "The manufacturer responds: 'We can share summary data but not patient-level data, and it will take 6 months.' Meanwhile, your competitor is about to publish their meta-analysis using only published data.",
              branches: [
                { id: 'd', text: "Affrettati a pubblicare prima i dati disponibili", nextNode: 'rush_publish' },
                { id: 'e', text: "Attendi i dati del produttore, anche se raccolti", nextNode: 'wait_data' },
                { id: 'f', text: "Publish now but pre-register an update when data arrives", nextNode: 'staged_approach' }
              ]
            },
            {
              id: 'search_fda',
              question: "Trovi i documenti informativi della FDA! Contengono i dati di 6 degli 8 studi mancanti. I dati sulla sicurezza cardiaca sono preoccupanti: eventi elevati in 4 studi su 6. E adesso?",
              branches: [
                { id: 'g', text: "Includi i dati FDA nella tua meta-analisi", nextNode: 'include_fda' },
                { id: 'h', text: "La qualit√† dei dati FDA non √® chiara: attieniti solo a quelli pubblicati", nextNode: 'proceed_published' },
                { id: 'i', text: "Esegui analisi parallele con e senza dati FDA", nextNode: 'sensitivity_analysis' }
              ]
            },
            {
              id: 'rush_publish',
              type: 'outcome',
              consequence: 'bad',
              title: "La corsa verso il In basso",
              text: "Hai battuto il tuo concorrente di 2 mesi. Ma entrambe le meta-analisi sono incomplete. Quando emergono i dati completi, entrambi si dimostrano distorti. La tua reputazione di rigore ne risente.",
              realCase: "L'incentivo accademico a pubblicare per primi spesso √® in conflitto con l'esigenza scientifica di essere completi."
            },
            {
              id: 'wait_data',
              type: 'outcome',
              consequence: 'good',
              title: "Patience Wins",
              text: "Il tuo concorrente pubblica per primo con dati incompleti. Aspetti. Quando viene visualizzata la meta-analisi completa, rivela il segnale di sicurezza cardiaca mancato. Il tuo articolo diventa il riferimento definitivo. Le linee guida cliniche citano TE.",
              realCase: "La meta-analisi di Nissen sul rosiglitazone ha avuto successo perch√© aspettava i dati della FDA che altri hanno ignorato."
            },
            {
              id: 'staged_approach',
              type: 'outcome',
              consequence: 'neutral',
              title: "La pragmatica via di mezzo",
              text: "Pubblica risultati preliminari con chiare limitazioni, pre-registrando un aggiornamento. Ci√≤ √® onesto, ma rischia di sovrainterpretare i risultati preliminari. Quando l'aggiornamento mostra risultati diversi, alcuni lo vedono come un \"capovolgimento\".",
              realCase: "Le revisioni sistematiche in corso utilizzano questo approccio, ma gestire la comunicazione √® impegnativo."
            },
            {
              id: 'include_fda',
              type: 'outcome',
              consequence: 'good',
              title: "Il quadro completo",
              text: "Your meta-analysis includes FDA data. The pooled effect shifts: RR 1.15 (0.98-1.35) ‚Äî no longer showing benefit, trend toward harm. You've revealed the truth hidden in grey literature. Regulators take notice.",
              realCase: "L'analisi del rosiglitazone di Nissen ha utilizzato i dati della FDA che hanno trasformato un farmaco \"benefico\" in un farmaco pericoloso uno."
            },
            {
              id: 'sensitivity_analysis',
              type: 'outcome',
              consequence: 'good',
              title: "Transparency Through Sensitivity",
              text: "Il tuo documento mostra: Solo pubblicato: RR 0,85 (vantaggio). Con dati FDA: RR 1,15 (tendenza al danno). Il contrasto √® netto. I lettori possono vedere come i bias di pubblicazione distorcano le prove. Il tuo articolo diventa un esempio didattico.",
              realCase: "Le migliori meta-analisi mostrano come i risultati cambiano con le diverse decisioni di inclusione."
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Why is searching ClinicalTrials.gov essential even if you have a comprehensive MEDLINE search?",
          options: [
            { id: 'a', text: "It has better search functionality than MEDLINE", correct: false },
            { id: 'b', text: "It contains registered trials that may never be published", correct: true },
            { id: 'c', text: "It has more recent publications", correct: false },
            { id: 'd', text: "It's required by PRISMA but not actually useful", correct: false }
          ],
          explanation: "Circa il 50% degli studi registrati non viene mai pubblicato e gli studi non pubblicati hanno maggiori probabilit√† di avere risultati negativi o dannosi. ClinicalTrials.gov rivela cosa manca nella letteratura pubblicata."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've mastered the FOUNDATION of meta-analysis.\n\n‚úì Module 1: The right QUESTION (PICO) ‚Äî learned from CAST's surrogate trap\n‚úì Module 2: PROTOCOL registration ‚Äî learned from HRT's healthy user bias\n‚úì Module 3: COMPREHENSIVE search ‚Äî learned from rosiglitazone's hidden data\n\nNext: You'll learn to SCREEN, EXTRACT, and ASSESS the studies you find.\n\nThe first three principles protect you from asking the wrong question. The next four protect you from getting the wrong answer."
        }
      }
    ]
  },
  // Module 4: The Screen
  {
    id: 4,
    title: "The Screen",
    subtitle: "Study Selection",
    principle: 3,
    story: "Vitamin E",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Every number needs a source"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CONTRADICTION: VITAMIN E ‚Äî SAVIOR OR KILLER?",
          source: "Annals Int Med 2005; 142:37-46 | Miller et al | PubMed: 15537682",
          timeline: [
            { year: "1993", text: "NHANES observational data suggests vitamin E reduces heart disease. Supplement sales soar to $600M/year.", type: "normal" },
            { year: "1996-2004", text: "Multiple RCTs completed: ATBC, GISSI, HOPE, HPS. Results are mixed, confusing.", type: "normal" },
            { year: "2004 (Jan)", text: "Meta-analysis A: Vitamin E 'may prevent' CVD. Includes 7 trials with any dose. RR 0.89 (0.80-0.99).", type: "normal" },
            { year: "2004 (Nov)", text: "Meta-analysis B: Vitamin E INCREASES mortality at high doses (‚â•400 IU). RR 1.04 (1.01-1.07). Uses dose-response analysis.", type: "crisis" },
            { year: "The Truth", text: "Stessi studi, diversi criteri di inclusione, conclusioni opposte. Le scelte del meta-analista hanno determinato la risposta prima dell'inizio dell'analisi.", type: "revelation" }
          ],
          realData: {
            endpoint: "All-cause mortality",
            drug: "High-dose vitamin E (‚â•400 IU/d)",
            placebo: "Control",
            rr: "1.04",
            ci: "1.01-1.07",
            nnh: "200"
          },
          hook: "Two honest researchers. Same year. Same trials. Opposite conclusions. The only difference: their inclusion criteria. Every eligibility decision is a hidden hypothesis."
        }
      },
      {
        type: 'content',
        content: {
          title: "Eligibility Criteria: The Hidden Thesis",
          sections: [
            {
              heading: "What Inclusion Criteria Do:",
              items: [
                "Define your population (which patients count?)",
                "Define adequate intervention (what dose? duration?)",
                "Define meaningful comparisons (what controls?)",
                "Define credible evidence (RCTs only? Observational?)"
              ]
            },
            {
              heading: "What Can Go Wrong:",
              items: [
                "Too broad: noise drowns signal",
                "Too narrow: cherry-picking",
                "Vague criteria: inconsistent application",
                "Post-hoc changes: bias toward desired result"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: SCREENING SISTEMATICO",
          title: "Da migliaia a inclusi",
          sections: [
            {
              heading: "Step 1: Operationalize Criteria",
              text: "Convertire PICO in regole di inclusione/esclusione verificabili. 'Adulti con diabete' diventa 'Et√† ‚â• 18 anni, diagnosi di T1DM o T2DM secondo i criteri ADA, qualsiasi impostazione.'"
            },
            {
              heading: "Step 2: Dual Screening",
              text: "Two reviewers independently screen titles/abstracts, then full texts. Calculate agreement (kappa). Disagreements resolved by discussion or third reviewer."
            },
            {
              heading: "Step 3: Document Decisions",
              text: "Record reason for every exclusion. PRISMA flow diagram shows: identified ‚Üí screened ‚Üí eligible ‚Üí included, with exclusion reasons."
            },
            {
              heading: "Step 4: Handle Borderline Cases",
              text: "Prespecificare le regole per le situazioni ambigue. In caso di dubbi, includere per la revisione del testo completo. Riporta analisi di sensibilit√† con/senza studi borderline."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'prisma-flow',
          title: "PRISMA Flow Generator",
          description: "Create a PRISMA 2020 flow diagram documenting your screening process"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'screen_decision_tree',
          title: "The Borderline Study",
          scenario: "Hai esaminato 2.847 record per la tua meta-analisi sull'ansia da meditazione. 23 studi sono chiaramente inclusi. Ma uno studio ‚Äì MBSR con componenti yoga ‚Äì si trova al limite. Il tuo protocollo diceva \"interventi di meditazione\" ma non affrontava specificamente programmi di consapevolezza con componenti misti.",
          realCase: "Le meta-analisi sulla vitamina E degli anni 2000 hanno mostrato conclusioni drammaticamente diverse in base ai criteri di inclusione. Miller et al. hanno incluso solo studi ad alte dosi e hanno riscontrato un aumento della mortalit√†. Altri, utilizzando criteri pi√π ampi, non hanno riscontrato alcun danno.",
          nodes: {
            start: {
              id: 'start',
              situation: "The borderline MBSR study (n=89) shows SMD = -0.15 (small effect). Your current 23 studies give SMD = -0.42 (p = 0.03). With this study: SMD = -0.38 (p = 0.07).",
              question: "Il tuo primo istinto?",
              branches: [
                { id: 'exclude_path', text: "Exclude it ‚Äî doesn't meet strict criteria", nextNode: 'exclude_consequence' },
                { id: 'include_path', text: "Include it ‚Äî MBSR is close enough", nextNode: 'include_consequence' },
                { id: 'investigate_path', text: "Wait ‚Äî I should check my protocol first", nextNode: 'check_protocol' }
              ]
            },
            exclude_consequence: {
              id: 'exclude_consequence',
              situation: "You exclude the study. Your result becomes significant (p = 0.03). The paper is accepted. Six months later, a reader emails: 'Your supplementary table shows 3 other included studies also had yoga components. Why was this one excluded?'",
              question: "Come rispondi?",
              branches: [
                { id: 'admit_error', text: "Riconosci l'incoerenza", nextNode: 'inconsistency_lesson' },
                { id: 'defend_decision', text: "Defend my original decision", nextNode: 'defense_fails' }
              ]
            },
            inconsistency_lesson: {
              id: 'inconsistency_lesson',
              situation: "Ti rendi conto di aver applicato i criteri in modo incoerente, mantenendo altri studi a componenti misti escludendo questo. Il fattore comune? L'effetto di questo studio ha diluito il tuo risultato.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE WARNING: Post-hoc exclusion that conveniently improves results is a form of selection bias. The Vitamin E controversies taught us: inclusion criteria must be applied blindly to results. Once you see the data, you can't unsee it."
            },
            defense_fails: {
              id: 'defense_fails',
              situation: "Sostieni che la componente yoga era \"pi√π prominente\" in questo studio. Il lettore risponde: \"Ho controllato: lo studio 7 della tua analisi prevedeva il 40% di tempo dedicato allo yoga\". Lo studio escluso aveva il 30%'. Non hai alcuna giustificazione oggettiva.",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA CONSEGUENZA: l'applicazione incoerente dei criteri senza documentazione mina l'intera analisi. √à cos√¨ che le meta-analisi sulla vitamina E hanno perso credibilit√†: i lettori non riuscivano a distinguere quali esclusioni fossero basate su principi o convenienti."
            },
            include_consequence: {
              id: 'include_consequence',
              situation: "You include the study. Your pooled SMD = -0.38 (95% CI: -0.79 to 0.03, p = 0.07). A reviewer writes: 'The result is not statistically significant. This seems like a negative finding.'",
              question: "Come inquadra questo nella tua discussione?",
              branches: [
                { id: 'negative_framing', text: "Meditation shows no significant benefit for anxiety", nextNode: 'oversimplified' },
                { id: 'nuanced_framing', text: "Segnala l'analisi di sensibilit√† e discuti la decisione borderline", nextNode: 'transparency_win' }
              ]
            },
            oversimplified: {
              id: 'oversimplified',
              situation: "Your paper concludes 'meditation was not effective.' But the effect size was moderate (SMD = -0.38) with wide CI. A different meta-analysis, excluding the borderline study, concludes 'meditation is effective.' Now there are contradictory reviews.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: Remember the Vitamin E story ‚Äî different inclusion criteria led to opposite conclusions. Neither was wrong, but neither told the whole truth. The borderline study's status should have been explicitly discussed."
            },
            transparency_win: {
              id: 'transparency_win',
              situation: "Your paper reports: 'In primary analysis (24 studies), SMD = -0.38 (p = 0.07). In sensitivity analysis excluding one borderline MBSR study, SMD = -0.45 (p = 0.03). Conclusions are sensitive to this decision.' Reviewers praise the transparency.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE GRADUAL REVEAL: By showing both analyses, you let readers see the truth: the evidence is at the borderline. Some will find this unsatisfying. But honest uncertainty beats false precision. This is how meta-analysis should work."
            },
            check_protocol: {
              id: 'check_protocol',
              situation: "Controlla la tua registrazione PROSPERO. Dice: \"Interventi di meditazione inclusi programmi basati sulla consapevolezza\". MBSR √® un programma basato sulla consapevolezza. Ma ti rendi conto di non aver specificato in anticipo cosa fare con i componenti misti.",
              question: "Qual ‚Äã‚Äã√® il tuo prossimo passo?",
              branches: [
                { id: 'protocol_amendment', text: "Presenta un emendamento al protocollo e documenta la decisione", nextNode: 'good_process' },
                { id: 'retroactive_rule', text: "Decidi ora in base ai dati", nextNode: 'biased_decision' }
              ]
            },
            good_process: {
              id: 'good_process',
              situation: "You file an amendment: 'Studies with ‚â•50% meditation time will be included; others in sensitivity analysis.' The borderline study has 70% meditation time. You include it. You document this BEFORE seeing its effect on your pooled estimate.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Pre-specification protects you from yourself. By setting the rule before seeing its consequences, you remove the temptation to game the inclusion criteria. This is Principle 2: 'Pre-specification is protection.'"
            },
            biased_decision: {
              id: 'biased_decision',
              situation: "Guarda prima i dati. Lo studio borderline diluisce il tuo effetto. Decidi di escluderlo. Ma ora la tua decisione √® contaminata: non puoi ignorare che escluderla rende il tuo risultato significativo.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE HOOK RETURNS: This is exactly how the Vitamin E controversies began. Researchers made 'reasonable' decisions that happened to align with their preferred conclusions. The sequence matters: rules first, data second."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Due revisori indipendenti esaminano 500 abstract. Il revisore A ne include 45, il revisore B ne include 52 e sono d'accordo su 38. Cosa suggerisce questo?",
          options: [
            { id: 'a', text: "Excellent agreement ‚Äî proceed to full-text", correct: false },
            { id: 'b', text: "Moderate agreement ‚Äî discuss disagreements, clarify criteria", correct: true },
            { id: 'c', text: "Scarso accordo: ricominciare con nuovi revisori", correct: false },
            { id: 'd', text: "L'accordo non pu√≤ essere valutato da queste informazioni", correct: false }
          ],
          explanation: "Ci√≤ rappresenta un kappa intorno a 0,65 (accordo moderato). I disaccordi su 21 abstract (14+7) necessitano di discussione. Spesso, criteri vaghi causano incoerenze: chiarirli migliora l'affidabilit√† per lo screening futuro."
        }
      }
    ]
  },
  // Module 5: The Extract
  {
    id: 5,
    title: "The Extract",
    subtitle: "Data Extraction",
    principle: 3,
    story: "DECREASE",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Every number needs a source"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA FRODE: DIMINUISCE ‚Äî QUANDO I DATI SONO TROPPO BUONI",
          source: "Erasmus MC Investigation 2012 | Eur Heart J 2014; 35:1972-1973",
          timeline: [
            { year: "1999", text: "Poldermans publishes DECREASE-I: beta-blockers reduce perioperative death by 90%! (0.7% vs 3.4%). Results seem miraculous.", type: "normal" },
            { year: "2002-09", text: "DECREASE-II, III, IV published. All show dramatic benefit. Poldermans leads European guideline committees. Beta-blockers become standard of care.", type: "normal" },
            { year: "2009", text: "POISE trial (8,351 patients) shows beta-blockers INCREASE mortality in surgery. Contradicts DECREASE completely.", type: "crisis" },
            { year: "2011", text: "Erasmus MC investigates. Finds: phantom patients, impossible data, consent forms forged. Poldermans fired.", type: "crisis" },
            { year: "2013", text: "Cochrane re-analyzes without DECREASE. Beta-blocker benefit vanishes. Guidelines based on fraud for 12 years.", type: "revelation" }
          ],
          realData: {
            endpoint: "Perioperative cardiac death (fabricated)",
            drug: "1/53 (claimed)",
            placebo: "9/59 (claimed)",
            rr: "0.09",
            ci: "0.02-0.66",
            nnh: "N/A ‚Äî I DATI SONO STATI FABBRICATI"
          },
          hook: "DECREASE showed I¬≤ = 0% when added to meta-analyses. Real medicine is messy. When heterogeneity vanishes, ask: Is this too perfect to be true?"
        }
      },
      {
        type: 'content',
        content: {
          title: "Data Integrity: Trust but Verify",
          sections: [
            {
              heading: "Red Flags for Problematic Data:",
              items: [
                "Results too good to be true (I¬≤=0% across diverse populations)",
                "Baseline characteristics perfectly balanced",
                "Implausible means/SDs (e.g., SD = mean/10 exactly)",
                "Duplicate publications with slightly different numbers",
                "Missing raw data despite requests"
              ]
            },
            {
              heading: "The GRIM Test:",
              items: [
                "Check if reported means are mathematically possible given N",
                "Example: Mean of 3.47 with N=25 is impossible (25√ó3.47=86.75, not an integer)",
                "Failed GRIM tests suggest fabrication or transcription errors"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: RIGOROSO ESTRAZIONE",
          title: "Acquisizione accurata dei dati",
          sections: [
            {
              heading: "Standardized Forms",
              text: "Create extraction forms with: study ID, population characteristics, intervention details, outcome definitions, timepoints, effect estimates, variance measures, risk of bias items."
            },
            {
              heading: "Dual Extraction",
              text: "Two extractors independently capture data. Compare forms, resolve discrepancies by checking source. Calculate error rate ‚Äî if high, retrain or simplify form."
            },
            {
              heading: "Contacting Authors",
              text: "Dati mancanti? Contatta gli autori. Documentare tutte le richieste e le risposte. Se nessuna risposta dopo 2 tentativi, segnalare le limitazioni. Considerare le implicazioni dell'intenzione di trattare."
            },
            {
              heading: "Data Verification",
              text: "Verificare la coerenza interna: la somma dei sottogruppi d√† il totale? Le percentuali corrispondono a Ns? La trama della foresta corrisponde al testo? Esegui test GRIM/SPRITE su dati sospetti."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'extraction-form',
          title: "Creatore di moduli di estrazione dati",
          description: "Crea moduli di estrazione standardizzati per la tua revisione sistematica"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'extract_decision_tree',
          title: "Il modello sospetto",
          scenario: "You're extracting data for a statin meta-analysis. One large trial (n=3,200) reports MI rates of exactly 4.0% treatment, 6.0% control. The lead author has had two recent retractions. When you add this study, I¬≤ drops from 45% to 0%.",
          realCase: "Gli studi DECREASE di Don Poldermans hanno mostrato una riduzione dei beta-bloccanti morte perioperatoria del 90%. Troppo bello per essere vero Nel 2012, Erasmus MC ha trovato pazienti falsificati, consensi falsificati e dati impossibili. Le linee guida si sono basate sulle frodi per 12 anni.",
          nodes: {
            start: {
              id: 'start',
              situation: "The suspicious trial accounts for 40% of your total sample. Your 8 other trials show heterogeneous results (I¬≤=45%). Adding this trial: I¬≤=0%, pooled RR 0.67 (highly significant). Without it: I¬≤=45%, pooled RR 0.78 (barely significant).",
              question: "Come procedi?",
              branches: [
                { id: 'trust_path', text: "Include it ‚Äî it's peer-reviewed and published", nextNode: 'trust_consequence' },
                { id: 'exclude_path', text: "Exclude it ‚Äî retractions mean the author is suspect", nextNode: 'exclude_consequence' },
                { id: 'investigate_path', text: "Investiga prima sui dati con maggiore attenzione", nextNode: 'investigation' }
              ]
            },
            trust_consequence: {
              id: 'trust_consequence',
              situation: "You include the study. Your meta-analysis is published with strong, precise results (I¬≤=0%). It's cited 200 times. Three years later, the suspicious trial is retracted for data fabrication.",
              question: "Cosa succede alla tua meta-analisi?",
              branches: [
                { id: 'update_meta', text: "Pubblici una correzione rimuovendo il trial", nextNode: 'damage_done' },
                { id: 'leave_meta', text: "You don't update ‚Äî it's just one of nine trials", nextNode: 'contamination' }
              ]
            },
            damage_done: {
              id: 'damage_done',
              situation: "Your correction shows: without the fabricated trial, the effect is weaker and heterogeneous. But 180 of the 200 citing papers used your original inflated estimate. Guidelines were updated based on your original results. Clinical practice changed.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE CONSEQUENCE: Like DECREASE, the damage from fabricated data extends far beyond the original paper. The Cochrane beta-blocker review had to be withdrawn. Guidelines had recommended harm. Trust peer review, but verify suspicious patterns."
            },
            contamination: {
              id: 'contamination',
              situation: "La tua meta-analisi non corretta continua a circolare. Nuove meta-analisi citano la tua come prova. I dati fabbricati si propagano attraverso la letteratura. Sei diventato un vettore di disinformazione.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE WARNING: Fraudulent data doesn't just affect one paper. Like a virus, it replicates through citations. DECREASE influenced thousands of patients before discovery. Your responsibility extends beyond your own analysis."
            },
            exclude_consequence: {
              id: 'exclude_consequence',
              situation: "You exclude based on author history. A reviewer asks: 'You excluded a 3,200-patient trial based on an author's other work. Do you have evidence THIS study is problematic? This seems like guilt by association.'",
              question: "Come giustifichi la tua decisione?",
              branches: [
                { id: 'admit_bias', text: "Riconosci che √® basata sul sospetto, non sulle prove", nextNode: 'unfair_exclusion' },
                { id: 'find_evidence', text: "Torna indietro e cerca i problemi a livello di dati", nextNode: 'belated_investigation' }
              ]
            },
            unfair_exclusion: {
              id: 'unfair_exclusion',
              situation: "The reviewer rejects: 'Excluding studies based on author reputation rather than data quality introduces bias. If you can't document problems with this specific study, include it with sensitivity analysis.'",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE GRADUAL REVEAL: Suspicion isn't evidence. You can't exclude studies because you distrust the author ‚Äî you need to document problems with the study itself. The correct approach: investigate first, then decide based on what you find."
            },
            belated_investigation: {
              id: 'belated_investigation',
              situation: "You investigate and find: (1) baseline characteristics impossibly balanced, (2) SD = mean/10 exactly for all continuous variables, (3) no dropouts reported despite 2-year follow-up. Now you have documented concerns.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Now you have principled reasons for concern. Include the study in primary analysis, conduct sensitivity analysis without it, and document the red flags. Let readers judge. This is transparency about uncertainty."
            },
            investigation: {
              id: 'investigation',
              situation: "Esamina il processo sospetto pi√π da vicino. Cosa controlli prima?",
              question: "Choose your investigation approach:",
              branches: [
                { id: 'check_balance', text: "Check baseline characteristics for impossible balance", nextNode: 'baseline_check' },
                { id: 'check_variance', text: "Controlla SD e varianze per modelli sospetti", nextNode: 'variance_check' },
                { id: 'check_registry', text: "Compare to ClinicalTrials.gov registration", nextNode: 'registry_check' }
              ]
            },
            baseline_check: {
              id: 'baseline_check',
              situation: "Baseline characteristics: Age 62.3 vs 62.4, BMI 27.8 vs 27.9, 52.0% vs 52.1% male. In 3,200 patients, these are impossibly precise. Real randomization produces more variation. GRIM test: 1,600 √ó 62.3 = 99,680 ‚Äî impossible to produce age 62.3 exactly.",
              question: "Cosa concludi?",
              branches: [
                { id: 'fabrication_flag', text: "Segnala per probabile fabbricazione: documenta e procedi con l'analisi di sensibilit√†", nextNode: 'documented_concern' },
                { id: 'contact_author', text: "Contatta l'autore per chiarimenti first", nextNode: 'author_contact' }
              ]
            },
            variance_check: {
              id: 'variance_check',
              situation: "You notice: LDL mean 142, SD 14.2. Systolic BP mean 138, SD 13.8. HbA1c mean 7.2, SD 0.72. Every SD is exactly 10% of the mean. This is statistically implausible ‚Äî different variables have different natural distributions.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE HOOK: The SPRITE test catches impossible combinations of means, SDs, and sample sizes. Real biological data is messy. When patterns are too clean, suspicion is warranted. Document this and conduct sensitivity analysis."
            },
            registry_check: {
              id: 'registry_check',
              situation: "ClinicalTrials.gov shows: original primary endpoint was 'composite CV events' (not MI alone), planned N was 2,400 (not 3,200), and follow-up was planned as 1 year (not 2). Three major deviations without explanation.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE QUESTION: Why did the sample grow by 33%? Why did the primary endpoint change? Why did follow-up extend? These aren't proof of fraud, but they're red flags requiring explanation. Compare registrations to publications ‚Äî always."
            },
            documented_concern: {
              id: 'documented_concern',
              situation: "You include the study in primary analysis, conduct sensitivity analysis without it, and note: 'One trial (Smith 2008) showed unusual baseline balance and variance patterns warranting scrutiny. Conclusions are robust to its exclusion.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: You've done your due diligence. You haven't accused anyone of fraud (which requires institutional investigation), but you've been transparent about concerns. Readers can draw their own conclusions."
            },
            author_contact: {
              id: 'author_contact',
              situation: "Invia un'e-mail all'autore corrispondente chiedendo informazioni sul saldo di base. Nessuna risposta dopo 3 settimane. Riprova. Ancora niente. L'istituzione dell'autore non ha informazioni di contatto. Il sito web del laboratorio non viene aggiornato da 4 anni.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE REPETITION: Document your attempts. 'Author contacted twice without response' is important information. With DECREASE, Poldermans was unresponsive to queries for years. Non-response isn't proof of fraud, but it limits verification."
            }
          }
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "E se i dati nella meta-analisi fossero stati fabbricati?",
          context: "For over a decade, the DECREASE trials shaped perioperative medicine worldwide. Led by Don Poldermans at Erasmus Medical Center, these trials showed beta-blockers reduced perioperative cardiac death by an astonishing 90%. Guidelines across the globe recommended beta-blockers before non-cardiac surgery. Then the investigation began.",
          stats: [
            { value: "90%", label: "Claimed Mortality Reduction", type: "" },
            { value: "11", label: "Papers Retracted", type: "danger" },
            { value: "2011", label: "Poldermans Fired", type: "" },
            { value: "10,000+", label: "Estimated Excess Deaths", type: "danger" }
          ],
          source: "Erasmus MC Investigation 2011 | POISE Trial - Lancet 2008",
          decisionScenario: "Stai aggiornando le linee guida perioperatorie. Gli studi DECREASE dominano la base di prove. Un collega nota che le dimensioni dell'effetto sembrano \"troppo belle per essere vere\": riduzioni della mortalit√† del 90% sono quasi inaudite in cardiologia.",
          pathA: {
            title: "Include DECREASE trials ‚Äî they're published and peer-reviewed",
            steps: [
              "Your meta-analysis shows strong benefit (OR 0.10)",
              "Guidelines recommend beta-blockers for all surgical patients",
              "Hospitals adopt mandatory beta-blocker protocols",
              "POISE trial (real data, n=8,351): beta-blockers INCREASE mortality (HR 1.33)",
              "L'indagine rivela che i dati DECREASE sono stati fabbricati",
              "Estimated 10,000+ excess deaths from guidelines based on fraud"
            ]
          },
          pathB: {
            title: "Flag impossible effect sizes ‚Äî investigate data integrity",
            steps: [
              "You note 90% mortality reduction is biologically implausible",
              "Richiedi dati grezzi agli investigatori (nessuna risposta)",
              "Conduct sensitivity analysis excluding DECREASE",
              "Without DECREASE: no clear benefit, possible harm signal",
              "Your cautious conclusions prevent widespread adoption",
              "When POISE publishes, your skepticism is validated"
            ]
          },
          revelation: "Meta-analysis assumes data integrity. When that assumption fails, the entire edifice collapses. The DECREASE fraud taught us: impossible effect sizes are a warning sign. A 90% mortality reduction from a simple beta-blocker should have triggered skepticism, not celebration. Your job is not just to pool numbers ‚Äî it is to question whether those numbers deserve to exist.",
          moduleConnection: "Questo √® il motivo per cui l'estrazione dei dati richiede vigilanza. Non sei una calcolatrice: sei un tutore. Ogni numero che estrai porta con s√© il peso della vita dei pazienti. Verifica, fai un controllo incrociato e quando qualcosa sembra troppo bello per essere vero, probabilmente lo √®."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A trial reports mean BMI of 27.3 kg/m¬≤ (SD 2.1) in a group of N=30 patients. Using the GRIM test (checking if 30 √ó 27.3 = 819 is plausible for BMI sum), what can you conclude?",
          options: [
            { id: 'a', text: "The mean is impossible ‚Äî definite fabrication", correct: false },
            { id: 'b', text: "La media √® possibile: i dati sono verificati", correct: false },
            { id: 'c', text: "I test GRIM si applicano a conteggi/dati discreti, non a misure continue come BMI", correct: true },
            { id: 'd', text: "Need more information to apply GRIM", correct: false }
          ],
          explanation: "GRIM (Incoerenza delle medie correlata alla granularit√†) si applica a dati discreti/di conteggio in cui i valori devono essere numeri interi. Il BMI √® continuo, quindi qualsiasi media √® matematicamente possibile. GRIM si applicherebbe al \"numero di sigarette al giorno\" ma non al peso o all'altezza."
        }
      }
    ]
  },
  // Module 6: The Assess (Risk of Bias)
  {
    id: 6,
    title: "The Assess",
    subtitle: "Risk of Bias",
    principle: 4,
    story: "ORBITA",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Bias hides in plain sight"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA RIVELAZIONE: ORBITA - LO STENT PLACEBO",
          source: "Lancet 2018; 391:31-40 | Al-Lamee et al | PubMed: 29103656",
          timeline: [
            { year: "1990s-2010s", text: "Hundreds of trials show PCI improves angina symptoms. Millions of procedures performed yearly. Patients report dramatic improvement.", type: "normal" },
            { year: "2007", text: "COURAGE trial: PCI doesn't reduce MI or death vs medical therapy. But symptoms improved ‚Äî so PCI continues for symptom relief.", type: "normal" },
            { year: "2015", text: "ORBITA begins: 200 patients with single-vessel disease. Half get PCI, half get sham (catheter inserted, no stent). Both groups blinded.", type: "normal" },
            { year: "2018", text: "Risultati: il tempo di esercizio √® migliorato di 28,4 secondi con PCI rispetto a 11,8 secondi con sham. Differenza: 16,6 s (IC 95%: da -8,9 a 42,0). NON significativo.", type: "crisis" },
            { year: "The Truth", text: "Il \"beneficio\" del PCI per l'angina stabile √® stato l'effetto placebo. Gli studi in cieco hanno misurato la convinzione, non la biologia. Ogni studio precedente era ad alto rischio di bias.", type: "revelation" }
          ],
          realData: {
            endpoint: "Exercise time increment at 6 weeks",
            drug: "PCI: +28.4 seconds",
            placebo: "Sham: +11.8 seconds",
            rr: "Diff: 16.6s",
            ci: "-8.9 to 42.0",
            nnh: "p = 0.20 (not significant)"
          },
          hook: "Senza un controllo fittizio, non stai misurando il trattamento. Stai misurando il rituale: il laboratorio di cateterizzazione, la procedura, il recupero, la convinzione che qualcosa sia stato fatto."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è PUNTO CHIAVE: ORBITA ha dimostrato che decenni di \"beneficio\" del PCI per l'angina stabile erano un effetto placebo. Milioni di stent sono stati posizionati sulla base di studi in cieco che misuravano i risultati soggettivi. Il rischio di bias non √® accademico: √® la differenza tra misurare la medicina e misurare le convinzioni."
        }
      },
      {
        type: 'content',
        content: {
          title: "The Five Domains of Bias (RoB 2)",
          sections: [
            {
              heading: "Domain 1: Randomization Process",
              items: [
                "La sequenza di assegnazione √® stata casuale?",
                "Was allocation concealed until enrollment?",
                "Were baseline differences due to chance?"
              ]
            },
            {
              heading: "Domain 2: Deviations from Intended Interventions",
              items: [
                "I partecipanti e il personale erano in cieco?",
                "Ci sono state deviazioni dal protocollo?",
                "Were deviations likely to affect outcomes?"
              ]
            },
            {
              heading: "Ambito 3: Risultato mancante Dati",
              items: [
                "I dati sui risultati erano completi?",
                "Could missingness be related to outcomes?",
                "Sono state utilizzate analisi appropriate?"
              ]
            },
            {
              heading: "Domains 4-5: Measurement & Selection",
              items: [
                "Could outcome measurement be influenced by knowledge of intervention?",
                "La selezione dei risultati √® stata influenzata dai risultati?"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: VALUTAZIONE ROB 2",
          title: "Systematic Bias Evaluation",
          sections: [
            {
              heading: "Signaling Questions",
              text: "Ogni dominio ha 3-5 domande di segnalazione a cui √® stata data risposta S√¨/probabilmente s√¨/probabilmente no/no/nessuna informazione. Questi influiscono sui giudizi a livello di dominio."
            },
            {
              heading: "Domain Judgments",
              text: "Basso rischio: √® improbabile che lo studio sia distorto per questo dominio Alcune preoccupazioni: solleva dubbi sull'affidabilit√† Alto rischio: dominio che probabilmente distorce seriamente i risultati"
            },
            {
              heading: "Overall Judgment",
              text: "Low risk: low risk in all domains\nSome concerns: some concerns in at least one domain\nHigh risk: high risk in at least one domain, OR some concerns in multiple domains"
            },
            {
              heading: "Implicazioni per la sintesi",
              text: "Gli studi ad alto rischio possono essere esclusi (rigorosi) o mantenuti con l'analisi di sensibilit√† (inclusiva). In ogni caso, il rischio di bias deve informare la tua valutazione di certezza (GRADE)."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'rob2-tool',
          title: "RoB 2 Assessment Interface",
          description: "Valutare il rischio di bias utilizzando lo strumento Cochrane RoB 2"
        }
      },
      {
        type: 'content',
        content: {
          title: "THE PATTERN: When Sham Surgery Exposes Placebo Effects",
          sections: [
            {
              heading: "FIDELITY (2013) ‚Äî Knee Meniscus Surgery",
              items: [
                "146 patients with meniscal tears ‚Üí arthroscopic resection vs sham",
                "Lysholm score difference: -1.6 points (95% CI: -7.2 to 4.0)",
                "One of the most common orthopedic procedures shown to be no better than placebo",
                "Source: NEJM 2013; PubMed 24369076"
              ]
            },
            {
              heading: "Vertebroplasty Sham Trials (2009) ‚Äî Spinal Fracture Treatment",
              items: [
                "Two trials: cement injection into fractured vertebrae vs sham (needle placement only)",
                "Pain reduction difference: 0.6 points on 0-10 scale (95% CI: -0.7 to 1.8)",
                "Procedure costing $5,000+ worked no better than inserting a needle",
                "Source: NEJM 2009; PubMed 19657121"
              ]
            },
            {
              heading: "CSAW (2018) ‚Äî Shoulder Decompression Surgery",
              items: [
                "313 patients with subacromial pain ‚Üí surgery vs arthroscopy vs no treatment",
                "Oxford Shoulder Score difference: -1.3 points (95% CI: -3.9 to 1.3)",
                "300,000 such surgeries performed annually in UK/US ‚Äî most unnecessary",
                "Source: Lancet 2018; PMC 5803129"
              ]
            },
            {
              heading: "L'AVVERTIMENTO: il pattern si ripete",
              items: [
                "Unblinded surgical trials overestimate benefit by 30-50%",
                "Patients WANT to believe expensive, invasive procedures work",
                "Surgeons BELIEVE in their craft ‚Äî impossible to blind them",
                "Without sham controls, we measure belief, not biology"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'rob_decision_tree',
          title: "The Unblinded Blood Pressure Trial",
          scenario: "You're assessing a trial of new antihypertensive Drug X. Year 1: double-blind. Years 2-4: open-label extension. Primary outcome: CV events (blinded adjudication). Secondary: quality of life, symptoms (unblinded staff collected).",
          realCase: "SYMPLICITY HTN-3 ha testato la denervazione renale per l'ipertensione resistente. Precedenti studi in cieco hanno mostrato drastici cali di 30 mmHg. Lo studio controllato-farsa? Solo 2,4 mmHg di differenza. La misurazione in cieco aveva notevolmente gonfiato il beneficio apparente.",
          nodes: {
            start: {
              id: 'start',
              situation: "The trial reports: Drug X reduced CV events by 18% (HR 0.82, p=0.04) and improved quality of life scores by 12 points (p<0.001). You're doing RoB 2 assessment. You need to rate each outcome separately.",
              question: "Which outcome do you assess first?",
              branches: [
                { id: 'primary_first', text: "Primary outcome (CV events)", nextNode: 'cv_assessment' },
                { id: 'secondary_first', text: "Secondary outcome (quality of life)", nextNode: 'qol_assessment' },
                { id: 'combined_assessment', text: "Valuta lo studio nel suo complesso, non in base al risultato", nextNode: 'combined_mistake' }
              ]
            },
            combined_mistake: {
              id: 'combined_mistake',
              situation: "Scrivi: \"Rischio complessivo di bias: alcune preoccupazioni dovute all'estensione in aperto\". Un revisore restituisce la tua valutazione: \"RoB 2 richiede una valutazione specifica per i risultati\". Gli eventi CV con aggiudicazione in cieco sono diversi dalla QoL con raccolta in cieco.'",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE HOOK: il rischio di bias non √® una propriet√† dello studio: √® una propriet√† di ciascun risultato all'interno dello studio. ORBITA ci ha insegnato: il cieco influisce profondamente sui risultati soggettivi ma in minima parte sui risultati oggettivi. Un solo giudizio non pu√≤ esprimere tutto ci√≤."
            },
            cv_assessment: {
              id: 'cv_assessment',
              situation: "For CV events: Events were adjudicated by a committee blinded to treatment allocation. They reviewed medical records, ECGs, and imaging without knowing which arm the patient was in. The open-label extension didn't affect their judgment.",
              question: "Risk of bias for CV outcome measurement?",
              branches: [
                { id: 'cv_low', text: "Low risk ‚Äî blinded adjudication protects the outcome", nextNode: 'cv_correct' },
                { id: 'cv_some', text: "Some concerns ‚Äî patients were unblinded, might report symptoms differently", nextNode: 'cv_overthinking' },
                { id: 'cv_high', text: "Rischio elevato: lo studio √® stato in aperto per 3 anni", nextNode: 'cv_wrong' }
              ]
            },
            cv_correct: {
              id: 'cv_correct',
              situation: "Esatto! Per i risultati oggettivi con valutazione in cieco, la mancanza di cieco dei partecipanti conta meno. La morte √® la morte. L'IM confermato dalle troponine e dall'ECG √® IM. Ci√≤ che conta √® l'accecamento dei giudici.",
              question: "Now assess the quality of life outcome:",
              branches: [
                { id: 'qol_from_cv', text: "Continue to QoL assessment", nextNode: 'qol_assessment' }
              ]
            },
            cv_overthinking: {
              id: 'cv_overthinking',
              situation: "Ti preoccupi che i pazienti non accecati possano riferire il dolore toracico in modo diverso, portando a ulteriori indagini. Questa √® una preoccupazione teorica, ma la commissione giudicatrice ha giudicato sulla base di criteri oggettivi (troponine, ECG), non solo dei resoconti dei pazienti.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE GRADUAL REVEAL: 'Some concerns' isn't wrong, but it may be overcautious. The key question: could knowledge of allocation affect the outcome measurement? For CV events with blinded adjudication using objective criteria, the answer is likely no."
            },
            cv_wrong: {
              id: 'cv_wrong',
              situation: "You rated high risk, but the adjudication was blinded. Open-label status affects outcomes differently. ORBITA showed: exercise time (objective but effort-dependent) was affected by placebo; mortality would not be. Context matters.",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA DOMANDA: chiediti: in che modo l'apertura del cieco potrebbe influenzare QUESTO risultato? Gli eventi CV confermati da giudici in cieco che utilizzano criteri oggettivi non possono essere influenzati dalla conoscenza del trattamento da parte del paziente o dello sperimentatore."
            },
            qol_assessment: {
              id: 'qol_assessment',
              situation: "Per la qualit√† della vita: un infermiere ricercatore (che conosceva l'assegnazione dei pazienti) ha somministrato il questionario. I pazienti sapevano di assumere il farmaco X o il placebo. L'infermiera registrava le risposte e poteva indagare o chiarire le risposte.",
              question: "Risk of bias for QoL outcome measurement?",
              branches: [
                { id: 'qol_low', text: "Low risk ‚Äî it's patient-reported, nurse just recorded", nextNode: 'qol_wrong_low' },
                { id: 'qol_some', text: "Some concerns ‚Äî subtle influence possible", nextNode: 'qol_insufficient' },
                { id: 'qol_high', text: "High risk ‚Äî subjective outcome, unblinded collection", nextNode: 'qol_correct' }
              ]
            },
            qol_wrong_low: {
              id: 'qol_wrong_low',
              situation: "Consider: the nurse knows the patient is on the 'new promising drug.' She asks about symptoms. The patient says 'maybe a bit better.' Unblinded, the nurse might probe: 'So your energy is improved?' Blinded, she'd record neutrally.",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA CONSEGUENZA: gli studi in cieco di SYMPLICITY hanno mostrato un calo della pressione arteriosa di 30 mmHg. Lo studio controllato con procedura simulata ha mostrato 2,4 mmHg. La differenza non era la procedura: era il contesto di misurazione. I risultati soggettivi richiedono l'occultamento."
            },
            qol_insufficient: {
              id: 'qol_insufficient',
              situation: "'Some concerns' understates the risk. The combination of: (1) subjective outcome, (2) unblinded patient, (3) unblinded assessor creates clear bias potential. This is textbook high risk for Domain 4 (measurement of the outcome).",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: Every ORBITA-like situation teaches the same lesson. Subjective outcomes + unblinding = high bias risk. 'Some concerns' is for ambiguous situations. This one is clear."
            },
            qol_correct: {
              id: 'qol_correct',
              situation: "You rate high risk for QoL. Your assessment now shows: CV events (low risk), QoL (high risk). The trial's abstract claims 'Drug X improved quality of life' ‚Äî but you've identified this claim rests on high-risk evidence.",
              question: "Come lo incorpori nella tua meta-analisi?",
              branches: [
                { id: 'exclude_qol', text: "Escludi il risultato QoL dalla sintesi", nextNode: 'exclusion_option' },
                { id: 'include_downgrade', text: "Include but downgrade certainty in GRADE", nextNode: 'best_approach' },
                { id: 'report_both', text: "Report CV events only, ignore QoL", nextNode: 'selective_reporting' }
              ]
            },
            exclusion_option: {
              id: 'exclusion_option',
              situation: "Se escludi tutti i dati QoL ad alto rischio, potresti non avere pi√π nulla da sintetizzare. La maggior parte degli studi sulla qualit√† della vita presentano limitazioni simili. L'esclusione potrebbe non essere pratica.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE WARNING: Excluding high-risk studies is an option, but requires pre-specification. A better approach: include, but transparently report the bias concern and downgrade certainty appropriately."
            },
            best_approach: {
              id: 'best_approach',
              situation: "You include the study, note high RoB for QoL, and when you reach GRADE assessment, you downgrade certainty for risk of bias. Your Summary of Findings table shows: CV events (moderate certainty), QoL (very low certainty).",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: RoB assessment flows into GRADE. High risk of bias ‚Üí downgrade certainty. This is how the system works: identify bias, quantify uncertainty, communicate honestly. Readers see which conclusions are trustworthy."
            },
            selective_reporting: {
              id: 'selective_reporting',
              situation: "Segnalando solo eventi CV, hai nascosto che lo studio affermava benefici in termini di QoL su prove ad alto rischio. Un lettore che controlla lo studio originale si chieder√† perch√© hai omesso un risultato significativo.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE HOOK RETURNS: Selective outcome reporting is a form of bias. Report all pre-specified outcomes, even if some have high RoB. The solution is transparent assessment, not omission."
            }
          }
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "What happens when biased trials drive your pooled estimate?",
          context: "Aprotinin was a blood-clotting drug used in cardiac surgery to reduce bleeding. For years, meta-analyses showed it reduced mortality. Sixty-four trials supported its use. But most were small, unblinded, and industry-funded. The evidence looked overwhelming until someone asked: what happens if we actually assess bias?",
          stats: [
            { value: "64", label: "Trials Showing Benefit", type: "" },
            { value: "Most", label: "High Risk of Bias", type: "danger" },
            { value: "1.53x", label: "True Mortality Risk", type: "danger" },
            { value: "2008", label: "Drug Withdrawn", type: "" }
          ],
          source: "Fergusson et al. NEJM 2008 | BART Trial - NEJM 2008; 358:2319-31",
          decisionScenario: "Stai scrivendo una meta-analisi sull'aprotinina per la chirurgia cardiaca. La tua ricerca ha trovato 64 prove. La maggior parte mostra un beneficio in termini di mortalit√†. Devi decidere come gestire il rischio di bias.",
          pathA: {
            title: "Include all trials ‚Äî more data is better",
            steps: [
              "Pool 64 trials regardless of bias risk",
              "Meta-analysis shows clear mortality benefit",
              "Drug continues widespread use in cardiac surgery",
              "BART trial (properly randomized, n=2,331) finally runs",
              "BART shows aprotinin INCREASES death (RR 1.53)",
              "Trial stopped early for harm, drug withdrawn worldwide"
            ]
          },
          pathB: {
            title: "Exclude high-risk-of-bias trials ‚Äî quality over quantity",
            steps: [
              "Assess bias: most trials small, unblinded, industry-funded",
              "Exclude high-risk trials, pool only low-risk evidence",
              "Benefit disappears when restricted to quality trials",
              "Consiglia di attendere un ampio studio indipendente",
              "BART conferma la tua cautela: il farmaco √® sempre stato dannoso",
              "La tua rigorosa analisi ha prevenuto danni"
            ]
          },
          revelation: "Garbage in, garbage out. A meta-analysis cannot fix the flaws in its component trials. The 64 aprotinin trials looked like overwhelming evidence ‚Äî but they were 64 pieces of biased evidence. When Fergusson assessed risk of bias rigorously, the benefit vanished. The BART trial proved the drug was killing patients. Risk of bias assessment is not academic nitpicking ‚Äî it is the difference between pooling evidence and pooling bias.",
          moduleConnection: "Ecco perch√© la valutazione RoB √® importante. √à necessario valutare ogni prova prima di metterla in pool. Un forest plot di 64 studi distorti non √® una prova: √® rumore organizzato. Il tuo compito √® separare il segnale dal rumore e la valutazione dei bias √® il tuo strumento principale."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Uno studio chirurgico mette a confronto la chirurgia a cielo aperto con la chirurgia laparoscopica. I pazienti e i chirurghi non possono essere accecati. L'outcome primario √® la mortalit√† a 30 giorni (dai registri dei decessi). Qual √® il rischio di distorsione per la misurazione dei risultati?",
          options: [
            { id: 'a', text: "High risk ‚Äî no blinding means high bias", correct: false },
            { id: 'b', text: "Basso rischio: la mortalit√† √® oggettiva e proveniente da registri indipendenti", correct: true },
            { id: 'c', text: "Some concerns ‚Äî lack of blinding always raises concerns", correct: false },
            { id: 'd', text: "Cannot assess without knowing randomization method", correct: false }
          ],
          explanation: "Il rischio di distorsione per la misurazione dei risultati dipende dal fatto che la conoscenza dell'intervento possa influenzare la misurazione. La morte risultante dai registri amministrativi √® oggettiva e non pu√≤ essere influenzata dallo stato di cecit√†. I risultati soggettivi (dolore, funzionalit√†) sarebbero ad alto rischio negli studi in cieco."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've completed the ASSESSMENT phase.\n\n‚úì Module 4: SCREENING studies ‚Äî learned from Vitamin E's contradictory meta-analyses\n‚úì Module 5: EXTRACTING data ‚Äî learned from DECREASE's fabricated numbers\n‚úì Module 6: ASSESSING bias ‚Äî learned from ORBITA's sham surgery revelation\n\nYou can now FIND studies, SELECT them rigorously, EXTRACT data carefully, and ASSESS their trustworthiness.\n\nNext: You'll learn to SYNTHESIZE studies into pooled estimates and INTERPRET what those numbers mean.\n\nThe hardest part begins now ‚Äî the statistics that can deceive even experts."
        }
      }
    ]
  },
  // Module 7: The Effect
  {
    id: 7,
    title: "The Effect",
    subtitle: "Effect Size Calculation",
    principle: 5,
    story: "SSRI",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La media pu√≤ mentire"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CONTROVERSY: SSRI ‚Äî WHEN NUMBERS DECEIVE",
          source: "PLoS Medicine 2008; Kirsch et al | JAMA 2010; Fournier et al | PubMed: 18303940",
          timeline: [
            { year: "1987-2007", text: "SSRIs become the most prescribed psychiatric medications worldwide. Prozac alone earns $2.6 billion annually. Depression treatment is transformed.", type: "normal" },
            { year: "Feb 2008", text: "Kirsch publishes FDA analysis: SSRIs show SMD = 0.32. Below NICE threshold of 0.50 for 'clinical significance.' Media erupts: 'Antidepressants no better than placebo!'", type: "crisis" },
            { year: "The Metric", text: "SMD divides raw difference by standard deviation. High variability ‚Üí small SMD. HDRS has high variability. The same 3-point improvement looks 'trivial' as SMD.", type: "normal" },
            { year: "Jan 2010", text: "Fournier re-analyzes: Mean difference = 2.7 HDRS points. For severe depression (HDRS ‚â•25): MD = 4.4 points. Clinically meaningful by any standard.", type: "revelation" },
            { year: "The Truth", text: "Stessi studi. Stessi pazienti. SMD ha detto \"non clinicamente significativo\". La differenza media ha detto \"aiuta i soggetti gravemente depressi\". La metrica ha scelto la narrazione.", type: "revelation" }
          ],
          realData: {
            endpoint: "Hamilton Depression Rating Scale (HDRS) change",
            drug: "SSRIs pooled",
            placebo: "Placebo pooled",
            rr: "SMD = 0.32 OR Mean Diff = 2.7 points",
            ci: "SMD: 0.24-0.40 | MD: 1.8-3.6",
            nnh: "Different metrics, same data, different stories"
          },
          hook: "THE QUESTION: If a depressed patient improves by 3 points on a 52-point scale, is that 'trivial' (SMD=0.32) or 'meaningful' (returning to normal life)? The metric cannot answer. Only the patient can."
        }
      },
      {
        type: 'content',
        content: {
          title: "Choosing the Right Effect Size",
          sections: [
            {
              heading: "For Binary Outcomes:",
              items: [
                "Risk Ratio (RR): intuitive, but can't pool if baseline risk varies greatly",
                "Odds Ratio (OR): mathematical properties allow pooling, but less intuitive",
                "Risk Difference (RD): absolute effect, varies with baseline risk",
                "Hazard Ratio (HR): for time-to-event outcomes"
              ]
            },
            {
              heading: "For Continuous Outcomes:",
              items: [
                "Mean Difference (MD): same scale ‚Üí easy interpretation",
                "Standardized Mean Difference (SMD/Cohen's d): different scales ‚Üí comparable",
                "Response Ratio: ratio of means, percentage change"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: SELEZIONE DELLA DIMENSIONE DELL'EFFETTO",
          title: "Corrispondenza della dimensione dell'effetto alla domanda",
          sections: [
            {
              heading: "When to Use Mean Difference",
              text: "All studies use the same outcome measure (e.g., all use HDRS for depression). Interpretation is straightforward: 'Treatment reduced depression by 3 points.'"
            },
            {
              heading: "When to Use SMD",
              text: "Studies use different scales measuring the same construct (e.g., HDRS vs BDI for depression). Interpretation requires anchoring: SMD of 0.5 = 'medium effect' in Cohen's conventions, but clinical meaning depends on context."
            },
            {
              heading: "When to Use Risk Ratio",
              text: "Most common for binary outcomes. Intuitive: 'Treatment reduces risk by 25%' (RR=0.75). Problematic when baseline risk varies widely across studies."
            },
            {
              heading: "Converting Between Metrics",
              text: "OR ‚âà RR when outcomes are rare (<10%). SMD ‚âà MD/pooled SD. Hazard ratios require individual patient data for accurate conversion."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'effect-calculator',
          title: "Effect Size Calculator",
          description: "Calculate effect sizes from various input formats"
        }
      },
      {
        type: 'content',
        content: {
          title: "THE GRAVEYARD OF BIOMARKERS: When Big Effects Don't Matter",
          sections: [
            {
              heading: "Homocysteine Lowering ‚Äî NORVIT (2006)",
              items: [
                "Il biomarcatore: omocisteina elevata ‚Üí 3 volte il rischio cardiovascolare (osservazionale studi)",
                "The intervention: B-vitamins dramatically lower homocysteine (30-40% reduction)",
                "The trial: 3,749 post-MI patients. Homocysteine dropped beautifully.",
                "The result: Primary composite RR 1.08 (0.93-1.25). TREND TOWARD HARM.",
                "Source: NEJM 2006 NORVIT"
              ]
            },
            {
              heading: "Niacin + Statin ‚Äî AIM-HIGH (2011) & HPS2-THRIVE (2014)",
              items: [
                "The biomarker: Niacin raises HDL by 25%, lowers triglycerides by 30%",
                "The hope: Adding niacin to statins would save more lives",
                "AIM-HIGH: HR 1,02 (0,87-1,21) per eventi CV ‚Äî NESSUN beneficio",
                "HPS2-THRIVE: RR 0.96 (0.90-1.03) for vascular events ‚Äî but MORE adverse events",
                "25,000+ patients, billions in drug costs, improved biomarkers, ZERO benefit"
              ]
            },
            {
              heading: "THE PATTERN: Effect Size ‚â† Clinical Benefit",
              items: [
                "Homocysteine: Large reduction (30%) ‚Üí no clinical benefit",
                "HDL cholesterol: Large increase (25%) ‚Üí no clinical benefit",
                "HbA1c: Large reduction (ACCORD) ‚Üí INCREASED mortality",
                "LA LEZIONE: un grande effetto su un surrogato non √® un beneficio per un paziente"
              ]
            },
            {
              heading: "THE WARNING: What Metric Matters?",
              items: [
                "Drug companies report biomarker effect sizes (impressive numbers)",
                "Patients care about mortality, hospitalizations, quality of life",
                "Meta-analyses must distinguish: Are we pooling surrogates or patient-important outcomes?",
                "Una meta-analisi sulla riduzione dell'omocisteina mostrerebbe \"prove forti\" ‚Äî della cosa sbagliata"
              ]
            }
          ]
        }
      },
      {
        type: 'scenario',
        content: {
          id: 'effect_scenario',
          title: "Le metriche concorrenti",
          situation: "You're meta-analyzing trials of exercise for depression. Most trials report mean HDRS scores, but three trials report 'response rate' (‚â•50% improvement). You could: (1) convert response rates to means using approximations, (2) report separate analyses, or (3) exclude the three trials.",
          question: "Qual √® l'approccio migliore?",
          choices: [
            {
              id: 'a',
              text: "Convert response rates to approximate means to include all trials",
              consequence: 'bad',
              result: "Le conversioni introducono errori sostanziali e presuppongono distribuzioni normali. L'approssimazione (SMD ‚âà logOR/1,81) presenta un'ampia incertezza. Stai aggiungendo una precisione che non hai."
            },
            {
              id: 'b',
              text: "Report separate analyses: one for continuous, one for binary",
              consequence: 'good',
              result: "Esatto! Ci√≤ mantiene l'integrit√† di ciascuna stima presentando tutte le prove disponibili. I lettori vedono entrambe le analisi e possono valutarne la coerenza."
            },
            {
              id: 'c',
              text: "Exclude the three trials to maintain consistency",
              consequence: 'neutral',
              result: "Accettabile se pre-specificato, ma spreca dati rilevanti. I tre studi possono contenere informazioni importanti su diverse popolazioni o intensit√† di intervento."
            }
          ],
          correct: 'b',
          principle: 5
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A trial reports mean pain scores of 4.2 (SD 2.0) in treatment and 5.8 (SD 2.4) in control (lower = better, N=50 each). What is the approximate SMD (Cohen's d)?",
          options: [
            { id: 'a', text: "-0.73 (favoring treatment)", correct: true },
            { id: 'b', text: "-1.60 (favoring treatment)", correct: false },
            { id: 'c', text: "+0.73 (favoring control)", correct: false },
            { id: 'd', text: "Cannot calculate without individual patient data", correct: false }
          ],
          explanation: "SMD = (Mean1 - Mean2) / pooled SD. Pooled SD ‚âà ‚àö[(2.0¬≤ + 2.4¬≤)/2] ‚âà 2.21. SMD = (4.2 - 5.8) / 2.21 = -1.6 / 2.21 ‚âà -0.73. The negative sign indicates treatment has lower (better) pain scores."
        }
      }
    ]
  },
  // Module 8: The Synthesize
  {
    id: 8,
    title: "The Synthesize",
    subtitle: "Meta-Analysis Models",
    principle: 5,
    story: "ISIS-4",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La media pu√≤ mentire"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA LEZIONE: ISIS-4 ‚Äî QUANDO MENTONO I PICCOLI STUDI",
          source: "Lancet 1995; 345:669-685 | ISIS-4 Collaborative | PubMed: 7661937",
          timeline: [
            { year: "1984-91", text: "Seven small trials (n=1,301 total) show magnesium reduces MI mortality by 55%! OR 0.45 (0.26-0.77). Strong biological rationale exists.", type: "normal" },
            { year: "1992", text: "LIMIT-2 (2,316 patients) confirms benefit: OR 0.74 (0.56-0.99). Enthusiasm grows. Meta-analysis shows clear benefit.", type: "normal" },
            { year: "1992-94", text: "ISIS-4 enrolls 58,050 patients ‚Äî the largest MI trial ever. Magnesium vs control.", type: "normal" },
            { year: "1995", text: "Risultati ISIS-4: mortalit√† 7,64% vs 7,24%. O 1,06 (0,99-1,14). NESSUN vantaggio. I piccoli studi erano SBAGLIATI.", type: "crisis" },
            { year: "The Truth", text: "I piccoli studi sovrastimano gli effetti. I bias di pubblicazione nascondevano piccoli studi negativi. La meta-analisi \"definitiva\" √® stata un artefatto di reporting selettivo.", type: "revelation" }
          ],
          realData: {
            endpoint: "5-week mortality in acute MI",
            drug: "2,216/29,011 (7.64%)",
            placebo: "2,103/29,039 (7.24%)",
            rr: "1.06",
            ci: "0.99-1.14",
            nnh: "No benefit (trend toward harm)"
          },
          hook: "Piccoli studi hanno mostrato una riduzione della mortalit√† del 55%. Il mega-processo non ha mostrato nulla. Questo √® il motivo per cui dobbiamo comprendere l'eterogeneit√†, i grafici a imbuto e gli intervalli di previsione, non solo le stime aggregate."
        }
      },
      {
        type: 'content',
        content: {
          title: "Fixed vs Random Effects",
          sections: [
            {
              heading: "Fixed Effect Model:",
              items: [
                "Assumes ONE true effect size underlying all studies",
                "Le differenze tra gli studi sono solo errori di campionamento",
                "Weights by inverse variance (larger studies count more)",
                "Narrower confidence intervals",
                "Appropriato quando gli studi sono identici in metodi/popolazione"
              ]
            },
            {
              heading: "Random Effects Model:",
              items: [
                "Assumes DISTRIBUTION of true effects across studies",
                "Studies estimate different (but related) effects",
                "Adds between-study variance (œÑ¬≤) to weights",
                "Wider confidence intervals (accounts for heterogeneity)",
                "Gives more weight to small studies than fixed effect"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: SCEGLIERE IL TUO MODELLO",
          title: "Quando raggruppare (e quando non farlo)",
          sections: [
            {
              heading: "Use Fixed Effect When:",
              text: "Gli studi sono metodologicamente identici (stesso protocollo, stessa popolazione, stesso periodo di tempo). Vuoi stimare l'effetto in questo contesto specifico. L'eterogeneit√† tra gli studi √® veramente pari a zero o banale."
            },
            {
              heading: "Use Random Effects When:",
              text: "Studies differ in populations, interventions, or methods. You want to generalize beyond included studies. Heterogeneity is expected (I¬≤ > 0%)."
            },
            {
              heading: "Don't Pool When:",
              text: "Heterogeneity is extreme (I¬≤ > 75% without explanation). Studies measure fundamentally different things. Mixing apples and oranges produces fruit salad, not insight."
            },
            {
              heading: "The Random Effects Caveat:",
              text: "Gli effetti casuali danno pi√π peso agli studi di piccole dimensioni. Se esiste un bias di pubblicazione, √® pi√π probabile che gli studi di piccole dimensioni siano distorti. Gli effetti casuali possono amplificare i bias."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'forest-plot',
          title: "Forest Plot Builder",
          description: "Build interactive forest plots with fixed or random effects"
        }
      },
      {
        type: 'content',
        content: {
          title: "LA SEDUZIONE: meta-analisi cumulativa e falsa fiducia",
          sections: [
            {
              heading: "La storia del magnesio: un avvertimento",
              items: [
                "1984: First small trial shows magnesium reduces MI mortality by 50%",
                "1985-1991: Six more small trials confirm benefit. Cumulative OR 0.45 (0.26-0.77)",
                "1992: LIMIT-2 (2,316 patients) adds to the evidence. OR now 0.56 (0.42-0.76)",
                "I meta-analisti dichiarano: 'Le prove sono conclusive. Ulteriori studi non sono etici.'"
              ]
            },
            {
              heading: "La realt√† del mega-esperimento",
              items: [
                "1995: ISIS-4 enrolls 58,050 patients ‚Äî larger than ALL previous trials combined",
                "Result: 7.64% vs 7.24% mortality. OR 1.06 (0.99-1.14)",
                "The 'conclusive' 50% benefit evaporated entirely",
                "Source: Lancet 2002 MAGIC trial; PubMed 12401244"
              ]
            },
            {
              heading: "What Went Wrong?",
              items: [
                "Small trials: selection bias, publication bias, optimism bias",
                "Cumulative meta-analysis: gave false impression of convergence",
                "Each new small positive trial 'confirmed' previous biased results",
                "Only the mega-trial had power to detect the truth: NO EFFECT"
              ]
            },
            {
              heading: "THE REPETITION: Small Studies Lie, Big Studies Tell Truth",
              items: [
                "This pattern repeats across medicine: TASTE (thrombus aspiration), IABP-SHOCK II (balloon pumps)",
                "Meta-analyses of small trials consistently overestimate benefits",
                "Quando i risultati sono in conflitto in base alla dimensione dello studio, fidarsi degli studi di grandi dimensioni",
                "THE QUESTION: Is your meta-analysis driven by small, potentially biased trials?"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'synthesize_decision_tree',
          title: "The I¬≤ Dilemma",
          scenario: "Your mortality meta-analysis of 12 trials: RR 0.78 (95% CI 0.65-0.93, p=0.006). I¬≤ = 82%. Two small trials show RR 0.3-0.4. Three mega-trials show RR 0.85-0.95. Your co-author wants to headline the 22% mortality reduction.",
          realCase: "ISIS-4: Seven small trials (n=1,301) showed magnesium reduced MI mortality by 55%. Then ISIS-4 (n=58,050) showed OR 1.06. The small studies were wrong. Their pooled estimate was an artifact of publication bias and small-study effects.",
          nodes: {
            start: {
              id: 'start',
              situation: "The forest plot shows clear heterogeneity. Small studies (n<500) cluster around RR 0.35. Large studies (n>2000) cluster around RR 0.90. Random effects gives more weight to the small studies than fixed effects would.",
              question: "Qual √® la tua interpretazione?",
              branches: [
                { id: 'report_pooled', text: "Il RR aggregato 0,78 √® il miglior rapporto riassuntivo it", nextNode: 'pooled_problem' },
                { id: 'investigate_pattern', text: "The pattern suggests small-study effects ‚Äî investigate", nextNode: 'small_study_investigation' },
                { id: 'trust_mega', text: "Trust the mega-trials ‚Äî they have more precise estimates", nextNode: 'mega_trial_bias' }
              ]
            },
            pooled_problem: {
              id: 'pooled_problem',
              situation: "You report RR 0.78. A journal reviewer calculates the prediction interval: RR 0.32-1.89. 'Your CI suggests benefit, but your PI suggests the treatment might double mortality in some settings. This must be in your abstract.'",
              question: "Come rispondi?",
              branches: [
                { id: 'add_pi', text: "Aggiungi l'intervallo di previsione all'abstract", nextNode: 'transparency_path' },
                { id: 'defend_ci', text: "L'CI √® la metrica convenzionale: il PI √® troppo conservativo", nextNode: 'ci_defense_fails' },
                { id: 'reframe_results', text: "Reframe as 'evidence of heterogeneity, no single estimate possible'", nextNode: 'honest_uncertainty' }
              ]
            },
            transparency_path: {
              id: 'transparency_path',
              situation: "Your revised abstract: 'RR 0.78 (95% CI 0.65-0.93); however, substantial heterogeneity (I¬≤=82%) yielded a prediction interval of 0.32-1.89, suggesting benefit varies widely across settings.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE GRADUAL REVEAL: The CI tells you about the average. The PI tells you about the range. When heterogeneity is high, the PI is the clinically relevant metric. It answers: 'What might happen in MY setting?'"
            },
            ci_defense_fails: {
              id: 'ci_defense_fails',
              situation: "The reviewer responds: 'The CI answers the wrong question. Clinicians need to know: will this work in my hospital? With I¬≤=82%, the answer is 'maybe, maybe not.' Your CI creates false certainty.'",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA CONSEGUENZA: ISIS-4 ci ha insegnato questa lezione. Piccoli studi hanno dimostrato una riduzione della mortalit√† del 55%. La mega-prova ha detto 0%. La stima aggregata di piccoli studi era fuorviante. L'eterogeneit√† non √® rumore: √® segnale."
            },
            honest_uncertainty: {
              id: 'honest_uncertainty',
              situation: "Your abstract now states: 'Treatment showed benefit in pooled analysis (RR 0.78), but extreme heterogeneity (I¬≤=82%) precludes a single summary estimate. Effect ranged from RR 0.30 in small studies to 0.95 in mega-trials. Subgroup analysis needed.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Sometimes the honest answer is 'we don't have one number.' When I¬≤ exceeds 75%, consider whether pooling is meaningful at all. The heterogeneity itself becomes the finding."
            },
            small_study_investigation: {
              id: 'small_study_investigation',
              situation: "Esamini i piccoli studi che mostrano RR 0,3-0,4. Entrambi erano monocentrici, entrambi pubblicati dallo stesso gruppo di ricerca, entrambi su riviste con fattori di impatto bassi. Uno √® del 1998, l'altro del 2001. Nessuno dei due √® stato replicato in modo indipendente.",
              question: "What does this pattern suggest?",
              branches: [
                { id: 'pub_bias_suspect', text: "Publication bias ‚Äî small negative trials weren't published", nextNode: 'funnel_analysis' },
                { id: 'fraud_suspect', text: "Possible fraud ‚Äî same group, implausible effects", nextNode: 'fraud_investigation' },
                { id: 'true_heterogeneity', text: "True heterogeneity ‚Äî different populations respond differently", nextNode: 'true_het_explore' }
              ]
            },
            funnel_analysis: {
              id: 'funnel_analysis',
              situation: "Your funnel plot shows clear asymmetry. Egger's test p=0.003. The lower-left quadrant (small negative trials) is empty. Trim-and-fill imputes 4 'missing' studies, changing RR from 0.78 to 0.91 (no longer significant).",
              question: "Come riporti questo?",
              branches: [
                { id: 'report_both', text: "Report original and trim-and-fill adjusted estimates", nextNode: 'balanced_reporting' },
                { id: 'dismiss_trim', text: "Trim-and-fill overcorrects ‚Äî report original only", nextNode: 'selective_reporting' }
              ]
            },
            balanced_reporting: {
              id: 'balanced_reporting',
              situation: "Your results section shows: 'Primary analysis: RR 0.78 (0.65-0.93). Publication bias assessment: funnel plot asymmetric (Egger p=0.003), trim-and-fill adjusted RR 0.91 (0.77-1.08). True effect likely between these estimates.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE HOOK RETURNS: Remember Turner's 2008 analysis ‚Äî 94% of published antidepressant trials were positive vs 51% submitted to FDA. The missing studies change everything. Report the uncertainty, not the convenient estimate."
            },
            selective_reporting: {
              id: 'selective_reporting',
              situation: "Consideri il trim-and-fill come \"eccessivamente conservatore\". Ma l‚Äôasimmetria √® reale. I piccoli studi negativi mancanti, se pubblicati, cambierebbero radicalmente la tua conclusione. Stai riportando una letteratura parziale, non la verit√†.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE WARNING: Trim-and-fill isn't perfect, but neither is ignoring funnel asymmetry. When Egger's p<0.10 and the funnel is visibly asymmetric, missing-study bias is plausible. Report both estimates and discuss the implications honestly."
            },
            fraud_investigation: {
              id: 'fraud_investigation',
              situation: "Scavi pi√π a fondo nei due studi anomali. Entrambi riportano SD identiche tra i gruppi. Le caratteristiche di base sono perfettamente abbinate. Il follow-up √® del 100% in entrambi. Il campanello d'allarme 'troppo bello per essere vero' suona.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE QUESTION: DECREASE showed the same patterns. When small studies drive your meta-analysis result with implausible precision, investigate. You can't prove fraud, but you can conduct sensitivity analysis excluding suspicious studies."
            },
            true_het_explore: {
              id: 'true_het_explore',
              situation: "Tu ipotizzi: forse i piccoli studi hanno utilizzato popolazioni di pazienti diverse (pi√π malati? sottogruppi specifici?). Ma controllando le caratteristiche: i mega-studi in realt√† avevano pazienti a rischio PI√ô ALTO. L'effetto del piccolo studio non √® spiegato dal case mix.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: When you can't explain heterogeneity by study characteristics, three explanations remain: chance, publication bias, or methodological differences. Each has different implications. Don't assume true heterogeneity without evidence."
            },
            mega_trial_bias: {
              id: 'mega_trial_bias',
              situation: "Ti concentri sulle mega-prove: RR ~0,90. Ma il tuo coautore sostiene: \"I mega-trial arruolano pazienti medi\". I piccoli studi potrebbero aver trovato popolazioni che realmente beneficiano di pi√π. Stai sprecando un segnale importante.'",
              question: "Who's right?",
              branches: [
                { id: 'mega_right', text: "Mega-trials are more reliable ‚Äî larger N means better estimate", nextNode: 'mega_wins' },
                { id: 'both_valid', text: "Both have value ‚Äî need subgroup analysis to understand", nextNode: 'subgroup_exploration' }
              ]
            },
            mega_wins: {
              id: 'mega_wins',
              situation: "Segnali solo la stima del mega-esperimento. Ma l‚ÄôISIS-4 ce lo ha insegnato: i mega-trial rispondono a una domanda (effetto medio su un‚Äôampia popolazione). Piccoli studi potrebbero rispondere a una domanda diversa (effetto in popolazioni specifiche). Entrambi potrebbero essere \"giusti\".",
              isEnding: true,
              outcome: 'neutral',
              lesson: "LA RIVELAZIONE GRADUALE: ISIS-4 vs piccoli studi non erano necessariamente \"sbagliati vs giusti\" - potrebbero essere \"domande diverse\". I piccoli studi hanno studiato i pazienti entro 6 ore dall'IM. ISIS-4 √® iscritto fino a 24 ore. Il trattamento precoce potrebbe davvero funzionare meglio."
            },
            subgroup_exploration: {
              id: 'subgroup_exploration',
              situation: "You conduct pre-specified subgroup analysis: time to treatment, patient age, disease severity. Time to treatment shows interaction (p=0.02): early treatment RR 0.65, late treatment RR 0.98. The small studies all used early treatment.",
              isEnding: true,
              outcome: 'good',
              lesson: "LA PROTEZIONE: l'eterogeneit√† pu√≤ contenere informazioni. Il trattamento funziona, ma solo all‚Äôinizio. ISIS-4 ha diluito il segnale includendo i pazienti in ritardo. L'analisi dei sottogruppi (se pre-specificata) pu√≤ recuperare risultati significativi da dati eterogenei."
            }
          }
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "E se gli stessi dati, analizzati in due modi, fornissero conclusioni opposte?",
          context: "Early surfactant administration in preterm infants was studied in multiple trials. Cochrane reviews synthesized the evidence. But a fascinating phenomenon emerged: the same trials, pooled with different statistical models, yielded different conclusions. One model said 'significant benefit.' The other said 'not significant.' Both were technically correct. Both could not both be true.",
          stats: [
            { value: "p=0.03", label: "Fixed-Effect Model", type: "success" },
            { value: "p=0.12", label: "Random-Effects Model", type: "" },
            { value: "I¬≤=45%", label: "Heterogeneity", type: "" },
            { value: "Opposite", label: "Conclusions", type: "danger" }
          ],
          source: "Cochrane Neonatal Reviews | Soll RF, Morley CJ",
          decisionScenario: "You are analyzing surfactant trials for preterm infants. Your meta-analysis shows moderate heterogeneity (I¬≤=45%). You must choose between fixed-effect and random-effects models.",
          pathA: {
            title: "Use fixed-effect model",
            steps: [
              "Assume all trials estimate one true effect",
              "Weight by inverse variance (large trials dominate)",
              "Get narrower confidence interval",
              "Result: RR 0.82 (95% CI: 0.69-0.98), p=0.03",
              "Conclusion: Significant benefit, recommend early surfactant",
              "But you assumed homogeneity when I¬≤=45% suggested otherwise"
            ]
          },
          pathB: {
            title: "Use random-effects model",
            steps: [
              "Assume trials estimate a distribution of effects",
              "Add between-study variance to weights",
              "Get wider confidence interval",
              "Result: RR 0.82 (95% CI: 0.64-1.05), p=0.12",
              "Conclusion: Non-significant, insufficient evidence",
              "Hai riconosciuto la variazione, ma hai perso la significativit√† statistica"
            ]
          },
          revelation: "The choice of model is not technical ‚Äî it is philosophical. Fixed-effect asks: 'What is THE effect?' Random-effects asks: 'What is the AVERAGE effect across different settings?' When heterogeneity exists, these are different questions with different answers. Neither model is 'wrong.' But pretending homogeneity exists when it doesn't is a lie your statistics tell.",
          moduleConnection: "Ecco perch√© la scelta del modello √® importante. La stessa stima puntuale (RR 0,82) diventa significativa o non significativa in base alle tue ipotesi. Prespecificare un modello primario, quindi segnalare il modello alternativo come analisi di sensibilit√† quando esiste eterogeneit√†."
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "What does it mean when a confidence interval barely excludes 1.0?",
          context: "In 2007, Steve Nissen published a meta-analysis of rosiglitazone (Avandia), a blockbuster diabetes drug. Forty-two trials. Twenty-eight thousand patients. The forest plot showed something disturbing: the pooled odds ratio for myocardial infarction was 1.43, with a 95% CI of 1.03-1.98. The confidence interval barely excluded 1.0. Some dismissed it as 'barely significant.' But Nissen saw a 43% increase in heart attacks.",
          stats: [
            { value: "42", label: "Trials Pooled", type: "" },
            { value: "28,000", label: "Patients", type: "" },
            { value: "1.43", label: "Odds Ratio per MI", type: "danger" },
            { value: "1.03-1.98", label: "95% CI", type: "" }
          ],
          source: "Nissen SE, Wolski K. NEJM 2007; 356:2457-71",
          decisionScenario: "Vedi l'appezzamento forestale di rosiglitazone. L'IC √® 1,03-1,98. Il limite inferiore esclude a malapena 1,0. Il tuo collega dice \"√à poco significativo, potrebbe essere rumore.\"",
          pathA: {
            title: "Focus on statistical significance ‚Äî 'just barely' means uncertain",
            steps: [
              "Note CI barely excludes 1.0",
              "Argue result could be due to chance",
              "Raccomanda di attendere ulteriori dati",
              "Drug continues widespread use",
              "Thousands more MIs occur while waiting",
              "Eventually FDA issues black-box warning anyway"
            ]
          },
          pathB: {
            title: "Focus on clinical significance ‚Äî 43% more heart attacks matters",
            steps: [
              "Point estimate is 43% increased MI risk",
              "Even lower CI bound (3% increase) is clinically meaningful",
              "28.000 pazienti non sono uno studio piccolo",
              "Raccomanda una revisione immediata della FDA",
              "FDA issues black-box warning",
              "European regulators withdraw the drug"
            ]
          },
          revelation: "Statistical significance is a threshold. Clinical significance is a judgment. The forest plot shows both ‚Äî you must see both. A 43% increase in heart attacks is not 'barely' anything. It is a signal that thousands of patients are being harmed. Nissen's meta-analysis changed practice because he understood: the question is not 'Is p < 0.05?' The question is 'Are patients being hurt?'",
          moduleConnection: "This is why forest plots matter. They show you not just the pooled estimate, but the precision and the clinical meaning. A CI of 1.03-1.98 tells you: even in the best case, MI risk is increased. The worst case is doubled. That is not statistical noise ‚Äî that is a drug that should not be on the market."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Una meta-analisi a effetti casuali fornisce di pi√π peso a piccoli studi rispetto a un‚Äôanalisi a effetti fissi. Perch√© questo √® potenzialmente problematico?",
          options: [
            { id: 'a', text: "Small studies have larger sampling error", correct: false },
            { id: 'b', text: "I piccoli studi hanno maggiori probabilit√† di essere pubblicati se mostrano risultati positivi", correct: true },
            { id: 'c', text: "Small studies use inferior methodology", correct: false },
            { id: 'd', text: "Small studies measure different outcomes", correct: false }
          ],
          explanation: "I bias di pubblicazione incidono in modo sproporzionato sui piccoli studi: i piccoli studi negativi spesso non vengono pubblicati, mentre quelli positivi riescono a sopravvivere. Dando pi√π peso a piccoli studi, gli effetti casuali possono amplificare questa distorsione, producendo stime aggregate gonfiate."
        }
      }
    ]
  },
  // Module 9: The Heterogeneity
  {
    id: 9,
    title: "The Heterogeneity",
    subtitle: "Beyond I-squared",
    principle: 5,
    story: "ACCORD",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La media pu√≤ mentire"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE PARADOX: ACCORD ‚Äî WHEN AVERAGES KILL",
          source: "NEJM 2008; 358:2545-2559 | ACCORD Study Group | PubMed: 18539917",
          timeline: [
            { year: "1998-2007", text: "Multiple trials suggest intensive glucose control (HbA1c < 7%) reduces complications. Meta-analyses support benefit.", type: "normal" },
            { year: "2003", text: "ACCORD begins: 10,251 diabetics randomized to intensive (HbA1c < 6.0%) vs standard (7.0-7.9%) control.", type: "normal" },
            { year: "Feb 2008", text: "DSMB stops intensive arm early. 257 deaths vs 203. HR 1.22 (95% CI: 1.01-1.46). p = 0.04.", type: "crisis" },
            { year: "The Paradox", text: "HbA1c lowered successfully (6.4% vs 7.5%). But MORE people died. The surrogate improved while patients worsened.", type: "crisis" },
            { year: "The Truth", text: "Subgroups diverged: patients with long diabetes duration, prior CVD, or hypoglycemic episodes were harmed. The average masked lethal heterogeneity.", type: "revelation" }
          ],
          realData: {
            endpoint: "All-cause mortality",
            drug: "257/5,128 (5.0%)",
            placebo: "203/5,123 (4.0%)",
            rr: "1.22",
            ci: "1.01-1.46",
            nnh: "95"
          },
          hook: "La media ha mostrato danni. Ma la media non √® una persona. Da qualche parte in quella media c‚Äôerano i pazienti che ne hanno beneficiato. E pazienti che sono morti. L'eterogeneit√† non √® un fastidio: √® dove si nasconde la verit√†."
        }
      },
      {
        type: 'content',
        content: {
          title: "Understanding Heterogeneity Metrics",
          sections: [
            {
              heading: "I¬≤ ‚Äî Percentage of Variance Due to Heterogeneity",
              items: [
                "0%: no heterogeneity (differences due to sampling only)",
                "25%: low heterogeneity",
                "50%: moderate heterogeneity",
                "75%+: high heterogeneity",
                "Limitation: depends on precision, not just variability"
              ]
            },
            {
              heading: "œÑ¬≤ ‚Äî Between-Study Variance",
              items: [
                "Absolute measure of heterogeneity",
                "Same units as effect size (squared)",
                "Doesn't depend on number or size of studies",
                "Harder to interpret directly"
              ]
            },
            {
              heading: "Prediction Interval ‚Äî The Crucial Metric",
              items: [
                "Dove si troverebbe il vero effetto in un NUOVO studio?",
                "Incorpora sia CI che eterogeneit√†",
                "If it crosses null, treatment may not work everywhere",
                "La domanda clinicamente rilevante"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "THE METODO: ESPLORARE L'ETEROGENEIT√Ä",
          title: "Trovare il segnale nel rumore",
          sections: [
            {
              heading: "Visual Inspection",
              text: "Guarda il diagramma della foresta. Gli intervalli di confidenza si sovrappongono? Ci sono valori anomali? Esiste uno schema (studi piccoli vs studi grandi, vecchi vs nuovi)?"
            },
            {
              heading: "Subgroup Analysis",
              text: "Pre-specified comparisons: dose, duration, population, risk of bias. Test for interaction (is the effect different between subgroups?). Beware multiple testing."
            },
            {
              heading: "Meta-Regression",
              text: "Dimensione dell'effetto del modello in funzione delle caratteristiche dello studio. Richiede pi√π di 10 studi per covariata. Rischio di errore ecologico: le associazioni a livello di studio potrebbero non riflettere il livello di paziente."
            },
            {
              heading: "Sensitivity Analysis",
              text: "Leave-one-out: ogni singolo studio determina il risultato? RoB alto vs basso: la qualit√† conta? Fisso vs casuale: la scelta del modello cambia la conclusione?"
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'heterogeneity-explorer',
          title: "Heterogeneity Explorer",
          description: "Visualizzare e interpretare I¬≤, œÑ¬≤ e intervalli di previsione"
        }
      },
      {
        type: 'content',
        content: {
          title: "THE TRAP: False Class Effects ‚Äî HES Fluids in Sepsis",
          sections: [
            {
              heading: "The Assumption",
              items: [
                "Colloid fluids (HES, albumin) maintain intravascular volume better than crystalloids",
                "Per decenni, questo era \"noto\" - aveva senso fisiologico",
                "Meta-analyses pooled all colloids vs crystalloids, assuming class effect"
              ]
            },
            {
              heading: "Prova 6S (2012) - La prima Crack",
              items: [
                "798 patients with severe sepsis: HES vs Ringer's acetate",
                "90-day mortality: RR 1.17 (95% CI: 1.01-1.36) ‚Äî HES HARMFUL",
                "Renal replacement therapy: RR 1.35 (1.01-1.80) ‚Äî HES caused kidney failure",
                "Source: NEJM 2012; PubMed 22738085"
              ]
            },
            {
              heading: "CHEST Trial (2012) ‚Äî Confirmation",
              items: [
                "7,000 ICU patients: HES vs saline",
                "90-day mortality: RR 1.06 (0.96-1.18) ‚Äî trend toward harm",
                "Renal replacement: RR 1.21 (1.00-1.45) ‚Äî significant kidney harm",
                "Source: NEJM 2012; DOI 10.1056/NEJMoa1209759"
              ]
            },
            {
              heading: "THE WARNING: Class Effects Are Hypotheses, Not Facts",
              items: [
                "HES, albumina e altri colloidi NON sono intercambiabili",
                "Una meta-analisi che ha messo insieme 'tutti i colloidi' ha nascosto che l'HES era specificamente dannoso",
                "Heterogeneity within a drug class can be life-or-death",
                "THE QUESTION: When you pool 'Drug Class X', are you assuming equivalence you can't prove?"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'heterogeneity_decision_tree',
          title: "Il problema dell'intervallo di previsione",
          scenario: "Drug X for fracture prevention: 8 trials, RR 0.70 (95% CI 0.58-0.85). I¬≤ = 68%. Prediction interval: RR 0.42-1.17. Your hospital committee asks: 'Should we add Drug X to formulary?'",
          realCase: "ACCORD ha mostrato un controllo intensivo del glucosio \"ha funzionato\" in media: l'HbA1c √® sceso dall'8,1% al 6,4%. Ma alcuni pazienti sono morti. L'eterogeneit√† media dei sottogruppi letali mascherati. Conoscere la media non √® sufficiente.",
          nodes: {
            start: {
              id: 'start',
              situation: "Il presidente della commissione afferma: 'RR 0,70 significa una riduzione della frattura del 30%. CI esclude 1.0. Questa √® una prova evidente. Approviamolo.' Il tuo farmacista clinico solleva la questione dell'intervallo di previsione.",
              question: "Come spieghi l'intervallo di previsione al comitato?",
              branches: [
                { id: 'explain_pi', text: "L'investigatore ci dice cosa aspettarci nel NOSTRO ospedale", nextNode: 'pi_explanation' },
                { id: 'support_chair', text: "Il presidente ha ragione: CI √® ci√≤ che conta per l'\"effetto medio\"", nextNode: 'chair_mistake' },
                { id: 'explore_heterogeneity', text: "Before deciding, we need to understand WHY effects vary", nextNode: 'heterogeneity_exploration' }
              ]
            },
            pi_explanation: {
              id: 'pi_explanation',
              situation: "You explain: 'The CI tells us we're confident the average is between 0.58-0.85. But our hospital isn't average. The PI tells us: in a new setting like ours, the true effect could range from 58% reduction to 17% INCREASE in fractures.'",
              question: "Il Il presidente chiede: \"Come pu√≤ un farmaco che funziona mediamente danneggiare alcuni pazienti?\"",
              branches: [
                { id: 'accord_example', text: "Use ACCORD as an example ‚Äî average benefit, subgroup harm", nextNode: 'accord_lesson' },
                { id: 'technical_explanation', text: "Explain œÑ¬≤ and between-study variance mathematically", nextNode: 'lost_committee' },
                { id: 'practical_implications', text: "Concentrarsi su cosa questo significa per la decisione sul formulario", nextNode: 'practical_path' }
              ]
            },
            accord_lesson: {
              id: 'accord_lesson',
              situation: "You explain ACCORD: 'Intensive glucose control lowered average HbA1c beautifully. But the trial was stopped ‚Äî 257 deaths vs 203. Patients with long diabetes duration, prior CVD, or hypoglycemia were harmed while others benefited. The average masked the harm.'",
              question: "Il comitato chiede: \"Allora cosa facciamo con il farmaco X?\"",
              branches: [
                { id: 'conditional_approval', text: "Approve with restrictions ‚Äî identify who benefits", nextNode: 'smart_approval' },
                { id: 'reject_drug', text: "Reject until we understand the heterogeneity", nextNode: 'cautious_rejection' }
              ]
            },
            smart_approval: {
              id: 'smart_approval',
              situation: "Tu proponi: \"Approvare il farmaco X per i pazienti che corrispondono agli studi clinici in cui ha funzionato meglio\". Osservando il forest plot: gli studi condotti su pazienti ad alto rischio (frattura precedente) mostrano RR 0,55. Gli studi condotti su pazienti a rischio moderato mostrano un RR 0,95.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Heterogeneity can guide personalization. Instead of giving everyone 'average' treatment, identify who benefits most. This is precision medicine informed by meta-analysis. The PI flagged that one size doesn't fit all."
            },
            cautious_rejection: {
              id: 'cautious_rejection',
              situation: "The committee delays approval pending subgroup analysis. Three months later, you present: 'Drug X works in high-risk patients (RR 0.55) but not low-risk (RR 0.98). We should approve for high-risk only.'",
              isEnding: true,
              outcome: 'good',
              lesson: "LA RIVELAZIONE GRADUALE: era necessaria cautela. L‚Äôapprovazione universale avrebbe esposto i pazienti a basso rischio a effetti collaterali senza alcun beneficio. Il PI che attraversa 1.0 era un segnale di avvertimento che il farmaco non funzionava ovunque."
            },
            lost_committee: {
              id: 'lost_committee',
              situation: "You explain œÑ¬≤ = 0.15, meaning between-study variance in log RR. The committee's eyes glaze over. The chair says: 'Let's just go with the significant CI.' Your technical accuracy didn't translate to better decision-making.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "L'AVVERTIMENTO: la correttezza tecnica non √® sufficiente. I decisori hanno bisogno di una traduzione clinica. \"Il farmaco potrebbe danneggiare alcuni pazienti\" √® pi√π chiaro di \"œÑ¬≤ √® alto\". Comunica l'incertezza in termini che contano per il tuo pubblico."
            },
            practical_path: {
              id: 'practical_path',
              situation: "You reframe: 'If we approve Drug X for everyone, most will benefit. But some ‚Äî we don't know exactly who ‚Äî might have MORE fractures. Are we comfortable with that uncertainty, or should we restrict approval?'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE QUESTION: The PI doesn't tell you what to do ‚Äî it tells you what you don't know. The decision depends on risk tolerance, reversibility of harm, and whether you can identify who's at risk. Frame uncertainty, let the committee decide."
            },
            chair_mistake: {
              id: 'chair_mistake',
              situation: "You support the chair. Drug X is approved for all patients. One year later: audit shows fracture rates unchanged in your low-risk patients, but two high-risk patients had adverse events. The drug wasn't harmful 'on average' ‚Äî but averages don't treat patients.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE CONSEQUENCE: ACCORD killed patients because decisions were based on averages. The CI told them 'the average benefits.' The truth was: some people benefit, some people die. The PI would have flagged this. You ignored the warning."
            },
            heterogeneity_exploration: {
              id: 'heterogeneity_exploration',
              situation: "You suggest: 'Before deciding, let's look at WHY effects vary.' You examine the 8 trials. Pattern emerges: 4 trials in high-risk patients (prior fracture) ‚Äî RR 0.55. 4 trials in moderate-risk patients ‚Äî RR 0.95.",
              question: "Cosa spiega questo modello?",
              branches: [
                { id: 'biological_explanation', text: "High-risk patients have more room to benefit", nextNode: 'subgroup_insight' },
                { id: 'trial_quality', text: "Maybe the high-risk trials had methodological problems", nextNode: 'quality_check' },
                { id: 'chance', text: "Potrebbe essere un caso con studi 4 contro 4", nextNode: 'credibility_assessment' }
              ]
            },
            subgroup_insight: {
              id: 'subgroup_insight',
              situation: "Biological plausibility: Drug X strengthens bones. Patients with prior fractures have weaker bones ‚Äî more potential for improvement. Patients with already-strong bones can't get much stronger. The heterogeneity reflects biology, not noise.",
              question: "In che modo questo cambia la tua raccomandazione?",
              branches: [
                { id: 'targeted_therapy', text: "Recommend Drug X only for high-risk patients", nextNode: 'precision_medicine' },
                { id: 'broad_approval', text: "Still approve broadly ‚Äî moderate-risk isn't harmed", nextNode: 'missed_opportunity' }
              ]
            },
            precision_medicine: {
              id: 'precision_medicine',
              situation: "Your recommendation: 'Formulary approval restricted to patients with prior fragility fracture, T-score ‚â§-2.5, or FRAX ‚â•20%.' The committee adopts this. Drug costs decrease (fewer treated), outcomes improve (treating responders).",
              isEnding: true,
              outcome: 'good',
              lesson: "THE REVELATION: The prediction interval wasn't a problem ‚Äî it was information. By understanding heterogeneity, you turned 'average effect' into personalized medicine. This is the positive use of Principle 6: The average can lie ‚Äî but the subgroups tell truth."
            },
            missed_opportunity: {
              id: 'missed_opportunity',
              situation: "Il farmaco X √® approvato per tutti. I pazienti ad alto rischio ne traggono beneficio. I pazienti a rischio moderato assumono pillole ogni giorno senza alcun beneficio, sperimentano effetti collaterali e sostengono costi. Avevi le informazioni per fare meglio, ma hai calcolato la media.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: 'Not harmful on average' isn't the same as 'beneficial for everyone.' ACCORD, ISIS-4, and countless meta-analyses show: heterogeneity is information. When the PI is wide, ask who benefits ‚Äî don't just treat everyone."
            },
            quality_check: {
              id: 'quality_check',
              situation: "You check: the high-risk trials have low RoB (proper blinding, allocation concealment). The moderate-risk trials also have low RoB. Trial quality doesn't explain the difference. The effect modification seems real.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Before trusting subgroup findings, verify they aren't confounded by study quality. Here, both subgroups have similar RoB. The differential effect is more likely to be real when quality is balanced."
            },
            credibility_assessment: {
              id: 'credibility_assessment',
              situation: "You apply ICEMAN criteria: Is the subgroup pre-specified? (Yes) Is the effect consistent in direction? (Yes) Is there biological plausibility? (Yes) Is the test of interaction significant? (p = 0.03) Credibility: moderate-high.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE GRADUAL REVEAL: Not all subgroup analyses are created equal. ICEMAN criteria help distinguish real effect modification from data dredging. When multiple criteria are met, you can cautiously act on the subgroup finding."
            }
          }
        }
      },
      {
        type: 'real-world-story',
        content: {
          rhetoricalQuestion: "Seven small trials agree. Then one large trial disagrees. Who is right?",
          context: "In the early 1990s, magnesium sulfate for acute myocardial infarction looked like a miracle. Seven small trials (total n=1,301) showed magnesium reduced mortality by 55%. A meta-analysis declared the evidence 'conclusive.' Some argued further trials were unethical. Then came ISIS-4 ‚Äî a mega-trial of 58,050 patients. The result shocked the field.",
          stats: [
            { value: "OR 0.44", label: "Small Trials Pooled", type: "success" },
            { value: "55%", label: "Claimed Mortality Reduction", type: "" },
            { value: "OR 1.06", label: "ISIS-4 Result", type: "danger" },
            { value: "58,050", label: "ISIS-4 Patients", type: "" }
          ],
          source: "ISIS-4 Collaborative Group. Lancet 1995; 345:669-85",
          decisionScenario: "Stai mettendo insieme gli studi sul magnesio per l'infarto miocardico acuto. La tua meta-analisi di piccoli studi mostra OR 0,44 (forte beneficio). Quindi ISIS-4 pubblica mostrando OR 1.06 (nessun vantaggio). L'eterogeneit√† √® enorme.",
          pathA: {
            title: "Assume homogeneity ‚Äî pool all trials together",
            steps: [
              "Includi sia piccoli studi che ISIS-4 in un'unica analisi",
              "Pooled estimate: somewhere between 0.44 and 1.06",
              "Result is a meaningless 'average' of contradictory findings",
              "CI is wide, heterogeneity is extreme",
              "Clinicians confused: does magnesium work or not?",
              "No one learns WHY the trials disagreed"
            ]
          },
          pathB: {
            title: "Investiga sull'eterogeneit√†: trova il messaggio nel rumore",
            steps: [
              "Ask: what differs between small trials and ISIS-4?",
              "Small trials: treatment within 6 hours of symptom onset",
              "ISIS-4: treatment up to 24 hours after symptom onset",
              "Hypothesis: magnesium works early but not late",
              "Subgroup analysis confirms time-dependent effect",
              "Scopri la modificazione dell'effetto, non la contraddizione"
            ]
          },
          revelation: "Heterogeneity is not noise. It is a message. The I¬≤ statistic tells you someone is different ‚Äî your job is to find out who. ISIS-4 was not 'wrong' and the small trials were not 'wrong.' They were answering different questions. Early magnesium might work. Late magnesium does not. The pooled estimate obscured the truth that subgroup analysis revealed.",
          moduleConnection: "This is why heterogeneity exploration matters. When your I¬≤ is high and studies conflict, you have three options: (1) pool anyway and get a meaningless average, (2) refuse to pool and waste data, or (3) investigate and discover what your data is trying to tell you. Option 3 is usually correct."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Two meta-analyses both show I¬≤ = 50%. Analysis A has œÑ¬≤ = 0.02 with mean RR 0.80. Analysis B has œÑ¬≤ = 0.50 with mean RR 0.80. What does this tell you?",
          options: [
            { id: 'a', text: "They have identical heterogeneity since I¬≤ is the same", correct: false },
            { id: 'b', text: "Analysis B has much more absolute variability in true effects", correct: true },
            { id: 'c', text: "L'analisi A √® pi√π affidabile", correct: false },
            { id: 'd', text: "Cannot compare without knowing number of studies", correct: false }
          ],
          explanation: "I¬≤ is a proportion (% variance due to heterogeneity) but œÑ¬≤ is absolute between-study variance. Two analyses can have identical I¬≤ but very different œÑ¬≤. Analysis B has 25√ó more absolute heterogeneity ‚Äî the true effects are far more spread out, meaning wider prediction intervals and more uncertainty about any specific application."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've mastered the SYNTHESIS phase.\n\n‚úì Module 7: EFFECT SIZES ‚Äî learned from SSRI's metric controversy\n‚úì Module 8: META-ANALYSIS MODELS ‚Äî learned from ISIS-4's small-study deception\n‚úì Module 9: HETEROGENEITY ‚Äî learned from ACCORD's lethal subgroups\n\nYou can now calculate pooled estimates, choose appropriate models, and interpret heterogeneity.\n\nFinal phase: QUALITY ASSURANCE ‚Äî detecting publication bias, rating certainty with GRADE, and reporting transparently.\n\nRemember: A beautiful forest plot means nothing if you've pooled garbage."
        }
      }
    ]
  },
  // Module 10: The Bias
  {
    id: 10,
    title: "The Bias",
    subtitle: "Publication Bias",
    principle: 6,
    story: "Antidepressants",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Certainty must be justified"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA RIVELAZIONE: TURNER'S EXPOS√â - LA MET√Ä MANCANTE",
          source: "NEJM 2008; 358:252-260 | Turner et al | PubMed: 18199864",
          timeline: [
            { year: "1987-2004", text: "12 antidepressivi approvati dalla FDA. Le aziende farmaceutiche sottopongono 74 studi alle autorit√† di regolamentazione. La letteratura pubblicata mostra che questi farmaci funzionano meravigliosamente.", type: "normal" },
            { year: "2006", text: "Turner, a former FDA reviewer, gains access to the FDA's internal trial database. He compares what FDA saw vs. what doctors read.", type: "normal" },
            { year: "The Count", text: "La FDA ha ricevuto 74 studi. 38 sono risultati positivi. 36 erano negativi o discutibili. La FDA ha riscontrato il 51% di positivit√†. Cosa hanno pubblicato le riviste?", type: "normal" },
            { year: "The Revelation", text: "Di 38 studi positivi: 37 pubblicati (97%). Su 36 studi negativi: 14 pubblicati (39%) e 11 di questi 14 sono stati 'rigirati' per apparire positivi.", type: "crisis" },
            { year: "Jan 2008", text: "Turner publishes: Published literature shows 94% positive trials. Reality: 51%. Effect sizes inflated 32%. Doctors prescribing based on a mirage.", type: "crisis" },
            { year: "The Question", text: "Quanti pazienti sono stati danneggiati da farmaci che 'funzionavano' nelle pubblicazioni ma non funzionavano nella realt√†? Non lo sapremo mai. Lo schedario li ha uccisi in silenzio.", type: "revelation" }
          ],
          realData: {
            endpoint: "Trial outcomes as assessed by FDA",
            drug: "74 trials submitted to FDA",
            placebo: "Published literature",
            rr: "FDA: 51% positive | Published: 94% positive",
            ci: "Effect size inflation: +32%",
            nnh: "Il divario tra verit√† e letteratura"
          },
          hook: "L'AVVERTIMENTO: ogni meta-analisi della letteratura pubblicata √® una meta-analisi di ci√≤ che l'industria voleva che tu vedessi. Lo schedario √® il luogo in cui le verit√† scomode vanno a morire. Turner ha dimostrato ci√≤ che tutti sospettavano: abbiamo letto narrativa travestita da scienza."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY TAKEAWAY: Turner proved that 94% of published antidepressant trials showed benefit while only 51% actually did. Effect sizes were inflated by 32%. Every meta-analysis you read is a summary of what survived the filing cabinet ‚Äî and the filing cabinet is full of inconvenient truths that never saw daylight."
        }
      },
      {
        type: 'content',
        content: {
          title: "THE LESSON: When One Positive Trial Drove Guidelines ‚Äî PROWESS",
          sections: [
            {
              heading: "The Single Hero Trial (2001)",
              items: [
                "PROWESS: 1,690 patients with severe sepsis. Activated Protein C (APC) vs placebo.",
                "Result: 28-day mortality 24.7% vs 30.8%. RR 0.81 (0.70-0.93). p = 0.005.",
                "FDA approves. Guidelines recommend APC for severe sepsis. Cost: $8,000/treatment.",
                "PROWESS diventa l'UNICA prova. Nessuna replica richiesta."
              ]
            },
            {
              heading: "Le repliche fallite (2005-2011)",
              items: [
                "ADDRESS trial (2005): Low-risk sepsis. Stopped early ‚Äî trend toward HARM in some subgroups.",
                "RESOLVE trial (2007): Pediatric sepsis. No benefit, more bleeding.",
                "Meta-analysts kept pooling: 'Overall still favors APC.' PROWESS dominated every meta-analysis."
              ]
            },
            {
              heading: "Il test definitivo - PROWESS-SHOCK (2012)",
              items: [
                "1,697 patients with septic shock. Rigorous replication of original PROWESS.",
                "Result: 28-day mortality 26.4% vs 24.2%. RR 1.09 (0.92-1.28).",
                "NO BENEFIT. Drug withdrawn from market worldwide.",
                "Source: NEJM 2012; PubMed 22616830"
              ]
            },
            {
              heading: "L'AVVERTIMENTO: Leave-One-Out avrebbe mostrato Questo",
              items: [
                "Every meta-analysis of APC was driven by PROWESS alone",
                "Remove PROWESS ‚Üí no significant effect remained",
                "One trial shouldn't drive guidelines. One trial shouldn't drive meta-analyses.",
                "LA DOMANDA: I risultati della meta-analisi sono sufficienti per rimuovere lo studio pi√π grande/primo?"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Detecting Publication Bias",
          sections: [
            {
              heading: "Funnel Plot",
              items: [
                "Plot effect size vs precision (SE or sample size)",
                "Symmetry expected if no bias: small studies scatter evenly",
                "Asymmetry suggests: publication bias, small-study effects, or true heterogeneity"
              ]
            },
            {
              heading: "Statistical Tests",
              items: [
                "Egger's test: regression of effect on SE (intercept ‚â† 0 suggests asymmetry)",
                "Peter's test: for binary outcomes, uses sample size",
                "Begg's test: rank correlation (less powerful)",
                "Note: all tests have low power with <10 studies"
              ]
            },
            {
              heading: "Contour-Enhanced Funnels",
              items: [
                "Shade regions by statistical significance",
                "If missing studies cluster in non-significant region ‚Üí publication bias likely",
                "If asymmetry spans significance zones ‚Üí may be other small-study effects"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: VALUTAZIONE E AGGIUSTAMENTO",
          title: "Oltre il Funnel Plot",
          sections: [
            {
              heading: "Compare Registered to Published",
              text: "Search ClinicalTrials.gov, ICTRP, FDA submissions. Calculate: % registered that were published, % published as positive. This is the strongest evidence."
            },
            {
              heading: "Trim-and-Fill",
              text: "Imputes 'missing' studies to achieve funnel symmetry. Provides adjusted pooled estimate. Major limitation: assumes asymmetry = publication bias (may overcorrect)."
            },
            {
              heading: "Selection Models",
              text: "Modella la probabilit√† di pubblicazione come funzione del valore p. Pi√π sofisticato del taglio e riempimento. Richiede ipotesi sul meccanismo di selezione."
            },
            {
              heading: "Limitations",
              text: "Asymmetry ‚â† publication bias. Could be: true heterogeneity (small studies in high-risk populations), methodological differences, chance (especially with few studies). Visual and statistical tests are hypothesis-generating, not confirmatory."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'funnel-plot',
          title: "Funnel Plot Builder",
          description: "Crea grafici a imbuto con il test di Egger e il miglioramento del contorno"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'funnel_decision_tree',
          title: "L'imbuto asimmetrico",
          scenario: "New medication meta-analysis: 15 trials, RR 0.72 (95% CI 0.58-0.89). Your funnel plot shows clear asymmetry. Small studies cluster on the positive side. Egger's p = 0.02. Trim-and-fill changes RR to 0.89 (95% CI 0.72-1.10, non-significant).",
          realCase: "Studio NEJM del 2008 di Turner: 74 studi sugli antidepressivi presentati alla FDA. La letteratura pubblicata ha mostrato il 94% di positivit√†. Verit√†: 51% positivo. Le dimensioni degli effetti sono aumentate del 32%. L'imbuto lo avrebbe mostrato, se qualcuno avesse guardato.",
          nodes: {
            start: {
              id: 'start',
              situation: "Il tuo coautore dice: 'L'imbuto √® chiaramente asimmetrico. Dovremmo riportare la stima corretta del taglio e riempimento come il nostro risultato principale: √® pi√π onesto.' Il biostatistico non √® d'accordo: \"Il trim-and-fill corregge eccessivamente\". Non sappiamo se si tratta di bias di pubblicazione.'",
              question: "Da che parte stai?",
              branches: [
                { id: 'support_trimfill', text: "Support co-author ‚Äî adjusted estimate is more honest", nextNode: 'trimfill_problems' },
                { id: 'support_stats', text: "Support biostatistician ‚Äî original estimate is valid", nextNode: 'original_defense' },
                { id: 'both_wrong', text: "Both are partially right ‚Äî report both estimates", nextNode: 'balanced_approach' }
              ]
            },
            trimfill_problems: {
              id: 'trimfill_problems',
              situation: "Segnali l'RR corretto 0,89 come risultato principale. Il revisore 2 chiede: \"Il processo di rifinitura e riempimento presuppone che l'asimmetria equivalga a un bias di pubblicazione\". E se l'asimmetria fosse dovuta a una reale eterogeneit√†: piccoli studi che arruolano pazienti ad alto rischio?'",
              question: "Come si verifica questo?",
              branches: [
                { id: 'check_contour', text: "Use contour-enhanced funnel plot", nextNode: 'contour_analysis' },
                { id: 'check_characteristics', text: "Compare patient characteristics across study sizes", nextNode: 'characteristic_check' },
                { id: 'admit_limitation', text: "Acknowledge we can't distinguish the causes", nextNode: 'honest_limitation' }
              ]
            },
            contour_analysis: {
              id: 'contour_analysis',
              situation: "Your contour-enhanced funnel shows: the 'missing' studies would fall in the non-significant zone (white area). Studies in the significant zone (shaded) are all published. This pattern suggests publication bias, not heterogeneity.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: Contour-enhanced funnels distinguish bias from heterogeneity. If missing studies cluster in non-significant areas, publication bias is likely. If they span significance zones, other explanations (heterogeneity, study quality) are possible."
            },
            characteristic_check: {
              id: 'characteristic_check',
              situation: "Si verifica: i piccoli studi positivi hanno caratteristiche di base simili ai grandi studi neutri. Nessuna differenza sistematica nel rischio del paziente. L‚Äôasimmetria non √® spiegata dal case mix: la bias di pubblicazione rimane la spiegazione pi√π probabile.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE GRADUAL REVEAL: Multiple lines of evidence converge on publication bias: (1) funnel asymmetry, (2) Egger's test, (3) missing studies in non-significant zone, (4) no case-mix explanation. Still can't prove it, but evidence is accumulating."
            },
            honest_limitation: {
              id: 'honest_limitation',
              situation: "You write: 'Funnel asymmetry and Egger's test suggest potential publication bias. Trim-and-fill adjusts for this (RR 0.89), but the adjustment assumes all asymmetry is bias. True effect likely lies between 0.72 and 0.89.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE QUESTION: When you can't distinguish causes, bracket the uncertainty. 'Effect between 0.72-0.89' is less precise but more honest than picking one estimate. Readers can judge based on their prior beliefs about publication bias."
            },
            original_defense: {
              id: 'original_defense',
              situation: "Riporti solo RR 0,72. L'editore della rivista risponde: 'Il tuo imbuto √® chiaramente asimmetrico. Le linee guida ICMJE richiedono di affrontare i bias di pubblicazione. Non √® possibile omettere questa analisi.'",
              question: "What do you do?",
              branches: [
                { id: 'add_analysis', text: "Aggiungere trim-and-fill come analisi di sensibilit√†", nextNode: 'proper_reporting' },
                { id: 'argue_editor', text: "Argue that Egger's test has high false positive rate", nextNode: 'editor_pushback' }
              ]
            },
            proper_reporting: {
              id: 'proper_reporting',
              situation: "Your revised manuscript: 'Primary analysis: RR 0.72 (0.58-0.89). Funnel plot asymmetry (Egger p=0.02) raises concern for publication bias. Sensitivity analysis with trim-and-fill: RR 0.89 (0.72-1.10).' Reviewers are satisfied.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE REPETITION: Turner's antidepressant analysis showed what happens when you only see published data. By reporting both estimates, you let readers see the uncertainty. The truth is probably somewhere between."
            },
            editor_pushback: {
              id: 'editor_pushback',
              situation: "The editor responds: 'Yes, Egger's test has limitations. But your asymmetry is visible and statistically significant. Not reporting it is selective reporting in itself. Either address publication bias or we cannot proceed.'",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA CONSEGUENZA: nascondere le prove di bias di pubblicazione √® di per s√© una forma di bias. CONSORT e PRISMA richiedono grafici a imbuto e valutazione. La trasparenza sull'incertezza non √® opzionale nelle moderne revisioni sistematiche."
            },
            balanced_approach: {
              id: 'balanced_approach',
              situation: "You propose reporting both: original as primary (following protocol), trim-and-fill as sensitivity. But you also do something the others didn't suggest: check trial registrations.",
              question: "What does the registry comparison show?",
              branches: [
                { id: 'registry_confirms', text: "15 published trials, but 23 registered ‚Äî 8 missing", nextNode: 'definitive_bias' },
                { id: 'registry_matches', text: "15 published, 15 registered ‚Äî no missing trials", nextNode: 'not_pub_bias' },
                { id: 'registry_unavailable', text: "Most trials pre-date registration requirements", nextNode: 'uncertain_outcome' }
              ]
            },
            definitive_bias: {
              id: 'definitive_bias',
              situation: "Trovate 8 studi registrati ma non pubblicati. Contatta gli investigatori. Tre forniscono i dati: tutti negativi (RR 0,95-1,10). Sommandoli: il RR aggregato diventa 0,85 (IC 95% 0,70-1,03). La stima originale era gonfiata da errori di pubblicazione.",
              isEnding: true,
              outcome: 'good',
              lesson: "LA RIVELAZIONE: Questo √® il gold standard: confrontare i dati registrati con quelli pubblicati. Turner ha fatto lo stesso per gli antidepressivi. L'hai fatto per la tua droga. Il registro dimostra ci√≤ che l'imbuto ha solo suggerito. Questa √® la prova definitiva di bias."
            },
            not_pub_bias: {
              id: 'not_pub_bias',
              situation: "Tutti i 15 studi registrati sono stati pubblicati. Nessuno studio mancante. L'asimmetria deve essere dovuta a qualcos'altro: probabilmente effetti di piccoli studi (pazienti ad alto rischio arruolati, cure pi√π variabili) piuttosto che studi negativi soppressi.",
              question: "Come cambia la tua interpretazione?",
              branches: [
                { id: 'revise_conclusion', text: "Report original estimate ‚Äî asymmetry isn't publication bias", nextNode: 'legitimate_small_study' },
                { id: 'still_cautious', text: "Still report trim-and-fill ‚Äî asymmetry is concerning regardless", nextNode: 'overcautious' }
              ]
            },
            legitimate_small_study: {
              id: 'legitimate_small_study',
              situation: "You write: 'Funnel asymmetry (Egger p=0.02) could suggest publication bias, but registry comparison shows all registered trials are published. Asymmetry likely reflects small-study effects (differential treatment effects in high-risk patients in smaller trials).'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE HOOK: Not all asymmetry is publication bias. Small studies often enroll sicker patients who benefit more. Registry comparison is the definitive test. Without it, funnel plots are suggestive but not conclusive."
            },
            overcautious: {
              id: 'overcautious',
              situation: "Hai riportato una stima aggiustata del trim-and-fill nonostante le prove contro i bias di pubblicazione. Una meta-analisi della concorrenza riporta la stima originale con un'adeguata giustificazione del registro. Il loro risultato √® citato come pi√π accurato. Il tuo sembra eccessivamente cauto.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE WARNING: Being too conservative can also be wrong. If registry comparison exonerates publication bias, trim-and-fill 'correction' introduces error. Match your adjustment to the evidence."
            },
            uncertain_outcome: {
              id: 'uncertain_outcome',
              situation: "La maggior parte delle prove risalgono al periodo 1998-2005, prima che fosse richiesta la registrazione. Non √® possibile determinare se gli studi negativi sono stati condotti ma non pubblicati. Le prove del registro sono incomplete.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE GRADUAL REVEAL: This is the historical reality for many questions. Pre-2005 trials often lack registration. Report the funnel asymmetry, Egger's test, and trim-and-fill. Acknowledge you can't determine the cause. Let readers judge."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Your funnel plot for 8 studies shows asymmetry with small positive studies missing. Egger's test p=0.08. What can you conclude?",
          options: [
            { id: 'a', text: "No publication bias since Egger's test is not significant", correct: false },
            { id: 'b', text: "Publication bias present since funnel is asymmetric", correct: false },
            { id: 'c', text: "Insufficient power to detect bias ‚Äî visual asymmetry is suggestive but inconclusive", correct: true },
            { id: 'd', text: "Need to perform trim-and-fill to determine if bias exists", correct: false }
          ],
          explanation: "With only 8 studies, Egger's test has very low power (<50% even with substantial bias). Visual asymmetry is suggestive but could be chance. The appropriate conclusion is uncertainty ‚Äî report the observation but acknowledge you can't confirm the cause."
        }
      }
    ]
  },
  // Module 11: The Certainty (GRADE)
  {
    id: 11,
    title: "The Certainty",
    subtitle: "GRADE Framework",
    principle: 6,
    story: "SPRINT",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Certainty must be justified"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE PARADOX: SPRINT vs ACCORD ‚Äî THE SAME TREATMENT, OPPOSITE ANSWERS",
          source: "NEJM 2015; 373:2103-2116 (SPRINT) | NEJM 2010; 362:1575-1585 (ACCORD BP)",
          timeline: [
            { year: "2003-2009", text: "ACCORD BP randomizes 4,733 diabetics to intensive (<120) vs standard (<140) BP control. The diabetes community waits for guidance.", type: "normal" },
            { year: "Mar 2010", text: "Risultati BP ACCORD: HR composito primario 0,88 (0,73-1,06). NON significativo. Gli eventi avversi gravi sono AUMENTATI. Il controllo intensivo non aiuta i diabetici.", type: "crisis" },
            { year: "2010-2015", text: "SPRINT excludes diabetics (citing ACCORD), enrolls 9,361 non-diabetics. Same intensive target (<120). Different population.", type: "normal" },
            { year: "Aug 2015", text: "SPRINT stopped EARLY for benefit. CV composite HR 0.75 (0.64-0.89). All-cause mortality HR 0.73 (0.60-0.90). Headlines: 'BP Revolution!'", type: "revelation" },
            { year: "The Paradox", text: "Same treatment: intensive BP control. SPRINT (non-diabetics): 25% benefit. ACCORD (diabetics): no benefit, more harm. The truth depends on WHO you treat.", type: "revelation" },
            { year: "The Warning", text: "Gli ospedali hanno applicato gli obiettivi SPRINT a TUTTI i pazienti, compresi i diabetici. Ma i diabetici avevano prove ACCORD che non mostravano alcun beneficio. L'indirettezza non √® astratta. √à una questione di vita o di morte.", type: "crisis" }
          ],
          realData: {
            endpoint: "Primary CV composite",
            drug: "SPRINT (non-diabetics): HR 0.75 (0.64-0.89)",
            placebo: "ACCORD BP (diabetics): HR 0.88 (0.73-1.06)",
            rr: "Stesso intervento, risultati opposti",
            ci: "SPRINT: significant benefit | ACCORD: null",
            nnh: "Context is everything"
          },
          hook: "LA DOMANDA: Un paziente diabetico chiede informazioni sul controllo intensivo della pressione arteriosa. Citi SPRINT. Ma SPRINT ha escluso i diabetici A CAUSA DELL‚ÄôACCORD. Hai applicato le prove all'esatta popolazione che erano state progettate per evitare. Questa √® indirettazza e GRADE esiste per coglierla."
        }
      },
      {
        type: 'content',
        content: {
          title: "GRADE: valutazione della certezza in evidenza",
          sections: [
            {
              heading: "Starting Point:",
              items: [
                "RCTs start at HIGH certainty",
                "Observational studies start at LOW certainty"
              ]
            },
            {
              heading: "Five Reasons to Rate DOWN:",
              items: [
                "1. Risk of bias (lack of blinding, attrition, etc.)",
                "2. Inconsistency (heterogeneity without explanation)",
                "3. Indiretta (diversa P, I, C o O dalla tua domanda)",
                "4. Imprecision (wide CI, small sample, few events)",
                "5. Distorsione da pubblicazione (studi mancanti)"
              ]
            },
            {
              heading: "Three Reasons to Rate UP (for observational):",
              items: [
                "1. Large effect (RR >2 or <0.5)",
                "2. Dose-response gradient",
                "3. All plausible confounders would reduce effect"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: ESPRESSIONE DI GIUDIZI DI GRADO",
          title: "Dalle prove alla certezza",
          sections: [
            {
              heading: "Risk of Bias",
              text: "Valutare GI√ô se la maggior parte delle prove proviene da studi con RoB elevato. Considerare quali ambiti contano di pi√π per questo risultato (il cieco √® cruciale per i risultati soggettivi, meno per la mortalit√†)."
            },
            {
              heading: "Indirectness",
              text: "Rate DOWN if: population differs from your target, intervention differs (dose, duration, formulation), comparator isn't relevant, outcomes are surrogates. SPRINT's exclusions create indirectness for diabetics."
            },
            {
              heading: "Imprecision",
              text: "Rate DOWN if: 95% CI includes both appreciable benefit and harm, or includes no effect and appreciable benefit/harm. Consider clinical decision thresholds, not just statistical significance."
            },
            {
              heading: "Final Certainty Levels",
              text: "HIGH: very confident in estimate\nMODERATE: moderately confident, true effect likely close\nLOW: limited confidence, true effect may differ substantially\nVERY LOW: very little confidence, true effect likely substantially different"
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'grade-builder',
          title: "GRADE Assessment Builder",
          description: "Build Summary of Findings tables with GRADE certainty ratings"
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'grade_decision_tree',
          title: "Il paziente diabetico",
          scenario: "Your hospital adopts SPRINT-based intensive BP control (<120 systolic) for all patients. A colleague asks about her 68-year-old diabetic patient with CKD stage 3. SPRINT excluded diabetics and used automated BP measurement you don't have.",
          realCase: "SPRINT √® stato uno studio fondamentale. Ma l‚ÄôACCORD BP (che INCLUDEva i diabetici) ha riscontrato che il controllo intensivo della BP NON riduceva gli eventi CV e AUMENTava gli eventi avversi. Stesso intervento, popolazione diversa, conclusione opposta.",
          nodes: {
            start: {
              id: 'start',
              situation: "Il responsabile della qualit√† dell'ospedale afferma: 'SPRINT ha mostrato una riduzione del 25% degli eventi CV con il controllo intensivo. Questo paziente diabetico dovrebbe ottenere lo stesso beneficio.' Il tuo collega √® scettico.",
              question: "How do you assess SPRINT's applicability?",
              branches: [
                { id: 'apply_sprint', text: "SPRINT √® la prova migliore: applicalo a tutti gli ipertesi", nextNode: 'application_problem' },
                { id: 'check_exclusions', text: "Primo controllo: questo tipo di paziente √® stato escluso da SPRINT?", nextNode: 'exclusion_discovery' },
                { id: 'find_direct_evidence', text: "Cerca studi che INCLUDONO i diabetici", nextNode: 'accord_discovery' }
              ]
            },
            application_problem: {
              id: 'application_problem',
              situation: "You apply intensive control. Six months later: the patient has hypotensive episodes, falls, and develops acute kidney injury requiring hospitalization. You wonder: 'Did SPRINT predict this?'",
              question: "Rivedi Criteri di esclusione di SPRINT. Cosa trovi?",
              branches: [
                { id: 'discover_exclusions', text: "SPRINT excluded diabetics, prior stroke, eGFR <20", nextNode: 'late_realization' },
                { id: 'check_accord', text: "You find ACCORD BP studied diabetics specifically", nextNode: 'accord_contrast' }
              ]
            },
            late_realization: {
              id: 'late_realization',
              situation: "Ti rendi conto: SPRINT ha escluso proprio i pazienti come il tuo. I criteri di esclusione non erano arbitrari: i ricercatori sospettavano che questi pazienti avrebbero potuto rispondere in modo diverso. Avevano ragione.",
              isEnding: true,
              outcome: 'bad',
              lesson: "LA CONSEGUENZA: I criteri di esclusione negli studi clinici sono spesso segnali. SPRINT ha escluso i diabetici perch√© ACCORD BP aveva gi√† dimostrato che il controllo intensivo della BP non li aiutava. L'applicazione di SPRINT alle popolazioni escluse ignora il contesto cruciale."
            },
            accord_contrast: {
              id: 'accord_contrast',
              situation: "ACCORD BP (4,733 diabetics): intensive vs standard BP control. Primary composite: HR 0.88 (95% CI 0.73-1.06), NOT significant. Serious adverse events: significantly higher with intensive control. The opposite of SPRINT.",
              isEnding: true,
              outcome: 'bad',
              lesson: "THE HOOK: Same intervention (intensive BP control), different population (diabetics vs non-diabetics), opposite conclusion. This is why indirectness matters in GRADE. Diabetic patients needed diabetic-specific evidence."
            },
            exclusion_discovery: {
              id: 'exclusion_discovery',
              situation: "You check SPRINT's eligibility criteria. Major exclusions: (1) Diabetes, (2) Prior stroke, (3) Symptomatic heart failure, (4) eGFR <20. Your colleague's patient meets exclusion criterion #1.",
              question: "In che modo ci√≤ influisce sul tuo punteggio di certezza GRADE?",
              branches: [
                { id: 'moderate_rating', text: "MODERATE ‚Äî one exclusion criterion, still reasonably applicable", nextNode: 'moderate_insufficient' },
                { id: 'low_rating', text: "LOW ‚Äî diabetics were specifically excluded, serious indirectness", nextNode: 'proper_grade' },
                { id: 'check_why', text: "Before rating, ask: WHY were diabetics excluded?", nextNode: 'exclusion_reason' }
              ]
            },
            moderate_insufficient: {
              id: 'moderate_insufficient',
              situation: "You rate MODERATE and recommend intensive control. A cardiologist colleague points out: 'ACCORD BP studied exactly this population and found no benefit. Your GRADE assessment should account for that DIRECT evidence, not just SPRINT's INDIRECT evidence.'",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE REPETITION: GRADE indirectness isn't just about distance from your question ‚Äî it's about whether BETTER evidence exists. For diabetics, ACCORD BP is direct evidence. SPRINT is indirect. Direct evidence trumps indirect."
            },
            proper_grade: {
              id: 'proper_grade',
              situation: "Valuti BASSO il livello di certezza per l'applicazione di SPRINT ai diabetici. La tua motivazione GRADE: \"Gravi indiretti - diabetici esplicitamente esclusi\". ACCORD BP (evidenza diretta per i diabetici) non ha riscontrato alcun beneficio. Impossibile estrapolare SPRINT a questa popolazione.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: GRADE indirectness forces you to ask: is this evidence actually about MY patient? When exclusion criteria match your patient, the answer is 'no.' Find direct evidence or downgrade substantially."
            },
            exclusion_reason: {
              id: 'exclusion_reason',
              situation: "Si indaga: SPRINT ha escluso i diabetici PERCH√â prove precedenti (ACCORD BP) hanno gi√† mostrato che il controllo intensivo della BP non ha apportato loro alcun beneficio. L'esclusione non √® stata arbitraria: era basata sull'evidenza.",
              question: "Cosa ti dice questo sull'applicazione di SPRINT ai diabetici?",
              branches: [
                { id: 'cannot_extrapolate', text: "SPRINT can't be extrapolated ‚Äî there's direct contrary evidence", nextNode: 'correct_understanding' },
                { id: 'sprint_better', text: "Maybe SPRINT's approach was better than ACCORD's", nextNode: 'protocol_differences' }
              ]
            },
            correct_understanding: {
              id: 'correct_understanding',
              situation: "Spieghi al responsabile della qualit√†: 'Non possiamo applicare SPRINT ai diabetici. Sono stati esclusi perch√© l'ACCORD non ha mostrato alcun beneficio nei diabetici. L'applicazione dei protocolli SPRINT alle popolazioni escluse contraddice la logica di progettazione dello studio.'",
              isEnding: true,
              outcome: 'good',
              lesson: "LA RIVELAZIONE GRADUALE: i criteri di esclusione spesso codificano prove precedenti. Capire PERCH√â una popolazione √® stata esclusa rivela ci√≤ che gi√† sappiamo di loro. SPRINT non ha studiato i diabetici perch√© conoscevamo gi√† la risposta."
            },
            protocol_differences: {
              id: 'protocol_differences',
              situation: "You compare: SPRINT used automated BP measurement (typically 5-10 mmHg lower than clinic readings). ACCORD used standard clinic measurements. A '120' target in SPRINT is like '125-130' in real clinics. But even accounting for this, ACCORD showed no benefit.",
              isEnding: true,
              outcome: 'neutral',
              lesson: "L'AVVERTIMENTO: le differenze di protocollo contano. Il valore 120 di SPRINT non √® lo stesso valore di 120 della vostra clinica. Ma il problema pi√π grande: ACCORD si rivolgeva direttamente ai diabetici. I cavilli metodologici non possono far s√¨ che la popolazione esclusa da SPRINT venga improvvisamente inclusa."
            },
            accord_discovery: {
              id: 'accord_discovery',
              situation: "You search for 'intensive blood pressure control diabetes RCT' and find ACCORD BP. 4,733 type 2 diabetics. Intensive (<120) vs standard (<140). Primary composite: HR 0.88 (0.73-1.06). Stroke: HR 0.59 (0.39-0.89). Adverse events: significantly higher.",
              question: "Come interpreta ACCORD BP?",
              branches: [
                { id: 'no_benefit', text: "Primary outcome negative ‚Äî intensive control doesn't help diabetics", nextNode: 'nuanced_interpretation' },
                { id: 'stroke_benefit', text: "Stroke was reduced ‚Äî some benefit exists", nextNode: 'outcome_tradeoff' },
                { id: 'both_results', text: "Report both ‚Äî primary negative, stroke positive, harms increased", nextNode: 'complete_picture' }
              ]
            },
            nuanced_interpretation: {
              id: 'nuanced_interpretation',
              situation: "You report: 'ACCORD BP, the direct evidence for diabetics, found intensive BP control did not reduce the primary CV composite. Apply SPRINT targets to diabetics is not supported by direct evidence.'",
              isEnding: true,
              outcome: 'good',
              lesson: "THE PROTECTION: The primary outcome is what the trial was designed and powered to detect. Secondary outcomes are hypothesis-generating. A negative primary outcome is the main message, even if secondaries show signals."
            },
            outcome_tradeoff: {
              id: 'outcome_tradeoff',
              situation: "Sottolinea la riduzione della corsa (HR 0,59). Ma il responsabile della qualit√† nota: ‚ÄúL'esito primario √® stato negativo. Gli eventi avversi gravi sono stati pi√π elevati. Stai scegliendo un risultato secondario ignorando i danni.'",
              isEnding: true,
              outcome: 'neutral',
              lesson: "THE QUESTION: When primary outcomes are negative but secondary outcomes positive, resist the temptation to focus on positive findings. GRADE requires assessing the entire evidence profile, including harms. Balance matters."
            },
            complete_picture: {
              id: 'complete_picture',
              situation: "Your assessment: 'For diabetics, intensive BP control: CV composite HR 0.88 (0.73-1.06, not significant), stroke HR 0.59 (0.39-0.89, significant), serious adverse events significantly higher. Balance uncertain. SPRINT does not apply ‚Äî ACCORD is the direct evidence.'",
              question: "Il tuo collega chiede: 'Allora cosa faccio per il mio paziente?'",
              branches: [
                { id: 'standard_target', text: "Standard target (<140) is supported ‚Äî less aggressive", nextNode: 'clinical_recommendation' },
                { id: 'shared_decision', text: "Discuss tradeoffs ‚Äî some patients might accept risks for stroke benefit", nextNode: 'individualized_care' }
              ]
            },
            clinical_recommendation: {
              id: 'clinical_recommendation',
              situation: "You recommend standard BP target (<140) based on ACCORD. The patient achieves 138/85 without adverse effects. Two years later: no CV events, no falls, stable kidney function. The evidence-appropriate target worked.",
              isEnding: true,
              outcome: 'good',
              lesson: "LA RIVELAZIONE: La certezza del GRADE non √® accademica: guida le decisioni reali. BASSA certezza per SPRINT‚Üídiabetici significava: non applicare i protocolli SPRINT. Le prove dirette dell‚ÄôACCORD hanno supportato un approccio diverso. Il paziente ha tratto beneficio dalla corretta valutazione delle prove."
            },
            individualized_care: {
              id: 'individualized_care',
              situation: "You discuss with the patient: 'Aggressive BP control might reduce stroke risk but increases other risks. Given your priorities...' The patient, having had a family member with stroke, chooses moderately intensive control (125-130) with close monitoring.",
              isEnding: true,
              outcome: 'good',
              lesson: "THE GRADUAL REVEAL: When evidence is uncertain (LOW certainty), patient preferences matter more. GRADE doesn't tell you what to do ‚Äî it tells you how confident to be. Uncertainty creates space for shared decision-making."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "You're rating GRADE certainty for a meta-analysis of 8 RCTs (n=12,000) showing Drug X reduces mortality (RR 0.85, 95% CI 0.78-0.93). I¬≤ = 0%, no publication bias detected, low risk of bias. What certainty?",
          options: [
            { id: 'a', text: "HIGH ‚Äî RCTs with no concerns across all domains", correct: true },
            { id: 'b', text: "MODERATE ‚Äî should rate down for imprecision given CI width", correct: false },
            { id: 'c', text: "MODERATE ‚Äî should rate down for potential residual confounding", correct: false },
            { id: 'd', text: "LOW ‚Äî mortality is too hard an endpoint to be certain about", correct: false }
          ],
          explanation: "This meets criteria for HIGH certainty: RCTs (start high), low RoB, no inconsistency (I¬≤=0%), no indirectness mentioned, precise estimate (CI excludes both 1.0 and large effects), no publication bias. Each domain is satisfactory, so no downgrading."
        }
      }
    ]
  },
  // Module 12: The Report
  {
    id: 12,
    title: "The Report",
    subtitle: "PRISMA 2020",
    principle: 6,
    story: "Reproducibility",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Certainty must be justified"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CRISIS: GLASZIOU'S AUDIT ‚Äî SYSTEMATIC IN NAME ONLY",
          source: "BMC Medicine 2014; 12:37 | Glasziou et al | PubMed: 24571522",
          timeline: [
            { year: "2000s", text: "Le revisioni sistematiche diventano il 'gold standard' delle prove. Cochrane ne produce migliaia. Le linee guida lo impongono. L'EBM poggia sulle sue fondamenta.", type: "normal" },
            { year: "2014", text: "Glasziou riunisce un team per replicare 18 influenti revisioni sistematiche. Hanno i documenti. Seguono le sezioni sui metodi. Tentano di riprodurre i risultati.", type: "normal" },
            { year: "The Attempt", text: "I membri del team seguono esattamente i metodi indicati in ciascuna revisione. Eseguono le ricerche. Applicano i criteri. Estraggono i dati. Raggruppano le stime.", type: "normal" },
            { year: "The Failure", text: "Completamente riproducibile: 2 su 18 (11%). Parzialmente riproducibile: 5 su 18 (28%). NON riproducibile: 11 su 18 (61%). Le fondamenta crollano.", type: "crisis" },
            { year: "The Causes", text: "Strategie di ricerca incomplete o mancanti. Criteri di ammissibilit√† ambigui. Estrazione dei dati non definita. Metodi statistici poco chiari. \"Sistematico\" era un'etichetta, non una pratica.", type: "crisis" },
            { year: "The Consequence", text: "Se non possiamo riprodurre una recensione, non possiamo verificarla. Se non possiamo verificarlo, non possiamo fidarci. Il 61% delle prove \"gold standard\" non erano verificabili.", type: "revelation" }
          ],
          realData: {
            endpoint: "Reproducibility of systematic reviews",
            drug: "18 influential reviews tested",
            placebo: "Tentativo di replica completa",
            rr: "Fully reproducible: 11% (2/18)",
            ci: "Partially: 28% | Failed: 61%",
            nnh: "Most 'systematic' reviews cannot be verified"
          },
          hook: "THE REPETITION: Every principle we've taught ‚Äî pre-specification, comprehensive search, transparent extraction, clear synthesis ‚Äî exists because without them, no one can check your work. And work that cannot be checked cannot be trusted. PRISMA 2020 is not bureaucracy. It is accountability."
        }
      },
      {
        type: 'content',
        content: {
          title: "THE HARM: When Irreproducible Reviews Killed",
          sections: [
            {
              heading: "The Cochrane Catastrofe del beta-bloccante (2014)",
              items: [
                "Cochrane review of perioperative beta-blockers: 'Reduces mortality' ‚Äî drove guidelines worldwide",
                "Based heavily on DECREASE trials by Poldermans (later proven fraudulent)",
                "When DECREASE was removed: benefit VANISHED, trend toward HARM remained",
                "Cochrane ha dovuto RITIRARE la revisione. Le linee guida raccomandavano danni per 12 anni.",
                "Quanti pazienti chirurgici sono morti a causa di dati fraudolenti amplificati da una revisione \"sistematica\"?"
              ]
            },
            {
              heading: "Lo scandalo del Tamiflu (2009-2014)",
              items: [
                "Cochrane reviewed oseltamivir (Tamiflu) for influenza. Governments stockpiled $9 billion worth.",
                "La revisione originale si basava sui riassunti dei produttori, non sullo studio completo report",
                "Quando Cochrane ha richiesto i report completi sugli studi clinici: Roche ha ritardato di 4 ANNI",
                "Final verdict: Tamiflu reduced symptoms by 17 hours. Did NOT reduce hospitalizations.",
                "$9 billion spent on a drug whose benefits were exaggerated by incomplete reporting"
              ]
            },
            {
              heading: "THE PATTERN: Irreproducibility Enables Harm",
              items: [
                "Se la revisione dei beta-bloccanti avesse richiesto dati di sperimentazione completi, la frode DECREASE sarebbe stata scoperta",
                "Se la revisione del Tamiflu avesse richiesto i rapporti sugli studi clinici in anticipo, l'esagerazione sarebbe stata visibile",
                "Irreproducible methods ‚Üí undetectable bias ‚Üí guidelines based on mirages ‚Üí patient harm",
                "PRISMA esiste perch√© metodi vaghi lasciano che frodi e giri di parole si nascondano in bella vista"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "PRISMA 2020: 27-Item Framework (with a 15-item training subset)",
          sections: [
            {
              heading: "Title & Abstract (Items 1-2)",
              items: [
                "Identify as systematic review/meta-analysis in title",
                "Structured abstract with all key information"
              ]
            },
            {
              heading: "Methods (Items 3-15)",
              items: [
                "Registrazione del protocollo e accesso",
                "Criteri di ammissibilit√† per gli studi",
                "Fonti e date delle informazioni",
                "Complete search strategy (at least one database)",
                "Selection, extraction, and RoB processes",
                "Misure degli effetti e metodi di sintesi"
              ]
            },
            {
              heading: "Results (Items 16-23)",
              items: [
                "Diagramma di flusso della selezione degli studi",
                "Caratteristiche degli studi inclusi studi",
                "Rischio di bias all'interno e tra gli studi",
                "Risultati di sintesi e indagini sull'eterogeneit√†"
              ]
            },
            {
              heading: "Discussion & Other (Items 24-27)",
              items: [
                "Interpretazione nel contesto di altre prove",
                "Limitazioni allo studio e alla revisione livello",
                "Finanziamenti e conflitti di interessi"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "IL METODO: RENDICONTAZIONE TRASPARENTE",
          title: "Rendere riproducibile la revisione",
          sections: [
            {
              heading: "Search Strategy Reporting",
              text: "Fornire stringhe di ricerca complete per TUTTI i database. Includere i dati della ricerca. Segnalare eventuali limiti applicati (lingua, dati, tipologia di pubblicazione). Inserisci le strategie complete nel supplemento se troppo lungo."
            },
            {
              heading: "Study Flow",
              text: "PRISMA flow diagram showing: records identified, duplicates removed, screened, assessed for eligibility, included. For exclusions at full-text stage, provide reasons for each."
            },
            {
              heading: "Data Transparency",
              text: "Includi appezzamenti forestali per tutti i risultati. Fornire i dati dei singoli studi in tabelle o supplementi. Condividi moduli di estrazione, giudizi RoB con giustificazioni e codice di analisi, se possibile."
            },
            {
              heading: "Living Reviews",
              text: "Considera se la tua recensione deve essere aggiornata periodicamente (revisione in tempo reale) o √® un'istantanea unica. Indica la frequenza di aggiornamento prevista e i trigger."
            }
          ]
        }
      },
      {
        type: 'tool',
        content: {
          id: 'prisma-checklist',
          title: "PRISMA Checklist Generator",
          description: "Genera una lista di controllo PRISMA 2020 completata per la tua revisione"
        }
      },
      {
        type: 'scenario',
        content: {
          id: 'report_scenario',
          title: "Il limite di parole",
          situation: "Il tuo diario ha un limite di 3.500 parole. La tua strategia di ricerca completa √® di 800 parole. I tuoi giudizi dettagliati su RoB sono di 600 parole. La piena conformit√† PRISMA supererebbe il limite del 40%. L'editor dice \"fai dei tagli\".",
          question: "Cosa tagli?",
          choices: [
            {
              id: 'a',
              text: "Abbreviate search strategy ‚Äî readers don't actually replicate searches",
              consequence: 'bad',
              result: "La ricerca √à il metodo. Senza di esso, nessuno pu√≤ verificare che tu abbia effettuato una ricerca completa. Inserisci la strategia completa in un supplemento: non ometterlo mai."
            },
            {
              id: 'b',
              text: "Move detailed methods to supplement, keep summary in main text",
              consequence: 'good',
              result: "Correct! PRISMA allows supplementary materials. Main text summarizes; supplement contains full search, RoB judgments, excluded studies list, sensitivity analyses. Everything remains available."
            },
            {
              id: 'c',
              text: "Elimina i metodi: ai lettori interessano solo i risultati e le conclusioni",
              consequence: 'bad',
              result: "Senza metodi, i risultati sono ininterpretabili. Come potrebbero i lettori sapere se ti sono mancati studi, pregiudizi categorizzati in modo errato o sottogruppi compromessi? I metodi abilitano la fiducia."
            }
          ],
          correct: 'b',
          principle: 6
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Quale elemento √® PI√ô essenziale per replicare una revisione sistematica?",
          options: [
            { id: 'a', text: "La strategia di ricerca completa per almeno un database", correct: true },
            { id: 'b', text: "Le valutazioni di certezza GRADE per ciascun risultato", correct: false },
            { id: 'c', text: "The forest plots showing pooled estimates", correct: false },
            { id: 'd', text: "La discussione di limitazioni", correct: false }
          ],
          explanation: "La strategia di ricerca √® il fondamento della riproducibilit√†. Senza sapere esattamente cosa hai cercato, come e quando, nessuno pu√≤ verificare l'identificazione del tuo studio. GRADE, forest plot e discussione sono importanti, ma dipendono prima dalla corretta identificazione dello studio."
        }
      }
    ]
  },
  // Module 13: The Capstone
  {
    id: 13,
    title: "The Capstone",
    subtitle: "Full Walkthrough",
    principle: null,
    slides: [
      {
        type: 'title',
        content: {
          title: "Il progetto Capstone",
          subtitle: "Apply Everything You've Learned",
          text: "Ora condurrai una mini meta-analisi dalla domanda alla conclusione, utilizzando gli strumenti di tutti i moduli precedenti."
        }
      },
      {
        type: 'content',
        content: {
          title: "Your Assignment",
          sections: [
            {
              heading: "The Question:",
              items: [
                "Does aspirin reduce cardiovascular events in primary prevention?"
              ]
            },
            {
              heading: "You Will:",
              items: [
                "1. Formulate PICO using the PICO Builder",
                "2. Develop a search strategy using the Search Builder",
                "3. Esaminare i record forniti utilizzando lo strumento PRISMA Flow",
                "4. Estrai i dati dai 5 riassunti degli studi forniti",
                "5. Assess risk of bias using RoB 2",
                "6. Calculate effect sizes",
                "7. Build a forest plot (fixed and random effects)",
                "8. Assess heterogeneity and prediction intervals",
                "9. Create a funnel plot and assess publication bias",
                "10. Rate certainty using GRADE",
                "11. Report findings using PRISMA checklist"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Dataset: Aspirin Primary Prevention Trials",
          sections: [
            {
              heading: "Studio 1: Physicians' Health Study (1989)",
              items: [
                "N=22,071 male physicians",
                "Aspirin 325mg every other day vs placebo",
                "MI events: 139/11,037 (1.26%) vs 239/11,034 (2.17%)",
                "RR = 0.58 (0.47-0.72)"
              ]
            },
            {
              heading: "Studio 2: Women's Health Study (2005)",
              items: [
                "N=39,876 female health professionals",
                "Aspirin 100mg every other day vs placebo",
                "MI events: 198/19,934 (0.99%) vs 193/19,942 (0.97%)",
                "RR = 1.02 (0.84-1.25)"
              ]
            },
            {
              heading: "Study 3: ASPREE (2018)",
              items: [
                "N=19,114 elderly (>70)",
                "Aspirin 100mg daily vs placebo",
                "CV events: 448/9,525 (4.7%) vs 474/9,589 (4.9%)",
                "RR = 0.95 (0.83-1.08)"
              ]
            },
            {
              heading: "Study 4: ARRIVE (2018)",
              items: [
                "N=12,546 moderate CV risk",
                "Aspirin 100mg daily vs placebo",
                "MI events: 98/6,270 (1.56%) vs 108/6,276 (1.72%)",
                "RR = 0.91 (0.69-1.19)"
              ]
            },
            {
              heading: "Study 5: ASCEND (2018)",
              items: [
                "N=15,480 diabetics",
                "Aspirin 100mg daily vs placebo",
                "Serious vascular events: 658/7,740 (8.5%) vs 743/7,740 (9.6%)",
                "RR = 0.88 (0.79-0.97)"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Capstone Verification Checkpoints",
          sections: [
            {
              heading: "‚úì CHECKPOINT 1: PICO Formulation",
              items: [
                "Utilizza PICO Builder strumento",
                "VERIFICARE: il tuo risultato √® IMPORTANTE PER IL PAZIENTE (non un surrogato)",
                "SELF-CHECK: Would CAST victims approve of your outcome choice?"
              ]
            },
            {
              heading: "‚úì CHECKPOINT 2: Risk of Bias Assessment",
              items: [
                "Utilizza lo strumento RoB 2 per TUTTI i 5 studi",
                "VERIFY: You rated each OUTCOME separately (remember ORBITA)",
                "SELF-CHECK: Could unblinding affect your outcome measurement?"
              ]
            },
            {
              heading: "‚úì CHECKPOINT 3: Forest Plot & Heterogeneity",
              items: [
                "Utilizza Forest Plot Builder: prova SIA gli effetti fissi che quelli casuali",
                "Utilizza l'Eterogeneit√† Explorer",
                "VERIFICA: hai calcolato l'INTERVALLO DI PREVISIONE (non solo CI)",
                "AUTOVERIFICA: il tuo PI incrocia 1.0? Cosa significa questo per la pratica clinica?"
              ]
            },
            {
              heading: "‚úì CHECKPOINT 4: Publication Bias Assessment",
              items: [
                "Use the Funnel Plot Builder",
                "VERIFICA: hai eseguito il test di Egger e lo hai interpretato correttamente",
                "AUTOVERIFICA: ci sono studi registrati che non sono stati pubblicati? (Ricorda il 94% contro il 51% di Turner)"
              ]
            },
            {
              heading: "‚úì CHECKPOINT 5: GRADE Certainty Rating",
              items: [
                "Utilizza GRADE Builder",
                "VERIFY: You considered INDIRECTNESS (Remember SPRINT vs ACCORD-BP)",
                "VERIFY: You downgraded appropriately for heterogeneity if I¬≤>50%",
                "AUTOVERIFICA: scommetteresti la tua carriera su questa valutazione di certezza?"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Capstone Deliverables",
          sections: [
            {
              heading: "Required Outputs (submit all 5):",
              items: [
                "1. PICO table with outcome hierarchy justification",
                "2. Tabella semaforo RoB 2 per tutti e 5 gli studi",
                "3. Forest plot con ENTRAMBE CI e intervallo di previsione etichettati",
                "4. Funnel plot with Egger's test result annotated",
                "5. GRADE Summary of Findings table"
              ]
            },
            {
              heading: "Key Questions to Answer:",
              items: [
                "Qual ‚Äã‚Äã√® l'RR raggruppato? (rapporto con IC al 95% E intervallo di previsione)",
                "What is I¬≤? What does it mean for clinical application?",
                "Esistono prove di bias di pubblicazione? Come hai valutato questo?",
                "What is your GRADE certainty? Justify each domain rating.",
                "Cosa consiglia per la pratica clinica? Per CHI?"
              ]
            },
            {
              heading: "250-Word Abstract",
              items: [
                "Contesto: perch√© questa domanda √® importante?",
                "Methods: How did you search, select, assess bias, synthesize?",
                "Results: Pooled RR, CI, PI, I¬≤, GRADE certainty",
                "Conclusione: cosa dovrebbero FARE i medici con queste evidenze?"
              ]
            }
          ]
        }
      },
      {
        type: 'principle',
        content: {
          text: "I sette principi guidano l'utente. La domanda modella la risposta. La pre-specificazione protegge. La ricerca approfondita trova la verit√†. Ogni numero necessita di verifica. I pregiudizi si nascondono in bella vista. La media pu√≤ mentire. La certezza deve essere giustificata."
        }
      }
    ]
  },
  // Module 14: Final Assessment
  {
    id: 14,
    title: "Final Assessment",
    subtitle: "Metti alla prova le tue conoscenze",
    principle: null,
    slides: [
      {
        type: 'title',
        content: {
          title: "Final Assessment",
          subtitle: "Comprehensive Examination",
          text: "Questa valutazione copre tutti i moduli. Per passare √® necessario il 70%. Prenditi il ‚Äã‚Äãtuo tempo: non c'√® limite di tempo."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "FINAL D1: Lo studio CAST ha scoperto che i farmaci antiaritmici che sopprimono con successo i PVC in realt√† aumentano la mortalit√†. Questa inversione √® avvenuta perch√© gli studi originali utilizzavano quale risultato problematico?",
          options: [
            { id: 'a', text: "Composite endpoint", correct: false },
            { id: 'b', text: "Surrogate endpoint (PVC suppression instead of mortality)", correct: true },
            { id: 'c', text: "Self-reported endpoint", correct: false },
            { id: 'd', text: "Time-to-event endpoint", correct: false }
          ],
          explanation: "CAST exemplifies the surrogate trap: PVC suppression (biomarker) seemed like a reasonable proxy for mortality, but the drugs that best suppressed PVCs actually increased death. Principle 1: 'The question shapes the answer.'"
        }
      },
      {
        type: 'quiz',
        content: {
          question: "FINALE D2: Sei a met√† di una meta-analisi quando noti un'interessante differenza di sottogruppo non nel tuo protocollo. Qual √® l'azione pi√π appropriata?",
          options: [
            { id: 'a', text: "Aggiungerla come analisi primaria", correct: false },
            { id: 'b', text: "Report it as exploratory, hypothesis-generating, with appropriate caveats", correct: true },
            { id: 'c', text: "Ignore it completely", correct: false },
            { id: 'd', text: "Amend your PROSPERO registration to include it as pre-specified", correct: false }
          ],
          explanation: "I risultati post-hoc possono essere riportati ma devono essere etichettati chiaramente come esplorativi. L'aggiunta all'analisi primaria √® HARKing. Ignorare le informazioni sui rifiuti. Modificare PROSPERO dopo l'analisi √® ingannevole."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "FINAL Q3: Your funnel plot shows asymmetry with small positive studies missing. Egger's test p=0.04. Which statement is most accurate?",
          options: [
            { id: 'a', text: "Publication bias is confirmed ‚Äî use trim-and-fill adjusted estimate", correct: false },
            { id: 'b', text: "Asimmetria rilevata: potrebbe essere bias di pubblicazione, effetti di piccoli studi o eterogeneit√†. Confrontare studi registrati e pubblicati per prove pi√π forti", correct: true },
            { id: 'c', text: "No publication bias since funnel asymmetry has many causes", correct: false },
            { id: 'd', text: "Need more studies to draw any conclusion", correct: false }
          ],
          explanation: "L'asimmetria dell'imbuto √® suggestiva ma non confermativa. Il gold standard consiste nel confrontare le registrazioni degli studi clinici con le pubblicazioni. Il test di Egger rileva l'asimmetria, non la sua causa."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "FINAL Q4: Una meta-analisi mostra RR 0,75 (95% CI 0,65-0,87) con intervallo di previsione 0,52-1,08. Cosa dice questo a un medico sull'applicazione di questo trattamento?",
          options: [
            { id: 'a', text: "Treatment is effective ‚Äî CI excludes 1.0", correct: false },
            { id: 'b', text: "Treatment is not effective ‚Äî prediction interval crosses 1.0", correct: false },
            { id: 'c', text: "On average treatment helps, but in some future settings may not work", correct: true },
            { id: 'd', text: "I risultati sono troppo eterogenei per essere interpretati", correct: false }
          ],
          explanation: "L'IC ci dice che l'effetto medio √® probabilmente benefico. L'intervallo di previsione ci dice che un nuovo studio (nuova impostazione) potrebbe mostrare effetti da 0,52 (grande beneficio) a 1,08 (leggero danno). Entrambi i pezzi contano."
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Q5 FINALE: Stai valutando la certezza dell'applicabilit√† di SPRINT a un paziente diabetico con insufficienza renale cronica. SPRINT ha escluso sia i diabetici che la malattia renale cronica avanzata. Quale dominio GRADE si applica?",
          options: [
            { id: 'a', text: "Risk of bias", correct: false },
            { id: 'b', text: "Inconsistency", correct: false },
            { id: 'c', text: "Indirectness", correct: true },
            { id: 'd', text: "Imprecision", correct: false }
          ],
          explanation: "Indirectness addresses the question: 'Does this evidence apply to MY population/intervention/comparison/outcome?' When your patient was excluded from the trial, the evidence is indirect for them."
        }
      },
      {
        type: 'content',
        content: {
          title: "Congratulations!",
          sections: [
            {
              heading: "Hai completato il corso sui metodi di meta-analisi",
              items: [
                "‚úì Learned to formulate PICO questions that matter",
                "‚úì Comprendi l'importanza della pre-registrazione",
                "‚úì Mastered comprehensive searching",
                "‚úì Practiced systematic screening and extraction",
                "‚úì Applied risk of bias assessment",
                "‚úì Calculated and interpreted effect sizes",
                "‚úì Built and interpreted forest plots",
                "‚úì Explored heterogeneity beyond I¬≤",
                "‚úì Detected and assessed publication bias",
                "‚úì Applied GRADE certainty framework",
                "‚úì Understood PRISMA reporting standards"
              ]
            },
            {
              heading: "I sette principi",
              text: "Remember: The question shapes the answer. Pre-specification is protection. What you don't search for, you won't find. Every number needs a source. Bias hides in plain sight. The average can lie. Certainty must be justified."
            }
          ]
        }
      }
    ]
  }
];

// ============================================================
// STATE MANAGEMENT
// ============================================================

let currentModule = 0;
let currentSlide = 0;
let gameState = {
  points: 0,
  earnedBadges: [],
  toolsUsed: [],
  modulesCompleted: [],
  scenariosCompleted: {},
  decisionTrees: {},
  quizAnswers: {}
};

// ============================================================
// INITIALIZATION
// ============================================================

document.addEventListener('DOMContentLoaded', () => {
  loadProgress();
  renderModuleList();
  renderSlides();
  goToModule(0);
  updateLevelBadge();
  checkBadges();
});

function renderModuleList() {
  const list = document.getElementById('moduleList');
  list.innerHTML = modules.map(m => `
    <div class="module-item ${m.id === currentModule ? 'active' : ''} ${gameState.modulesCompleted.includes(m.id) ? 'completed' : ''}"
         data-module="${m.id}" onclick="goToModule(${m.id})"
         role="button" tabindex="0" ${m.id === currentModule ? 'aria-current="true"' : ''}
         aria-label="Module ${m.id}: ${m.title}${gameState.modulesCompleted.includes(m.id) ? ' (completed)' : ''}">
      <div class="module-number" aria-hidden="true">${m.id}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}</div>
      </div>
    </div>
  `).join('');
}

function renderSlides() {
  const container = document.getElementById('slideContainer');
  const module = modules[currentModule];

  container.innerHTML = module.slides.map((slide, idx) => {
    let content = '';

    switch(slide.type) {
      case 'title':
        content = `
          <h1 class="slide-title">${slide.content.title}</h1>
          <p style="text-align: center; font-size: 1.2rem; color: var(--gold); margin-bottom: 2rem;">${slide.content.subtitle}</p>
          <div class="slide-content">
            <p style="font-size: 1.1rem; line-height: 1.8; text-align: center;">${slide.content.text}</p>
          </div>
        `;
        break;

      case 'principle-display':
        content = `
          <div class="principle-display">
            <div class="principle-text">"${slide.content.principle}"</div>
          </div>
        `;
        break;

      case 'story':
        content = `
          <div class="story-box">
            <div class="story-label">${slide.content.label}</div>
            <div class="story-text">${slide.content.text}</div>
            <div class="story-hook">"${slide.content.hook}"</div>
          </div>
        `;
        break;

      case 'story-deep':
        content = `
          <div class="story-deep">
            <div class="story-label">${slide.content.label}</div>
            ${slide.content.source ? `<div class="real-data-source">üìö Source: ${slide.content.source}</div>` : ''}

            <div class="story-timeline">
              ${slide.content.timeline.map(event => `
                <div class="timeline-event ${event.type || ''}">
                  <div class="timeline-year">${event.year}</div>
                  <div class="timeline-text">${event.text}</div>
                </div>
              `).join('')}
            </div>

            ${slide.content.realData ? `
              <div class="real-data-card">
                <div class="real-data-header">
                  <strong>üìä The Data That Changed Everything</strong>
                </div>
                <div class="real-data-stat">
                  <span class="label">Endpoint:</span>
                  <span style="color: var(--gold);">${slide.content.realData.endpoint}</span>
                </div>
                <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem; margin: 1rem 0;">
                  <div class="real-data-stat">
                    <span class="value" style="color: var(--red);">${slide.content.realData.drug}</span>
                    <span class="label">Drug</span>
                  </div>
                  <div class="real-data-stat">
                    <span class="value">${slide.content.realData.placebo}</span>
                    <span class="label">Placebo</span>
                  </div>
                </div>
                <div class="real-data-stat">
                  <span class="value" style="color: var(--red);">RR ${slide.content.realData.rr}</span>
                  <span class="label">(95% CI: ${slide.content.realData.ci})</span>
                </div>
                ${slide.content.realData.nnh ? `
                  <div class="real-data-stat" style="margin-top: 0.5rem;">
                    <span class="value">${slide.content.realData.nnh}</span>
                    <span class="label">NNH (number needed to harm)</span>
                  </div>
                ` : ''}
              </div>
            ` : ''}

            <div class="story-hook" style="margin-top: 1.5rem; font-size: 1.15rem;">
              "${slide.content.hook}"
            </div>
          </div>
        `;
        break;

      case 'decision-tree':
        content = renderDecisionTree(slide.content);
        break;

      case 'real-world-story':
        content = `
          <div class="real-world-story">
            <div class="story-rhetorical-question">${slide.content.rhetoricalQuestion}</div>

            ${slide.content.context ? `<p style="color: rgba(255,255,255,0.85); line-height: 1.7; margin-bottom: 1.5rem;">${slide.content.context}</p>` : ''}

            <div class="story-stats-box">
              <div class="story-stats-header">
                <span>THE REAL DATA</span>
              </div>
              <div class="story-stats-grid">
                ${slide.content.stats.map(stat => `
                  <div class="story-stat-item">
                    <span class="story-stat-value ${stat.type || ''}">${stat.value}</span>
                    <span class="story-stat-label">${stat.label}</span>
                  </div>
                `).join('')}
              </div>
              ${slide.content.source ? `<div class="story-source">Source: ${slide.content.source}</div>` : ''}
            </div>

            <div class="story-decision-tree">
              <div class="story-decision-header">
                <span>THE DECISION</span>
              </div>
              <div class="story-decision-scenario">${slide.content.decisionScenario}</div>

              <div class="story-path path-wrong">
                <div class="story-path-label">PATH A: ${slide.content.pathA.title}</div>
                <div class="story-path-content">
                  ${slide.content.pathA.steps.map(step => `
                    <div class="story-path-arrow">&#8594; ${step}</div>
                  `).join('')}
                </div>
              </div>

              <div class="story-path path-right">
                <div class="story-path-label">PATH B: ${slide.content.pathB.title}</div>
                <div class="story-path-content">
                  ${slide.content.pathB.steps.map(step => `
                    <div class="story-path-arrow">&#8594; ${step}</div>
                  `).join('')}
                </div>
              </div>
            </div>

            <div class="story-revelation">
              <div class="story-revelation-header">
                <span>THE REVELATION</span>
              </div>
              <div class="story-revelation-text">${slide.content.revelation}</div>
            </div>

            ${slide.content.moduleConnection ? `
              <div class="story-connection">
                <strong>Connection to this module:</strong> ${slide.content.moduleConnection}
              </div>
            ` : ''}
          </div>
        `;
        break;

      case 'content':
        content = `
          <h2 class="slide-title">${slide.content.title}</h2>
          <div class="slide-content">
            ${slide.content.sections.map(s => `
              <div class="method-box">
                <h3>${s.heading}</h3>
                ${s.items ? `<ul>${s.items.map(i => `<li>${i}</li>`).join('')}</ul>` : ''}
                ${s.text ? `<p style="line-height: 1.7; color: rgba(255,255,255,0.85);">${s.text}</p>` : ''}
              </div>
            `).join('')}
          </div>
        `;
        break;

      case 'method':
        content = `
          <div class="method-box">
            <div class="method-label">${slide.content.label}</div>
            <h2 style="color: var(--cream); margin-bottom: 1rem;">${slide.content.title}</h2>
            ${slide.content.sections.map(s => `
              <div style="margin-bottom: 1rem;">
                <h4 style="color: var(--gold); margin-bottom: 0.5rem;">${s.heading}</h4>
                <p style="color: rgba(255,255,255,0.85); line-height: 1.6; white-space: pre-line;">${s.text}</p>
              </div>
            `).join('')}
          </div>
        `;
        break;

      case 'tool':
        content = renderTool(slide.content);
        break;

      case 'scenario':
        content = renderScenario(slide.content);
        break;

      case 'quiz':
        content = renderQuiz(slide.content, idx);
        break;

      case 'principle':
        content = `
          <div class="slide-content" style="text-align: center; padding: 3rem;">
            <p style="font-size: 1.3rem; line-height: 1.8; color: var(--cream);">${slide.content.text}</p>
          </div>
        `;
        break;
    }

    return `<div class="slide ${idx === currentSlide ? 'active' : ''}" data-slide="${idx}">${content}</div>`;
  }).join('');

  updateSlideNav();
}

// ============================================================
// TOOLS
// ============================================================

function renderTool(tool) {
  if (tool.id === 'pico-builder') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üîß</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Population (Who?)</label>
          <input type="text" id="pico-p" placeholder="ad es. Adulti con diabete di tipo 2">
        </div>
        <div class="tool-input-group">
          <label>Intervention (What treatment?)</label>
          <input type="text" id="pico-i" placeholder="e.g., SGLT2 inhibitors">
        </div>
        <div class="tool-input-group">
          <label>Comparator (Compared to?)</label>
          <input type="text" id="pico-c" placeholder="e.g., Placebo or standard care">
        </div>
        <div class="tool-input-group">
          <label>Outcome (What matters to patients?)</label>
          <input type="text" id="pico-o" placeholder="e.g., Cardiovascular death, hospitalization for heart failure">
        </div>

        <button class="tool-btn" onclick="generatePICO()">Generate Research Question</button>

        <div class="tool-output" id="pico-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'search-builder') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üîç</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Population Terms</label>
          <input type="text" id="search-pop" placeholder="e.g., diabetes, diabetic, T2DM">
        </div>
        <div class="tool-input-group">
          <label>Intervention Terms</label>
          <input type="text" id="search-int" placeholder="e.g., rosiglitazone, Avandia, thiazolidinedione">
        </div>
        <div class="tool-input-group">
          <label>Outcome Terms</label>
          <input type="text" id="search-out" placeholder="e.g., myocardial infarction, heart attack, cardiovascular">
        </div>

        <button class="tool-btn" onclick="generateSearch()">Generate Search Strategy</button>

        <div class="tool-output" id="search-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'prisma-flow') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üìä</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
          <div class="tool-input-group">
            <label>Records from databases</label>
            <input type="number" id="prisma-db" value="2847">
          </div>
          <div class="tool-input-group">
            <label>Records from other sources</label>
            <input type="number" id="prisma-other" value="156">
          </div>
          <div class="tool-input-group">
            <label>Duplicates removed</label>
            <input type="number" id="prisma-dup" value="423">
          </div>
          <div class="tool-input-group">
            <label>Records screened</label>
            <input type="number" id="prisma-screen" value="2580">
          </div>
          <div class="tool-input-group">
            <label>Records excluded (title/abstract)</label>
            <input type="number" id="prisma-excl1" value="2489">
          </div>
          <div class="tool-input-group">
            <label>Full-text assessed</label>
            <input type="number" id="prisma-ft" value="91">
          </div>
          <div class="tool-input-group">
            <label>Full-text excluded</label>
            <input type="number" id="prisma-excl2" value="68">
          </div>
          <div class="tool-input-group">
            <label>Studies included</label>
            <input type="number" id="prisma-incl" value="23">
          </div>
        </div>

        <button class="tool-btn" onclick="generatePRISMA()">Generate Flow Diagram</button>

        <div class="tool-output" id="prisma-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'extraction-form') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üìã</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Study ID / First Author (Year)</label>
          <input type="text" id="extract-id" placeholder="e.g., Smith 2021">
        </div>
        <div class="tool-input-group">
          <label>Population (N, characteristics)</label>
          <input type="text" id="extract-pop" placeholder="e.g., N=500 adults with T2DM, mean age 62">
        </div>
        <div class="tool-input-group">
          <label>Intervention details</label>
          <input type="text" id="extract-int" placeholder="ad es. Farmaco X 100 mg al giorno per 12 settimane">
        </div>
        <div class="tool-input-group">
          <label>Comparator details</label>
          <input type="text" id="extract-comp" placeholder="e.g., Placebo, identical appearance">
        </div>
        <div class="tool-input-group">
          <label>Outcome (events/total or mean ¬± SD)</label>
          <input type="text" id="extract-out" placeholder="e.g., MI: 23/250 vs 45/250">
        </div>
        <div class="tool-input-group">
          <label>Follow-up duration</label>
          <input type="text" id="extract-followup" placeholder="e.g., 24 months">
        </div>

        <button class="tool-btn" onclick="generateExtraction()">Add to Extraction Table</button>

        <div class="tool-output" id="extraction-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'rob2-tool') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">‚öñÔ∏è</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Study ID</label>
          <input type="text" id="rob-id" placeholder="e.g., Smith 2021">
        </div>

        <div style="margin: 1rem 0;">
          <strong>Domain 1: Randomization</strong>
          <select id="rob-d1" style="width: 100%; margin-top: 0.5rem; padding: 0.5rem;">
            <option value="low">Low risk</option>
            <option value="some">Some concerns</option>
            <option value="high">High risk</option>
          </select>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Domain 2: Deviations from interventions</strong>
          <select id="rob-d2" style="width: 100%; margin-top: 0.5rem; padding: 0.5rem;">
            <option value="low">Low risk</option>
            <option value="some">Some concerns</option>
            <option value="high">High risk</option>
          </select>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Domain 3: Missing outcome data</strong>
          <select id="rob-d3" style="width: 100%; margin-top: 0.5rem; padding: 0.5rem;">
            <option value="low">Low risk</option>
            <option value="some">Some concerns</option>
            <option value="high">High risk</option>
          </select>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Domain 4: Measurement of outcome</strong>
          <select id="rob-d4" style="width: 100%; margin-top: 0.5rem; padding: 0.5rem;">
            <option value="low">Low risk</option>
            <option value="some">Some concerns</option>
            <option value="high">High risk</option>
          </select>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Domain 5: Selection of reported result</strong>
          <select id="rob-d5" style="width: 100%; margin-top: 0.5rem; padding: 0.5rem;">
            <option value="low">Low risk</option>
            <option value="some">Some concerns</option>
            <option value="high">High risk</option>
          </select>
        </div>

        <button class="tool-btn" onclick="generateRoB()">Calculate Overall Risk of Bias</button>

        <div class="tool-output" id="rob-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'effect-calculator') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üî¢</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Effect type</label>
          <select id="effect-type" onchange="updateEffectInputs()" style="width: 100%; padding: 0.5rem;">
            <option value="binary">Binary (events/N for each group)</option>
            <option value="continuous">Continuous (mean, SD, N)</option>
          </select>
        </div>

        <div id="binary-inputs">
          <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
            <div class="tool-input-group">
              <label>Treatment events</label>
              <input type="number" id="eff-e1" value="23">
            </div>
            <div class="tool-input-group">
              <label>Treatment N</label>
              <input type="number" id="eff-n1" value="250">
            </div>
            <div class="tool-input-group">
              <label>Control events</label>
              <input type="number" id="eff-e2" value="45">
            </div>
            <div class="tool-input-group">
              <label>Control N</label>
              <input type="number" id="eff-n2" value="250">
            </div>
          </div>
        </div>

        <div id="continuous-inputs" style="display: none;">
          <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
            <div class="tool-input-group">
              <label>Treatment mean</label>
              <input type="number" step="0.01" id="eff-m1" value="4.2">
            </div>
            <div class="tool-input-group">
              <label>Treatment SD</label>
              <input type="number" step="0.01" id="eff-sd1" value="2.0">
            </div>
            <div class="tool-input-group">
              <label>Treatment N</label>
              <input type="number" id="eff-cn1" value="50">
            </div>
            <div class="tool-input-group">
              <label>Control mean</label>
              <input type="number" step="0.01" id="eff-m2" value="5.8">
            </div>
            <div class="tool-input-group">
              <label>Control SD</label>
              <input type="number" step="0.01" id="eff-sd2" value="2.4">
            </div>
            <div class="tool-input-group">
              <label>Control N</label>
              <input type="number" id="eff-cn2" value="50">
            </div>
          </div>
        </div>

        <button class="tool-btn" onclick="calculateEffect()">Calculate Effect Size</button>

        <div class="tool-output" id="effect-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'forest-plot') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üå≤</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Load Example Dataset</label>
          <select id="forest-preset" style="width: 100%; padding: 0.5rem; margin-bottom: 0.5rem;" onchange="loadForestPreset()">
            <option value="">‚Äî Select a real-world dataset ‚Äî</option>
            <option value="aspirin">Aspirin for Primary Prevention (ASCEND, ASPREE, ARRIVE)</option>
            <option value="cast">CAST: Antiarrhythmics (the story that started it all)</option>
            <option value="magnesium">Magnesium in MI (ISIS-4 vs small trials)</option>
            <option value="ssri">SSRIs vs Placebo (publication bias example)</option>
            <option value="hrt">HRT & CHD (observational vs RCT)</option>
          </select>
        </div>

        <div class="tool-input-group">
          <label>Studies (one per line: Name, RR, LowerCI, UpperCI)</label>
          <textarea id="forest-data" rows="8" placeholder="Study1, 0.75, 0.58, 0.97
Study2, 0.82, 0.65, 1.03
Study3, 0.90, 0.78, 1.04">PHS 1989, 0.58, 0.47, 0.72
WHS 2005, 1.02, 0.84, 1.25
ASPREE 2018, 0.95, 0.83, 1.08
ARRIVE 2018, 0.91, 0.69, 1.19
ASCEND 2018, 0.88, 0.79, 0.97</textarea>
        </div>

        <div class="tool-input-group">
          <label>Model</label>
          <select id="forest-model" style="width: 100%; padding: 0.5rem;">
            <option value="random">Random effects (DerSimonian-Laird)</option>
            <option value="fixed">Fixed effect (Inverse Variance)</option>
          </select>
        </div>

        <div style="display: flex; gap: 0.5rem; flex-wrap: wrap;">
          <button class="tool-btn" onclick="generateForest()">üå≤ Forest Plot</button>
          <button class="tool-btn" onclick="generateFunnelFromForest()" style="background: var(--navy);">üìä Funnel Plot</button>
        </div>

        <div id="forest-output" style="display: none; margin-top: 1rem;"></div>
      </div>
    `;
  }

  if (tool.id === 'heterogeneity-explorer') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üìà</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Pooled RR (or enter from forest plot)</label>
          <input type="number" step="0.01" id="het-rr" value="0.85">
        </div>
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
          <div class="tool-input-group">
            <label>95% CI Lower</label>
            <input type="number" step="0.01" id="het-lower" value="0.72">
          </div>
          <div class="tool-input-group">
            <label>95% CI Upper</label>
            <input type="number" step="0.01" id="het-upper" value="1.00">
          </div>
        </div>
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1rem;">
          <div class="tool-input-group">
            <label>I¬≤ (%)</label>
            <input type="number" id="het-i2" value="68">
          </div>
          <div class="tool-input-group">
            <label>œÑ¬≤ (tau-squared)</label>
            <input type="number" step="0.001" id="het-tau2" value="0.045">
          </div>
        </div>
        <div class="tool-input-group">
          <label>Number of studies</label>
          <input type="number" id="het-k" value="5">
        </div>

        <button class="tool-btn" onclick="calculateHeterogeneity()">Calculate Prediction Interval</button>

        <div class="tool-output" id="het-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'funnel-plot') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">üîª</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Studies (one per line: Name, logRR, SE)</label>
          <textarea id="funnel-data" rows="6" placeholder="Study1, -0.29, 0.12
Study2, 0.02, 0.10">PHS 1989, -0.54, 0.11
WHS 2005, 0.02, 0.10
ASPREE 2018, -0.05, 0.07
ARRIVE 2018, -0.09, 0.14
ASCEND 2018, -0.13, 0.05</textarea>
        </div>

        <button class="tool-btn" onclick="generateFunnel()">Generate Funnel Plot & Run Egger's Test</button>

        <div id="funnel-output" style="display: none; margin-top: 1rem;"></div>
      </div>
    `;
  }

  if (tool.id === 'grade-builder') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">‚≠ê</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 1rem; color: var(--light-text);">${tool.description}</p>

        <div class="tool-input-group">
          <label>Outcome</label>
          <input type="text" id="grade-outcome" value="Cardiovascular events">
        </div>

        <div class="tool-input-group">
          <label>Study design</label>
          <select id="grade-design" style="width: 100%; padding: 0.5rem;">
            <option value="rct">RCTs (start HIGH)</option>
            <option value="obs">Observational (start LOW)</option>
          </select>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Rate down domains:</strong>
          <div style="margin-top: 0.5rem; display: grid; gap: 0.5rem;">
            <label>Risk of bias
              <select id="grade-rob" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">Not serious (0)</option>
                <option value="-1">Serious (-1)</option>
                <option value="-2">Very serious (-2)</option>
              </select>
            </label>
            <label>Inconsistency
              <select id="grade-incon" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">Not serious (0)</option>
                <option value="-1">Serious (-1)</option>
                <option value="-2">Very serious (-2)</option>
              </select>
            </label>
            <label>Indirectness
              <select id="grade-indir" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">Not serious (0)</option>
                <option value="-1">Serious (-1)</option>
                <option value="-2">Very serious (-2)</option>
              </select>
            </label>
            <label>Imprecision
              <select id="grade-imprec" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">Not serious (0)</option>
                <option value="-1">Serious (-1)</option>
                <option value="-2">Very serious (-2)</option>
              </select>
            </label>
            <label>Publication bias
              <select id="grade-pub" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">Undetected / none (0)</option>
                <option value="-1">Suspected (-1)</option>
                <option value="-2">Strongly suspected (-2)</option>
              </select>
            </label>
          </div>
        </div>

        <div style="margin: 1rem 0;">
          <strong>Rate up domains (observational only):</strong>
          <div style="margin-top: 0.5rem;">
            <label>Large effect
              <select id="grade-up-large" style="width: 100%; padding: 0.35rem; margin-top: 0.25rem;">
                <option value="0">None (0)</option>
                <option value="1">Large effect (+1)</option>
                <option value="2">Very large effect (+2)</option>
              </select>
            </label>
            <label style="display: block; margin-top: 0.5rem;"><input type="checkbox" id="grade-up-dose"> Dose-response gradient (+1)</label>
            <label style="display: block; margin-top: 0.25rem;"><input type="checkbox" id="grade-up-confound"> All plausible confounders would reduce observed effect (+1)</label>
          </div>
        </div>

        <button class="tool-btn" onclick="calculateGRADE()">Calculate Certainty</button>

        <div class="tool-output" id="grade-output" style="display: none;"></div>
      </div>
    `;
  }

  if (tool.id === 'prisma-checklist') {
    return `
      <div class="tool-panel">
        <div class="tool-header">
          <span class="tool-icon">‚úì</span>
          <span class="tool-title">${tool.title}</span>
        </div>
        <p style="margin-bottom: 0.5rem; color: var(--light-text);">${tool.description}</p>
        <p style="margin-bottom: 1rem; color: var(--light-text);"><strong>Training subset:</strong> this calculator scores 15 core PRISMA items, not the full 27-item checklist.</p>

        <div style="max-height: 300px; overflow-y: auto; margin-bottom: 1rem;">
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="1"> 1. Title identifies as systematic review</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="2"> 2. Structured abstract</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="3"> 3. Rationale stated</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="4"> 4. Objectives stated (PICO)</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="5"> 5. Protocol registered</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="6"> 6. Eligibility criteria</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="7"> 7. Information sources</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="8"> 8. Search strategy (full for ‚â•1 database)</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="9"> 9. Selection process</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="10"> 10. Data extraction process</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="11"> 11. Effect measures</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="12"> 12. Synthesis methods</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="13"> 13. RoB assessment method</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="14"> 14. Certainty assessment method</label>
          </div>
          <div style="margin-bottom: 0.5rem;">
            <label><input type="checkbox" class="prisma-item" data-item="15"> 15. Flow diagram</label>
          </div>
        </div>

        <button class="tool-btn" onclick="calculatePRISMA()">Calculate Completeness</button>

        <div class="tool-output" id="prisma-checklist-output" style="display: none;"></div>
      </div>
    `;
  }

  return `<div class="tool-panel"><p>Tool: ${tool.id}</p></div>`;
}

function generatePICO() {
  const p = document.getElementById('pico-p').value || '[Population]';
  const i = document.getElementById('pico-i').value || '[Intervention]';
  const c = document.getElementById('pico-c').value || '[Comparator]';
  const o = document.getElementById('pico-o').value || '[Outcome]';

  const output = document.getElementById('pico-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>Your Research Question:</strong>

In ${p}, does ${i} compared to ${c} improve ${o}?

<strong>PICO Table:</strong>
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ P (Population)  ‚îÇ ${p.substring(0,30)}${p.length > 30 ? '...' : ''}
‚îÇ I (Intervention)‚îÇ ${i.substring(0,30)}${i.length > 30 ? '...' : ''}
‚îÇ C (Comparator)  ‚îÇ ${c.substring(0,30)}${c.length > 30 ? '...' : ''}
‚îÇ O (Outcome)     ‚îÇ ${o.substring(0,30)}${o.length > 30 ? '...' : ''}
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¥‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò

<strong>Outcome Hierarchy Check:</strong>
${o.toLowerCase().includes('death') || o.toLowerCase().includes('mortality') ? '‚úì Mortality endpoint ‚Äî excellent!' :
  o.toLowerCase().includes('event') || o.toLowerCase().includes('hospitalization') ? '‚úì Clinical event ‚Äî good patient-important outcome' :
  '‚ö†Ô∏è Consider whether this is a surrogate or patient-important outcome'}
  `;

  awardPoints(25, 'PICO tool used');
  trackToolUse('pico-builder');
}

function generateSearch() {
  const pop = document.getElementById('search-pop').value || 'diabetes';
  const int = document.getElementById('search-int').value || 'drug';
  const out = document.getElementById('search-out').value || 'outcome';

  const popTerms = pop.split(',').map(t => t.trim()).filter(t => t);
  const intTerms = int.split(',').map(t => t.trim()).filter(t => t);
  const outTerms = out.split(',').map(t => t.trim()).filter(t => t);

  const output = document.getElementById('search-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>MEDLINE Search Strategy:</strong>

1. Population:
   (${popTerms.map(t => `"${t}"[tiab]`).join(' OR ')})

2. Intervention:
   (${intTerms.map(t => `"${t}"[tiab]`).join(' OR ')})

3. Outcome:
   (${outTerms.map(t => `"${t}"[tiab]`).join(' OR ')})

4. Combined:
   #1 AND #2 AND #3

<strong>Also Search:</strong>
‚ñ° EMBASE (different syntax)
‚ñ° CENTRAL (Cochrane trials)
‚ñ° ClinicalTrials.gov
‚ñ° WHO ICTRP
‚ñ° Reference lists of included studies
  `;

  awardPoints(25, 'Search builder used');
  trackToolUse('search-builder');
}

function generatePRISMA() {
  const db = parseInt(document.getElementById('prisma-db').value) || 0;
  const other = parseInt(document.getElementById('prisma-other').value) || 0;
  const dup = parseInt(document.getElementById('prisma-dup').value) || 0;
  const screen = parseInt(document.getElementById('prisma-screen').value) || 0;
  const excl1 = parseInt(document.getElementById('prisma-excl1').value) || 0;
  const ft = parseInt(document.getElementById('prisma-ft').value) || 0;
  const excl2 = parseInt(document.getElementById('prisma-excl2').value) || 0;
  const incl = parseInt(document.getElementById('prisma-incl').value) || 0;

  const output = document.getElementById('prisma-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>PRISMA 2020 Flow Diagram</strong>

‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ           IDENTIFICATION                         ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ Records from databases: ${db.toLocaleString().padStart(6)}                  ‚îÇ
‚îÇ Records from other sources: ${other.toLocaleString().padStart(4)}              ‚îÇ
‚îÇ ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ                   ‚îÇ
‚îÇ Total records: ${(db + other).toLocaleString().padStart(6)}                     ‚îÇ
‚îÇ Duplicates removed: ${dup.toLocaleString().padStart(6)}                      ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ           SCREENING                              ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ Records screened: ${screen.toLocaleString().padStart(6)}                      ‚îÇ
‚îÇ Records excluded: ${excl1.toLocaleString().padStart(6)}                      ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ           ELIGIBILITY                            ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ Full-text assessed: ${ft.toLocaleString().padStart(5)}                       ‚îÇ
‚îÇ Full-text excluded: ${excl2.toLocaleString().padStart(5)}                       ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ           INCLUDED                               ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ Studies in review: ${incl.toLocaleString().padStart(6)}                      ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò

<strong>Yield Rates:</strong>
‚Ä¢ Title/abstract screen yield: ${((ft/screen)*100).toFixed(1)}%
‚Ä¢ Full-text inclusion rate: ${((incl/ft)*100).toFixed(1)}%
‚Ä¢ Overall database yield: ${((incl/db)*100).toFixed(2)}%
  `;

  awardPoints(25, 'PRISMA flow generated');
  trackToolUse('prisma-flow');
}

let extractedStudies = [];

function generateExtraction() {
  const study = {
    id: document.getElementById('extract-id').value || 'Unknown',
    pop: document.getElementById('extract-pop').value || '-',
    int: document.getElementById('extract-int').value || '-',
    comp: document.getElementById('extract-comp').value || '-',
    out: document.getElementById('extract-out').value || '-',
    followup: document.getElementById('extract-followup').value || '-'
  };

  extractedStudies.push(study);

  const output = document.getElementById('extraction-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>Data Extraction Table (${extractedStudies.length} studies)</strong>

${extractedStudies.map((s, i) => `
Study ${i+1}: ${s.id}
‚îú‚îÄ Population: ${s.pop}
‚îú‚îÄ Intervention: ${s.int}
‚îú‚îÄ Comparator: ${s.comp}
‚îú‚îÄ Outcome: ${s.out}
‚îî‚îÄ Follow-up: ${s.followup}
`).join('\n')}

<strong>Next:</strong> Enter another study or proceed to risk of bias assessment.
  `;

  // Clear inputs for next study
  document.getElementById('extract-id').value = '';
  document.getElementById('extract-pop').value = '';
  document.getElementById('extract-int').value = '';
  document.getElementById('extract-comp').value = '';
  document.getElementById('extract-out').value = '';
  document.getElementById('extract-followup').value = '';

  awardPoints(15, 'Study extracted');
  trackToolUse('extraction-form');
}

function generateRoB() {
  const id = document.getElementById('rob-id').value || 'Study';
  const d1 = document.getElementById('rob-d1').value;
  const d2 = document.getElementById('rob-d2').value;
  const d3 = document.getElementById('rob-d3').value;
  const d4 = document.getElementById('rob-d4').value;
  const d5 = document.getElementById('rob-d5').value;

  const domains = [d1, d2, d3, d4, d5];
  let overall = 'Low risk';

  const highCount = domains.filter(d => d === 'high').length;
  const someCount = domains.filter(d => d === 'some').length;

  if (highCount > 0) {
    overall = 'High risk';
  } else if (someCount >= 2) {
    overall = 'Some concerns (multiple domains)';
  } else if (someCount === 1) {
    overall = 'Some concerns';
  }

  const getColor = (val) => val === 'low' ? 'üü¢' : val === 'some' ? 'üü°' : 'üî¥';

  const output = document.getElementById('rob-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>Risk of Bias Assessment: ${id}</strong>

${getColor(d1)} Domain 1 (Randomization): ${d1}
${getColor(d2)} Domain 2 (Deviations): ${d2}
${getColor(d3)} Domain 3 (Missing data): ${d3}
${getColor(d4)} Domain 4 (Measurement): ${d4}
${getColor(d5)} Domain 5 (Selection): ${d5}

‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ‚îÅ
OVERALL: ${overall === 'Low risk' ? 'üü¢' : overall.includes('High') ? 'üî¥' : 'üü°'} ${overall}

<strong>Interpretation:</strong>
${overall === 'Low risk' ?
  'Study unlikely to be seriously biased. Results can be weighted appropriately.' :
  overall.includes('High') ?
  'Study has serious limitations. Consider sensitivity analysis excluding it.' :
  'Study raises some concerns. Report in table; may downgrade GRADE certainty.'}
  `;

  awardPoints(20, 'RoB assessment completed');
  trackToolUse('rob2-tool');
}

function updateEffectInputs() {
  const type = document.getElementById('effect-type').value;
  document.getElementById('binary-inputs').style.display = type === 'binary' ? 'block' : 'none';
  document.getElementById('continuous-inputs').style.display = type === 'continuous' ? 'block' : 'none';
}

function calculateEffect() {
  const type = document.getElementById('effect-type').value;
  const output = document.getElementById('effect-output');
  output.style.display = 'block';

  if (type === 'binary') {
    const e1 = parseInt(document.getElementById('eff-e1').value);
    const n1 = parseInt(document.getElementById('eff-n1').value);
    const e2 = parseInt(document.getElementById('eff-e2').value);
    const n2 = parseInt(document.getElementById('eff-n2').value);

    // Continuity correction for zero cells
    const cc = (e1 === 0 || e2 === 0 || e1 === n1 || e2 === n2) ? 0.5 : 0;
    const r1 = (e1 + cc) / (n1 + 2*cc);
    const r2 = (e2 + cc) / (n2 + 2*cc);
    const rr = r1 / r2;
    const logRR = Math.log(rr);
    const seLogRR = Math.sqrt(1/(e1+cc) - 1/(n1+2*cc) + 1/(e2+cc) - 1/(n2+2*cc));
    const lowerRR = Math.exp(logRR - 1.96 * seLogRR);
    const upperRR = Math.exp(logRR + 1.96 * seLogRR);

    const or = ((e1+cc) * (n2-e2+cc)) / ((e2+cc) * (n1-e1+cc));
    const seLogOR = Math.sqrt(1/(e1+cc) + 1/(n1-e1+cc) + 1/(e2+cc) + 1/(n2-e2+cc));
    const lowerOR = Math.exp(Math.log(or) - 1.96 * seLogOR);
    const upperOR = Math.exp(Math.log(or) + 1.96 * seLogOR);

    const rd = r1 - r2;
    const seRD = Math.sqrt(r1*(1-r1)/n1 + r2*(1-r2)/n2);
    const lowerRD = rd - 1.96 * seRD;
    const upperRD = rd + 1.96 * seRD;

    output.innerHTML = `
<strong>Effect Size Calculations (Binary Outcome)</strong>

Treatment: ${e1}/${n1} (${(r1*100).toFixed(1)}%)
Control: ${e2}/${n2} (${(r2*100).toFixed(1)}%)

<strong>Risk Ratio (RR):</strong> ${rr.toFixed(2)} (95% CI: ${lowerRR.toFixed(2)}-${upperRR.toFixed(2)})
  log(RR) = ${logRR.toFixed(3)}, SE = ${seLogRR.toFixed(3)}

<strong>Odds Ratio (OR):</strong> ${or.toFixed(2)} (95% CI: ${lowerOR.toFixed(2)}-${upperOR.toFixed(2)})

<strong>Risk Difference (RD):</strong> ${(rd*100).toFixed(1)}% (95% CI: ${(lowerRD*100).toFixed(1)}% to ${(upperRD*100).toFixed(1)}%)
  NNT = ${rd !== 0 ? Math.abs(Math.round(1/rd)) + (rd < 0 ? ' (benefit)' : ' (harm)') : 'N/A (no difference)'}

<strong>Interpretation:</strong>
${rr < 1 ? `Treatment reduces events by ${((1-rr)*100).toFixed(0)}% relative to control.` :
  rr > 1 ? `Treatment increases events by ${((rr-1)*100).toFixed(0)}% relative to control.` :
  'No difference between groups.'}
    `;
  } else {
    const m1 = parseFloat(document.getElementById('eff-m1').value);
    const sd1 = parseFloat(document.getElementById('eff-sd1').value);
    const cn1 = parseInt(document.getElementById('eff-cn1').value);
    const m2 = parseFloat(document.getElementById('eff-m2').value);
    const sd2 = parseFloat(document.getElementById('eff-sd2').value);
    const cn2 = parseInt(document.getElementById('eff-cn2').value);

    const md = m1 - m2;
    const pooledSD = Math.sqrt(((cn1-1)*sd1*sd1 + (cn2-1)*sd2*sd2) / (cn1 + cn2 - 2));
    const seMD = Math.sqrt(sd1*sd1/cn1 + sd2*sd2/cn2);
    const lowerMD = md - 1.96 * seMD;
    const upperMD = md + 1.96 * seMD;

    const smd = md / pooledSD;
    const seSMD = Math.sqrt((cn1 + cn2)/(cn1 * cn2) + smd*smd/(2*(cn1 + cn2)));
    const lowerSMD = smd - 1.96 * seSMD;
    const upperSMD = smd + 1.96 * seSMD;

    let effectSize = 'negligible';
    if (Math.abs(smd) >= 0.8) effectSize = 'large';
    else if (Math.abs(smd) >= 0.5) effectSize = 'medium';
    else if (Math.abs(smd) >= 0.2) effectSize = 'small';

    output.innerHTML = `
<strong>Effect Size Calculations (Continuous Outcome)</strong>

Treatment: mean = ${m1.toFixed(2)}, SD = ${sd1.toFixed(2)}, N = ${cn1}
Control: mean = ${m2.toFixed(2)}, SD = ${sd2.toFixed(2)}, N = ${cn2}
Pooled SD = ${pooledSD.toFixed(2)}

<strong>Mean Difference (MD):</strong> ${md.toFixed(2)} (95% CI: ${lowerMD.toFixed(2)} to ${upperMD.toFixed(2)})
  SE = ${seMD.toFixed(3)}

<strong>Standardized Mean Difference (SMD/Cohen's d):</strong>
  d = ${smd.toFixed(2)} (95% CI: ${lowerSMD.toFixed(2)} to ${upperSMD.toFixed(2)})
  SE = ${seSMD.toFixed(3)}

<strong>Interpretation (Cohen's conventions):</strong>
  Effect size: ${effectSize} (|d| ${Math.abs(smd).toFixed(2)})
  ${smd < 0 ? 'Treatment group has LOWER scores than control.' :
    smd > 0 ? 'Treatment group has HIGHER scores than control.' :
    'No difference between groups.'}
    `;
  }

  awardPoints(25, 'Effect size calculated');
  trackToolUse('effect-calculator');
}

function _escHtml(s) {
  const d = document.createElement('div');
  d.textContent = s;
  return d.innerHTML;
}

function generateForest() {
  const data = document.getElementById('forest-data').value;
  const model = document.getElementById('forest-model').value;

  const studies = data.split('\n').filter(l => l.trim()).map(line => {
    const parts = line.split(',').map(p => p.trim());
    return {
      name: _escHtml(parts[0]),
      rr: parseFloat(parts[1]),
      lower: parseFloat(parts[2]),
      upper: parseFloat(parts[3]),
      logRR: Math.log(parseFloat(parts[1])),
      se: (Math.log(parseFloat(parts[3])) - Math.log(parseFloat(parts[2]))) / (2 * 1.96)
    };
  });

  // Calculate pooled effect (inverse variance)
  let sumW = 0, sumWY = 0, sumW2 = 0;
  const weights = [];
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    weights.push(w);
    sumW += w;
    sumWY += w * s.logRR;
    sumW2 += w * w;
  });

  const pooledLogRR = sumWY / sumW;
  const pooledRR = Math.exp(pooledLogRR);

  // Q statistic and heterogeneity
  let Q = 0;
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    Q += w * Math.pow(s.logRR - pooledLogRR, 2);
  });

  const df = studies.length - 1;
  const I2 = Math.max(0, ((Q - df) / Q) * 100);
  const tau2 = Math.max(0, (Q - df) / (sumW - sumW2/sumW));

  // Random effects pooled
  let sumWr = 0, sumWYr = 0;
  const weightsRE = [];
  studies.forEach(s => {
    const wr = 1 / (s.se * s.se + tau2);
    weightsRE.push(wr);
    sumWr += wr;
    sumWYr += wr * s.logRR;
  });
  const pooledLogRRr = sumWYr / sumWr;
  const pooledRRr = Math.exp(pooledLogRRr);
  const sePooledRE = Math.sqrt(1 / sumWr);
  const lowerPooledRE = Math.exp(pooledLogRRr - 1.96 * sePooledRE);
  const upperPooledRE = Math.exp(pooledLogRRr + 1.96 * sePooledRE);

  const sePooledFE = Math.sqrt(1 / sumW);
  const lowerPooledFE = Math.exp(pooledLogRR - 1.96 * sePooledFE);
  const upperPooledFE = Math.exp(pooledLogRR + 1.96 * sePooledFE);

  const usedWeights = model === 'random' ? weightsRE : weights;
  const totalWeight = usedWeights.reduce((a, b) => a + b, 0);
  const weightPct = usedWeights.map(w => (w / totalWeight) * 100);

  const usedRR = model === 'random' ? pooledRRr : pooledRR;
  const usedLower = model === 'random' ? lowerPooledRE : lowerPooledFE;
  const usedUpper = model === 'random' ? upperPooledRE : upperPooledFE;

  // Prediction interval (using proper t-distribution)
  const piDF = Math.max(1, studies.length - 2);
  const tCrit = getTCritical(piDF);
  const sePooled = model === 'random' ? sePooledRE : sePooledFE;
  const piWidth = tCrit * Math.sqrt(tau2 + sePooled*sePooled);
  const piLower = Math.exp((model === 'random' ? pooledLogRRr : pooledLogRR) - piWidth);
  const piUpper = Math.exp((model === 'random' ? pooledLogRRr : pooledLogRR) + piWidth);

  // === BUILD INTERACTIVE PLOTLY FOREST PLOT ===
  const output = document.getElementById('forest-output');
  output.style.display = 'block';

  // Create plot container
  output.innerHTML = `
    <div id="forestPlotArea" style="width:100%; height:${Math.max(300, studies.length * 35 + 120)}px;"></div>
    <div class="stats-panel" style="margin-top:1rem;">
      <div class="stats-grid">
        <div class="stat-item">
          <div class="stat-value">${usedRR.toFixed(2)}</div>
          <div class="stat-label">Pooled RR</div>
        </div>
        <div class="stat-item">
          <div class="stat-value">${usedLower.toFixed(2)}-${usedUpper.toFixed(2)}</div>
          <div class="stat-label">95% CI</div>
        </div>
        <div class="stat-item">
          <div class="stat-value">${I2.toFixed(1)}%</div>
          <div class="stat-label">I¬≤ heterogeneity</div>
        </div>
        <div class="stat-item">
          <div class="stat-value">${piLower.toFixed(2)}-${piUpper.toFixed(2)}</div>
          <div class="stat-label">Prediction Interval</div>
        </div>
      </div>
      <div class="stat-interpretation">
        <strong>Interpretation:</strong> ${usedLower > 1 ? '‚ö†Ô∏è Treatment INCREASES risk (statistically significant).' :
          usedUpper < 1 ? '‚úì Treatment REDUCES risk (statistically significant).' :
          '‚óã No statistically significant effect (CI crosses 1.0).'}
        ${I2 > 50 ? '<br><strong>Warning:</strong> High heterogeneity (I¬≤ > 50%) ‚Äî consider exploring sources of variation.' : ''}
        ${piLower < 1 && piUpper > 1 ? '<br><strong>Note:</strong> Prediction interval crosses null ‚Äî true effect in a new study could go either direction.' : ''}
      </div>
    </div>
  `;

  // Check if Plotly is loaded
  if (typeof Plotly !== 'undefined') {
    const yValues = studies.map((s, i) => studies.length - i);
    const studyNames = studies.map(s => s.name);

    // Study points trace
    const studyTrace = {
      x: studies.map(s => s.rr),
      y: yValues,
      mode: 'markers',
      type: 'scatter',
      marker: {
        size: weightPct.map(w => Math.max(8, Math.min(24, w * 1.5))),
        color: '#1E2761',
        symbol: 'square',
        line: { color: '#0d1b2a', width: 1 }
      },
      error_x: {
        type: 'data',
        symmetric: false,
        array: studies.map(s => s.upper - s.rr),
        arrayminus: studies.map(s => s.rr - s.lower),
        color: '#1E2761',
        thickness: 2,
        width: 4
      },
      text: studies.map((s, i) => `${s.name}<br>RR: ${s.rr.toFixed(2)} (${s.lower.toFixed(2)}-${s.upper.toFixed(2)})<br>Weight: ${weightPct[i].toFixed(1)}%`),
      hoverinfo: 'text',
      name: 'Studies'
    };

    // Pooled effect diamond
    const pooledTrace = {
      x: [usedRR],
      y: [0],
      mode: 'markers',
      type: 'scatter',
      marker: {
        size: 16,
        color: '#D4AF37',
        symbol: 'diamond',
        line: { color: '#8B7500', width: 2 }
      },
      error_x: {
        type: 'data',
        symmetric: false,
        array: [usedUpper - usedRR],
        arrayminus: [usedRR - usedLower],
        color: '#D4AF37',
        thickness: 3,
        width: 0
      },
      text: [`Pooled (${model})<br>RR: ${usedRR.toFixed(2)} (${usedLower.toFixed(2)}-${usedUpper.toFixed(2)})`],
      hoverinfo: 'text',
      name: 'Pooled'
    };

    // Null effect line
    const nullLine = {
      x: [1, 1],
      y: [-0.5, studies.length + 0.5],
      mode: 'lines',
      type: 'scatter',
      line: { color: '#888', width: 1, dash: 'dash' },
      hoverinfo: 'skip',
      showlegend: false
    };

    // Prediction interval
    const piTrace = {
      x: [piLower, piUpper],
      y: [-0.5, -0.5],
      mode: 'lines+markers',
      type: 'scatter',
      line: { color: '#888', width: 1, dash: 'dot' },
      marker: { size: 6, color: '#888', symbol: 'line-ns-open' },
      text: [`Prediction Interval: ${piLower.toFixed(2)}-${piUpper.toFixed(2)}`],
      hoverinfo: 'text',
      name: 'Prediction Interval'
    };

    const layout = {
      xaxis: {
        title: 'Risk Ratio (log scale)',
        type: 'log',
        showgrid: true,
        gridcolor: '#eee',
        zeroline: false,
        tickvals: [0.25, 0.5, 1, 2, 4],
        ticktext: ['0.25', '0.5', '1', '2', '4']
      },
      yaxis: {
        tickvals: [...yValues, 0],
        ticktext: [...studyNames, `<b>Pooled (${model})</b>`],
        showgrid: false,
        zeroline: false
      },
      annotations: [
        { x: 0.5, y: -0.08, xref: 'paper', yref: 'paper', text: '‚Üê Favors Treatment', showarrow: false, font: { size: 10, color: '#22c55e' } },
        { x: 0.95, y: -0.08, xref: 'paper', yref: 'paper', text: 'Favors Control ‚Üí', showarrow: false, font: { size: 10, color: '#C53030' } }
      ],
      showlegend: false,
      margin: { l: 150, r: 50, t: 30, b: 60 },
      paper_bgcolor: 'white',
      plot_bgcolor: 'white',
      hovermode: 'closest'
    };

    Plotly.newPlot('forestPlotArea', [nullLine, studyTrace, pooledTrace, piTrace], layout, { responsive: true });
  } else {
    // Fallback to text-based plot if Plotly not loaded
    output.innerHTML += '<p style="color:#888; padding:1rem;">Plotly not loaded. Showing text summary only.</p>';
  }

  awardPoints(50, 'Forest plot generated');
  trackToolUse('forest-plot');
}

// ============================================================
// FUNNEL PLOT FROM FOREST DATA (INTERACTIVE - Plotly)
// ============================================================

function generateFunnelFromForest() {
  const data = document.getElementById('forest-data').value;
  const output = document.getElementById('forest-output');
  output.style.display = 'block';

  const rawLines = data
    .split('\n')
    .map(line => line.trim())
    .filter(line => line);

  const studies = rawLines
    .map(line => {
      const parts = line.split(',').map(p => p.trim());
      if (parts.length < 4) return null;
      const rr = parseFloat(parts[1]);
      const lower = parseFloat(parts[2]);
      const upper = parseFloat(parts[3]);
      if (!Number.isFinite(rr) || !Number.isFinite(lower) || !Number.isFinite(upper)) return null;
      if (rr <= 0 || lower <= 0 || upper <= 0 || upper <= lower) return null;
      const logRR = Math.log(rr);
      const se = (Math.log(upper) - Math.log(lower)) / (2 * 1.96);
      if (!Number.isFinite(logRR) || !Number.isFinite(se) || se <= 0) return null;
      return { name: _escHtml(parts[0]), rr, lower, upper, logRR, se };
    })
    .filter(Boolean);

  const invalidRows = rawLines.length - studies.length;

  if (studies.length < 3) {
    output.innerHTML = `
      <div class="stats-panel">
        <strong>Need at least 3 valid studies to run funnel and Egger analysis.</strong><br>
        Provide rows in this format: <code>Study, RR, lower_CI, upper_CI</code>.<br>
        Valid rows: ${studies.length}. Excluded invalid rows: ${invalidRows}.
      </div>
    `;
    return;
  }

  // Calculate pooled effect
  let sumW = 0, sumWY = 0;
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    sumW += w;
    sumWY += w * s.logRR;
  });
  if (!Number.isFinite(sumW) || sumW <= 0 || !Number.isFinite(sumWY)) {
    output.innerHTML = `
      <div class="stats-panel">
        <strong>Unable to compute pooled effect from provided data.</strong><br>
        Check that all studies have valid numeric CIs with lower &lt; upper.
      </div>
    `;
    return;
  }
  const pooledLogRR = sumWY / sumW;

  // Egger's test
  const n = studies.length;
  const precision = studies.map(s => 1 / s.se);
  const standardized = studies.map(s => s.logRR / s.se);

  const meanP = precision.reduce((a, b) => a + b, 0) / n;
  const meanS = standardized.reduce((a, b) => a + b, 0) / n;

  let num = 0, denP = 0;
  for (let i = 0; i < n; i++) {
    num += (precision[i] - meanP) * (standardized[i] - meanS);
    denP += Math.pow(precision[i] - meanP, 2);
  }

  let intercept = NaN;
  let pValue = NaN;
  let eggerEstimable = n >= 3 && Number.isFinite(denP) && denP > 0;
  if (eggerEstimable) {
    const slope = num / denP;
    intercept = meanS - slope * meanP;

    let residualSS = 0;
    for (let i = 0; i < n; i++) {
      const predicted = intercept + slope * precision[i];
      residualSS += Math.pow(standardized[i] - predicted, 2);
    }
    const mse = residualSS / (n - 2);
    const seIntercept = Math.sqrt(mse * (1 / n + (meanP * meanP) / denP));
    const tStat = intercept / seIntercept;
    const eggerDF = n - 2;
    if (!Number.isFinite(seIntercept) || seIntercept <= 0 || !Number.isFinite(tStat) || eggerDF <= 0) {
      eggerEstimable = false;
    } else {
      pValue = 2 * (1 - tCDF(Math.abs(tStat), eggerDF));
      if (!Number.isFinite(pValue)) eggerEstimable = false;
    }
  }

  const lowPower = n < 10;
  const asymmetryDetected = eggerEstimable && !lowPower && pValue < 0.10;
  const interceptDisplay = eggerEstimable ? intercept.toFixed(3) : 'N/A';
  const pValueDisplay = eggerEstimable ? pValue.toFixed(4) : 'N/A';
  const asymmetryDisplay = !eggerEstimable
    ? 'Not estimable'
    : lowPower
      ? 'Low power (k<10)'
      : (asymmetryDetected ? 'Yes' : 'No');

  let interpretation = '';
  if (!eggerEstimable) {
    interpretation = "Egger's test is not estimable for this dataset (need >=3 valid studies and variation in precision).";
  } else if (lowPower) {
    interpretation = `Egger's test has limited power with only ${n} studies. Treat the p-value as exploratory and rely on visual/clinical assessment.`;
  } else if (asymmetryDetected) {
    interpretation = "Funnel plot asymmetry detected (Egger p < 0.10). This may reflect publication bias, small-study effects, or heterogeneity.";
  } else {
    interpretation = "No statistical evidence of funnel asymmetry. This does not rule out publication bias.";
  }
  if (invalidRows > 0) {
    interpretation += ` Data quality note: excluded ${invalidRows} invalid row(s).`;
  }

  output.innerHTML = `
    <div id="funnelPlotArea" style="width:100%; height:350px; margin-bottom:1rem;"></div>
    <div class="stats-panel">
      <div class="stats-grid">
        <div class="stat-item">
          <div class="stat-value">${interceptDisplay}</div>
          <div class="stat-label">Egger's Intercept</div>
        </div>
        <div class="stat-item">
          <div class="stat-value">${pValueDisplay}</div>
          <div class="stat-label">P-value</div>
        </div>
        <div class="stat-item">
          <div class="stat-value">${asymmetryDisplay}</div>
          <div class="stat-label">Asymmetry signal (p < 0.10, k>=10)</div>
        </div>
      </div>
      <div class="stat-interpretation">
        <strong>Interpretation:</strong> ${interpretation}
      </div>
    </div>
  `;

  if (typeof Plotly !== 'undefined') {
    const maxSE = Math.max(...studies.map(s => s.se)) * 1.2;

    const seRange = Array.from({length: 50}, (_, i) => (i / 49) * maxSE);
    const lowerBound = seRange.map(se => Math.exp(pooledLogRR - 1.96 * se));
    const upperBound = seRange.map(se => Math.exp(pooledLogRR + 1.96 * se));

    const funnelTrace = {
      x: [...lowerBound, ...upperBound.reverse()],
      y: [...seRange, ...seRange.reverse()],
      fill: 'toself',
      fillcolor: 'rgba(30,39,97,0.1)',
      line: { color: 'transparent' },
      hoverinfo: 'skip',
      showlegend: false
    };

    const pooledLine = {
      x: [Math.exp(pooledLogRR), Math.exp(pooledLogRR)],
      y: [0, maxSE],
      mode: 'lines',
      line: { color: '#D4AF37', width: 2, dash: 'dash' },
      hoverinfo: 'skip',
      showlegend: false
    };

    const nullLine = {
      x: [1, 1],
      y: [0, maxSE],
      mode: 'lines',
      line: { color: '#888', width: 1, dash: 'dot' },
      hoverinfo: 'skip',
      showlegend: false
    };

    const studyPoints = {
      x: studies.map(s => s.rr),
      y: studies.map(s => s.se),
      mode: 'markers',
      type: 'scatter',
      marker: { size: 10, color: '#1E2761', line: { color: '#0d1b2a', width: 1 } },
      text: studies.map(s => `${s.name}<br>RR: ${s.rr.toFixed(2)}<br>SE: ${s.se.toFixed(3)}`),
      hoverinfo: 'text',
      name: 'Studies'
    };

    const layout = {
      xaxis: { title: 'Risk Ratio (log scale)', type: 'log', showgrid: true, gridcolor: '#eee' },
      yaxis: { title: 'Standard Error', autorange: 'reversed', showgrid: true, gridcolor: '#eee' },
      showlegend: false,
      margin: { l: 60, r: 30, t: 30, b: 50 },
      paper_bgcolor: 'white',
      plot_bgcolor: 'white'
    };

    Plotly.newPlot('funnelPlotArea', [funnelTrace, pooledLine, nullLine, studyPoints], layout, { responsive: true });
  }

  awardPoints(50, 'Funnel plot generated');
  trackToolUse('funnel-plot');
}

// Normal CDF approximation
function normalCDF(x) {
  const a1 =  0.254829592, a2 = -0.284496736, a3 =  1.421413741;
  const a4 = -1.453152027, a5 =  1.061405429, p  =  0.3275911;
  const sign = x < 0 ? -1 : 1;
  x = Math.abs(x) / Math.sqrt(2);
  const t = 1.0 / (1.0 + p * x);
  const y = 1.0 - (((((a5 * t + a4) * t) + a3) * t + a2) * t + a1) * t * Math.exp(-x * x);
  return 0.5 * (1.0 + sign * y);
}

// T-distribution critical values (two-tailed 95%, df 1-30 and approximation for larger)
const tCriticalValues = {
  1: 12.706, 2: 4.303, 3: 3.182, 4: 2.776, 5: 2.571,
  6: 2.447, 7: 2.365, 8: 2.306, 9: 2.262, 10: 2.228,
  11: 2.201, 12: 2.179, 13: 2.160, 14: 2.145, 15: 2.131,
  16: 2.120, 17: 2.110, 18: 2.101, 19: 2.093, 20: 2.086,
  21: 2.080, 22: 2.074, 23: 2.069, 24: 2.064, 25: 2.060,
  26: 2.056, 27: 2.052, 28: 2.048, 29: 2.045, 30: 2.042
};

function getTCritical(df) {
  if (df <= 0) return 12.706;
  if (df <= 30) return tCriticalValues[df] || tCriticalValues[Math.round(df)];
  // For df > 30, use approximation approaching 1.96
  return 1.96 + 2.4 / df;
}

// T-distribution CDF approximation (for p-value calculation)
function tCDF(t, df) {
  // Use regularized incomplete beta function approximation
  const x = df / (df + t * t);
  const a = df / 2;
  const b = 0.5;
  // For |t| > 0, use beta function approximation
  if (Math.abs(t) < 1e-10) return 0.5;
  const betaIncomplete = incompleteBeta(x, a, b);
  return t > 0 ? 1 - 0.5 * betaIncomplete : 0.5 * betaIncomplete;
}

// Incomplete beta function approximation using continued fractions
function incompleteBeta(x, a, b) {
  if (x === 0) return 0;
  if (x === 1) return 1;
  // Use series expansion for small x
  const bt = Math.exp(
    lgamma(a + b) - lgamma(a) - lgamma(b) +
    a * Math.log(x) + b * Math.log(1 - x)
  );
  if (x < (a + 1) / (a + b + 2)) {
    return bt * betaCF(x, a, b) / a;
  } else {
    return 1 - bt * betaCF(1 - x, b, a) / b;
  }
}

// Continued fraction for incomplete beta
function betaCF(x, a, b) {
  const maxIter = 100, eps = 1e-10;
  let am = 1, bm = 1, az = 1;
  const qab = a + b, qap = a + 1, qam = a - 1;
  let bz = 1 - qab * x / qap;
  for (let m = 1; m <= maxIter; m++) {
    const em = m, tem = em + em;
    let d = em * (b - m) * x / ((qam + tem) * (a + tem));
    const ap = az + d * am;
    const bp = bz + d * bm;
    d = -(a + em) * (qab + em) * x / ((a + tem) * (qap + tem));
    const app = ap + d * az;
    const bpp = bp + d * bz;
    const aold = az;
    am = ap / bpp; bm = bp / bpp;
    az = app / bpp; bz = 1;
    if (Math.abs(az - aold) < eps * Math.abs(az)) break;
  }
  return az;
}

// Log gamma function (Lanczos approximation)
function lgamma(x) {
  const g = 7;
  const c = [0.99999999999980993, 676.5203681218851, -1259.1392167224028,
    771.32342877765313, -176.61502916214059, 12.507343278686905,
    -0.13857109526572012, 9.9843695780195716e-6, 1.5056327351493116e-7];
  if (x < 0.5) {
    return Math.log(Math.PI / Math.sin(Math.PI * x)) - lgamma(1 - x);
  }
  x -= 1;
  let a = c[0];
  for (let i = 1; i < g + 2; i++) a += c[i] / (x + i);
  const t = x + g + 0.5;
  return 0.5 * Math.log(2 * Math.PI) + (x + 0.5) * Math.log(t) - t + Math.log(a);
}

// ============================================================
// PRESET DATASETS (Real-world meta-analysis data)
// ============================================================

const forestPresets = {
  aspirin: {
    name: "Aspirina per la prevenzione primaria",
    description: "Major trials of aspirin for cardiovascular prevention in people without prior CVD",
    data: `PHS 1989, 0.58, 0.47, 0.72
BDT 1988, 0.97, 0.87, 1.09
TPT 1998, 0.80, 0.61, 1.05
HOT 1998, 0.85, 0.73, 0.99
PPP 2001, 0.71, 0.48, 1.04
WHS 2005, 1.02, 0.84, 1.25
POPADAD 2008, 0.98, 0.76, 1.26
JPAD 2008, 0.80, 0.58, 1.10
AAA 2010, 1.08, 0.86, 1.36
JPPP 2014, 0.94, 0.77, 1.15
ARRIVE 2018, 0.96, 0.81, 1.13
ASCEND 2018, 0.88, 0.79, 0.97
ASPREE 2018, 0.95, 0.83, 1.08`
  },
  cast: {
    name: "CAST: Antiarrhythmic Drugs After MI",
    description: "Lo studio che ha ucciso oltre 50.000 americani: ponendo la domanda sbagliata",
    data: `Encainide 1989, 2.38, 1.59, 3.57
Flecainide 1989, 2.64, 1.60, 4.36
Moricizine 1992, 1.69, 1.10, 2.58`
  },
  magnesium: {
    name: "Magnesium in Acute MI",
    description: "Small trials vs mega-trial ‚Äî the danger of small-study effects",
    data: `Morton 1984, 0.09, 0.01, 1.54
Rasmussen 1986, 0.25, 0.07, 0.89
Smith 1986, 0.45, 0.09, 2.13
Abraham 1987, 0.75, 0.31, 1.78
Feldstedt 1988, 0.56, 0.23, 1.36
Ceremuzynski 1989, 0.25, 0.06, 1.10
Shechter 1990, 0.16, 0.04, 0.69
LIMIT-2 1992, 0.74, 0.56, 0.99
ISIS-4 1995, 1.06, 0.99, 1.14`
  },
  ssri: {
    name: "SSRIs vs Placebo (Published vs All Trials)",
    description: "Turner 2008: Publication bias in antidepressant trials",
    data: `Published + Positive, 0.65, 0.58, 0.73
Published + Negative, 0.92, 0.80, 1.06
Unpublished + Negative, 0.95, 0.86, 1.05
Unpublished + Questionable, 0.88, 0.77, 1.01`
  },
  hrt: {
    name: "HRT and Coronary Heart Disease",
    description: "Observational studies suggested benefit, but RCTs showed harm",
    data: `NHS 1985, 0.50, 0.30, 0.80
Framingham 1985, 0.50, 0.30, 0.90
NHANES 1987, 0.66, 0.46, 0.96
Uppsala 1988, 0.90, 0.70, 1.20
Rancho 1991, 0.59, 0.35, 0.99
NHS 1991, 0.56, 0.40, 0.80
Leisure World 1996, 0.62, 0.50, 0.76
WHI 2002, 1.29, 1.02, 1.63
HERS 1998, 0.99, 0.81, 1.22`
  }
};

function loadForestPreset() {
  const preset = document.getElementById('forest-preset').value;
  if (!preset || !forestPresets[preset]) return;

  const data = forestPresets[preset];
  document.getElementById('forest-data').value = data.data;

  // Show info about the dataset
  const output = document.getElementById('forest-output');
  output.style.display = 'block';
  output.innerHTML = `
    <div style="background: rgba(30,39,97,0.15); padding: 1rem; border-radius: 8px; margin-bottom: 1rem;">
      <strong style="color: var(--navy);">üìö ${data.name}</strong>
      <p style="margin-top: 0.5rem; color: var(--light-text); font-size: 0.9rem;">${data.description}</p>
      <p style="margin-top: 0.5rem; font-size: 0.85rem; color: var(--teal);">Click "Forest Plot" or "Funnel Plot" to analyze this data.</p>
    </div>
  `;
}

// ============================================================
// INTERACTIVE DATA TABLE EDITOR
// ============================================================

function addStudyRow() {
  const table = document.getElementById('study-data-table');
  if (!table) return;

  const tbody = table.querySelector('tbody');
  const rowCount = tbody.children.length + 1;

  const row = document.createElement('tr');
  row.innerHTML = `
    <td><input type="text" value="Study ${rowCount}" onchange="updateForestData()"></td>
    <td><input type="number" step="0.01" value="1.00" onchange="updateForestData()"></td>
    <td><input type="number" step="0.01" value="0.80" onchange="updateForestData()"></td>
    <td><input type="number" step="0.01" value="1.25" onchange="updateForestData()"></td>
    <td class="row-actions"><button class="delete-row" onclick="deleteStudyRow(this)">‚úï</button></td>
  `;
  tbody.appendChild(row);
  updateForestData();
}

function deleteStudyRow(btn) {
  const row = btn.closest('tr');
  if (row) {
    row.remove();
    updateForestData();
  }
}

function updateForestData() {
  const table = document.getElementById('study-data-table');
  if (!table) return;

  const rows = table.querySelectorAll('tbody tr');
  const lines = [];

  rows.forEach(row => {
    const inputs = row.querySelectorAll('input');
    if (inputs.length >= 4) {
      const name = inputs[0].value;
      const rr = inputs[1].value;
      const lower = inputs[2].value;
      const upper = inputs[3].value;
      lines.push(`${name}, ${rr}, ${lower}, ${upper}`);
    }
  });

  const textarea = document.getElementById('forest-data');
  if (textarea) {
    textarea.value = lines.join('\n');
  }
}

// Legacy text forest for compatibility
function generateForestLegacy() {
  const data = document.getElementById('forest-data').value;
  const model = document.getElementById('forest-model').value;

  const studies = data.split('\n').filter(l => l.trim()).map(line => {
    const parts = line.split(',').map(p => p.trim());
    return {
      name: _escHtml(parts[0]),
      rr: parseFloat(parts[1]),
      lower: parseFloat(parts[2]),
      upper: parseFloat(parts[3]),
      logRR: Math.log(parseFloat(parts[1])),
      se: (Math.log(parseFloat(parts[3])) - Math.log(parseFloat(parts[2]))) / (2 * 1.96)
    };
  });

  let sumW = 0, sumWY = 0, sumW2 = 0;
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    sumW += w;
    sumWY += w * s.logRR;
    sumW2 += w * w;
  });

  const pooledLogRR = sumWY / sumW;
  const pooledRR = Math.exp(pooledLogRR);

  let Q = 0;
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    Q += w * Math.pow(s.logRR - pooledLogRR, 2);
  });

  const df = studies.length - 1;
  const I2 = Math.max(0, ((Q - df) / Q) * 100);
  const tau2 = Math.max(0, (Q - df) / (sumW - sumW2/sumW));

  let sumWr = 0, sumWYr = 0;
  studies.forEach(s => {
    const wr = 1 / (s.se * s.se + tau2);
    sumWr += wr;
    sumWYr += wr * s.logRR;
  });
  const pooledLogRRr = sumWYr / sumWr;
  const pooledRRr = Math.exp(pooledLogRRr);
  const sePooledRE = Math.sqrt(1 / sumWr);
  const lowerPooledRE = Math.exp(pooledLogRRr - 1.96 * sePooledRE);
  const upperPooledRE = Math.exp(pooledLogRRr + 1.96 * sePooledRE);

  const sePooledFE = Math.sqrt(1 / sumW);
  const lowerPooledFE = Math.exp(pooledLogRR - 1.96 * sePooledFE);
  const upperPooledFE = Math.exp(pooledLogRR + 1.96 * sePooledFE);

  const usedRR = model === 'random' ? pooledRRr : pooledRR;
  const usedLower = model === 'random' ? lowerPooledRE : lowerPooledFE;
  const usedUpper = model === 'random' ? upperPooledRE : upperPooledFE;

  const minLog = Math.log(0.3);
  const maxLog = Math.log(2.0);
  const range = maxLog - minLog;
  const width = 50;

  const getPos = (rr) => Math.round(((Math.log(rr) - minLog) / range) * width);
  const nullPos = getPos(1.0);

  let forestText = `
<strong>Forest Plot (${model === 'random' ? 'Random Effects' : 'Fixed Effect'})</strong>

                              0.3   0.5     1.0    1.5  2.0
Study                RR (95% CI)  ‚îÇ${' '.repeat(nullPos-1)}‚îÇ
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îº${'‚îÄ'.repeat(width)}‚î§
`;

  studies.forEach(s => {
    const pos = getPos(s.rr);
    const lowerPos = Math.max(0, getPos(s.lower));
    const upperPos = Math.min(width, getPos(s.upper));

    let line = ' '.repeat(width + 1);
    line = line.substring(0, lowerPos) + '‚îú' + '‚îÄ'.repeat(Math.max(0, upperPos - lowerPos - 1)) + '‚î§' + line.substring(upperPos + 1);
    line = line.substring(0, pos) + '‚ñ†' + line.substring(pos + 1);

    const name = (s.name + ' '.repeat(15)).substring(0, 15);
    const ci = `${s.rr.toFixed(2)} (${s.lower.toFixed(2)}-${s.upper.toFixed(2)})`;
    forestText += `${name}  ${ci.padEnd(16)} ‚îÇ${line}‚îÇ\n`;
  });

  const pooledPos = getPos(usedRR);
  const pooledLowerPos = Math.max(0, getPos(usedLower));
  const pooledUpperPos = Math.min(width, getPos(usedUpper));
  let pooledLine = ' '.repeat(width + 1);
  pooledLine = pooledLine.substring(0, pooledLowerPos) + '<' + '‚ïê'.repeat(Math.max(0, pooledUpperPos - pooledLowerPos - 1)) + '>' + pooledLine.substring(pooledUpperPos + 1);
  pooledLine = pooledLine.substring(0, pooledPos) + '‚óÜ' + pooledLine.substring(pooledPos + 1);

  forestText += `‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îº${'‚îÄ'.repeat(width)}‚î§
Pooled (${model})    ${usedRR.toFixed(2)} (${usedLower.toFixed(2)}-${usedUpper.toFixed(2)})   ‚îÇ${pooledLine}‚îÇ

<strong>Heterogeneity:</strong>
Q = ${Q.toFixed(2)}, df = ${df}, p ${Q > df * 2 ? '< 0.05' : '‚â• 0.05'}
I¬≤ = ${I2.toFixed(1)}% ${I2 < 25 ? '(low)' : I2 < 50 ? '(moderate)' : I2 < 75 ? '(substantial)' : '(considerable)'}
œÑ¬≤ = ${tau2.toFixed(4)}

<strong>Interpretation:</strong>
${usedLower > 1 ? 'Treatment INCREASES events (statistically significant).' :
  usedUpper < 1 ? 'Treatment REDUCES events (statistically significant).' :
  'No statistically significant effect (CI crosses 1.0).'}
`;

  const output = document.getElementById('forest-output');
  output.style.display = 'block';
  output.innerHTML = `<pre style="font-family: monospace; font-size: 0.8rem; overflow-x: auto;">${forestText}</pre>`;

  awardPoints(50, 'Forest plot generated');
  trackToolUse('forest-plot');
}

function calculateHeterogeneity() {
  const rr = parseFloat(document.getElementById('het-rr').value);
  const lower = parseFloat(document.getElementById('het-lower').value);
  const upper = parseFloat(document.getElementById('het-upper').value);
  const i2 = parseFloat(document.getElementById('het-i2').value);
  const tau2 = parseFloat(document.getElementById('het-tau2').value);
  const k = parseInt(document.getElementById('het-k').value);

  const logRR = Math.log(rr);
  const tau = Math.sqrt(tau2);

  // Prediction interval (approximate)
  const tCrit = getTCritical(Math.max(1, k - 2));
  const sePooled = (Math.log(upper) - Math.log(lower)) / (2 * 1.96);
  const piWidth = tCrit * Math.sqrt(tau2 + sePooled*sePooled);
  const piLower = Math.exp(logRR - piWidth);
  const piUpper = Math.exp(logRR + piWidth);

  const output = document.getElementById('het-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>Heterogeneity Analysis</strong>

Pooled effect: RR ${rr.toFixed(2)} (95% CI: ${lower.toFixed(2)}-${upper.toFixed(2)})
Number of studies: ${k}

<strong>Heterogeneity metrics:</strong>
‚Ä¢ I¬≤ = ${i2.toFixed(1)}%
  ${i2 < 25 ? '‚Üí Low heterogeneity' :
    i2 < 50 ? '‚Üí Moderate heterogeneity' :
    i2 < 75 ? '‚Üí Substantial heterogeneity' :
    '‚Üí Considerable heterogeneity'}

‚Ä¢ œÑ¬≤ = ${tau2.toFixed(4)}
‚Ä¢ œÑ = ${tau.toFixed(3)} (SD of true effects on log scale)

<strong>95% Prediction Interval:</strong>
RR ${piLower.toFixed(2)} to ${piUpper.toFixed(2)}

${piLower < 1 && piUpper > 1 ?
  '‚ö†Ô∏è CRITICAL: Prediction interval crosses 1.0\nIn some future settings, the treatment may not work or may cause harm.' :
  piUpper < 1 ?
  '‚úì Prediction interval below 1.0 ‚Äî treatment likely beneficial across settings.' :
  '‚ö†Ô∏è Prediction interval above 1.0 ‚Äî treatment may cause harm in some settings.'}

<strong>Clinical interpretation:</strong>
The confidence interval tells you: "The average effect is probably ${rr.toFixed(2)}."
The prediction interval tells you: "A new study would probably find an effect between ${piLower.toFixed(2)} and ${piUpper.toFixed(2)}."

${i2 > 50 ? '\n‚ö†Ô∏è With I¬≤ > 50%, explore sources of heterogeneity through subgroup analysis or meta-regression.' : ''}
  `;

  awardPoints(25, 'Heterogeneity analyzed');
  trackToolUse('heterogeneity-explorer');
}

function generateFunnel() {
  const data = document.getElementById('funnel-data').value;
  const output = document.getElementById('funnel-output');
  output.style.display = 'block';

  const rawLines = data
    .split('\n')
    .map(line => line.trim())
    .filter(line => line);

  const studies = rawLines
    .map(line => {
      const parts = line.split(',').map(p => p.trim());
      if (parts.length < 3) return null;
      const logRR = parseFloat(parts[1]);
      const se = parseFloat(parts[2]);
      if (!Number.isFinite(logRR) || !Number.isFinite(se) || se <= 0) return null;
      return {
        name: _escHtml(parts[0]),
        logRR,
        se
      };
    })
    .filter(Boolean);

  const invalidRows = rawLines.length - studies.length;

  if (studies.length < 3) {
    output.innerHTML = `
      <div class="stats-panel">
        <strong>Need at least 3 valid studies to run funnel and Egger analysis.</strong><br>
        Provide rows in this format: <code>Study, logRR, SE</code>.<br>
        Valid rows: ${studies.length}. Excluded invalid rows: ${invalidRows}.
      </div>
    `;
    return;
  }

  // Calculate pooled effect for reference line
  let sumW = 0, sumWY = 0;
  studies.forEach(s => {
    const w = 1 / (s.se * s.se);
    sumW += w;
    sumWY += w * s.logRR;
  });
  if (!Number.isFinite(sumW) || sumW <= 0 || !Number.isFinite(sumWY)) {
    output.innerHTML = `
      <div class="stats-panel">
        <strong>Unable to compute pooled effect from provided data.</strong><br>
        Check that all studies contain valid numeric logRR and SE values.
      </div>
    `;
    return;
  }
  const pooledLogRR = sumWY / sumW;

  // Egger's test (weighted linear regression of standardized effects on precision)
  const precisions = studies.map(s => 1 / s.se);
  const standardizedEffects = studies.map(s => s.logRR / s.se);
  const n = studies.length;

  let sumXY = 0, sumX2 = 0, sumY = 0, sumX = 0;
  for (let i = 0; i < n; i++) {
    const x = precisions[i];
    const y = standardizedEffects[i];
    sumXY += x * y;
    sumX2 += x * x;
    sumY += y;
    sumX += x;
  }

  const den = n * sumX2 - sumX * sumX;
  let intercept = NaN;
  let pValue = NaN;
  let eggerEstimable = n >= 3 && Number.isFinite(den) && den !== 0;

  if (eggerEstimable) {
    const slope = (n * sumXY - sumX * sumY) / den;
    intercept = (sumY - slope * sumX) / n;

    const residuals = precisions.map((p, i) => standardizedEffects[i] - (intercept + slope * p));
    const mse = residuals.reduce((s, r) => s + r * r, 0) / (n - 2);
    const meanPrec = sumX / n;
    const ssPrec = precisions.reduce((s, p) => s + (p - meanPrec) * (p - meanPrec), 0);
    const seIntercept = Math.sqrt(mse * (1 / n + (meanPrec * meanPrec) / ssPrec));
    const t = intercept / seIntercept;
    const eggerDF = n - 2;

    if (!Number.isFinite(seIntercept) || seIntercept <= 0 || !Number.isFinite(t) || eggerDF <= 0) {
      eggerEstimable = false;
    } else {
      pValue = 2 * (1 - tCDF(Math.abs(t), eggerDF));
      if (!Number.isFinite(pValue)) eggerEstimable = false;
    }
  }

  const lowPower = n < 10;
  const asymmetryDetected = eggerEstimable && !lowPower && pValue < 0.10;
  const asymmetryLabel = !eggerEstimable
    ? 'Not estimable'
    : lowPower
      ? 'Low power (k<10)'
      : (asymmetryDetected ? 'Yes' : 'No');

  // Build text funnel plot with dynamic axis bounds
  const width = 50;
  const height = 12;
  const xVals = studies.map(s => s.logRR);
  let minX = Math.min(...xVals);
  let maxX = Math.max(...xVals);
  if (!Number.isFinite(minX) || !Number.isFinite(maxX)) {
    minX = -0.8;
    maxX = 0.4;
  } else {
    const xRange = maxX - minX;
    const xPad = xRange > 0 ? xRange * 0.10 : 0.10;
    minX -= xPad;
    maxX += xPad;
  }

  const minY = 0;
  let maxY = Math.max(...studies.map(s => s.se));
  if (!Number.isFinite(maxY) || maxY <= 0) {
    maxY = 0.2;
  } else {
    maxY *= 1.10;
  }
  if (maxY <= minY) {
    maxY = minY + 0.2;
  }

  const clamp = (v, lo, hi) => Math.max(lo, Math.min(hi, v));
  const getXPos = (logRR) => {
    const pos = Math.round(((logRR - minX) / (maxX - minX)) * width);
    return clamp(pos, 0, width);
  };
  const getYPos = (se) => {
    const pos = Math.round((1 - (se - minY) / (maxY - minY)) * height);
    return clamp(pos, 0, height);
  };

  let grid = Array(height + 1).fill().map(() => Array(width + 1).fill(' '));

  // Add reference line
  const refPos = getXPos(pooledLogRR);
  for (let y = 0; y <= height; y++) {
    if (refPos >= 0 && refPos <= width) grid[y][refPos] = '|';
  }

  // Add studies
  studies.forEach((s, i) => {
    const x = getXPos(s.logRR);
    const y = getYPos(s.se);
    if (x >= 0 && x <= width && y >= 0 && y <= height) {
      grid[y][x] = String.fromCharCode(65 + i); // A, B, C, etc.
    }
  });

  let interpretation = '';
  if (!eggerEstimable) {
    interpretation = "Egger's test is not estimable for this dataset (need >=3 valid studies and variation in precision).";
  } else if (lowPower) {
    interpretation = `Egger's test has limited power with only ${n} studies. Treat the p-value as exploratory and rely on visual/clinical assessment.`;
  } else if (asymmetryDetected) {
    interpretation = 'Funnel asymmetry detected (Egger p < 0.10). This may reflect publication bias, small-study effects, or heterogeneity.';
  } else {
    interpretation = 'No statistical evidence of funnel asymmetry. This does not rule out publication bias.';
  }
  if (invalidRows > 0) {
    interpretation += ` Data quality note: excluded ${invalidRows} invalid row(s).`;
  }

  let funnelText = `
<strong>Funnel Plot</strong>

SE (precision)
${minY.toFixed(2)} +${'-'.repeat(width)}+
`;

  for (let y = 0; y <= height; y++) {
    const seVal = minY + (1 - y / height) * (maxY - minY);
    const label = y % 4 === 0 ? seVal.toFixed(2) : '    ';
    funnelText += `${label} |${grid[y].join('')}|\n`;
  }

  funnelText += `${maxY.toFixed(2)} +${'-'.repeat(width)}+
      ${minX.toFixed(1)}${' '.repeat(Math.round(width / 2) - 6)}0.0${' '.repeat(Math.round(width / 2) - 6)}${maxX.toFixed(1)}
                    log(RR)

<strong>Legend:</strong> ${studies.map((s, i) => `${String.fromCharCode(65 + i)}=${s.name}`).join(', ')}
Reference line at pooled log(RR) = ${pooledLogRR.toFixed(3)}

<strong>Egger's Test for Funnel Plot Asymmetry:</strong>
Intercept = ${eggerEstimable ? intercept.toFixed(3) : 'N/A'}
P-value = ${eggerEstimable ? pValue.toFixed(4) : 'N/A'}
Asymmetry signal (p < 0.10, k>=10): ${asymmetryLabel}

<strong>Interpretation:</strong>
${interpretation}

<strong>Caution:</strong> With ${n} studies, statistical tests for asymmetry can have limited power.
Visual inspection and comparison to trial registries are more informative.
  `;

  output.innerHTML = `<pre style="font-family: monospace; font-size: 0.75rem; overflow-x: auto;">${funnelText}</pre>`;

  awardPoints(30, 'Funnel plot generated');
  trackToolUse('funnel-plot');
}

function calculateGRADE() {
  const outcome = document.getElementById('grade-outcome').value;
  const design = document.getElementById('grade-design').value;
  const rob = parseInt(document.getElementById('grade-rob').value, 10) || 0;
  const incon = parseInt(document.getElementById('grade-incon').value, 10) || 0;
  const indir = parseInt(document.getElementById('grade-indir').value, 10) || 0;
  const imprec = parseInt(document.getElementById('grade-imprec').value, 10) || 0;
  const pub = parseInt(document.getElementById('grade-pub').value, 10) || 0;
  const upLarge = parseInt(document.getElementById('grade-up-large').value, 10) || 0;
  const upDose = document.getElementById('grade-up-dose').checked;
  const upConfound = document.getElementById('grade-up-confound').checked;

  let level = design === 'rct' ? 4 : 2; // RCTs start HIGH (4), observational starts LOW (2)
  const downgrades = [];
  const upgrades = [];

  const applyDowngrade = (label, points) => {
    if (points < 0) {
      level += points;
      downgrades.push(`${label} (${points})`);
    }
  };

  applyDowngrade('Risk of bias', rob);
  applyDowngrade('Inconsistency', incon);
  applyDowngrade('Indirectness', indir);
  applyDowngrade('Imprecision', imprec);
  applyDowngrade('Publication bias', pub);

  if (design === 'obs') {
    if (upLarge === 1) {
      level += 1;
      upgrades.push('Large effect (+1)');
    } else if (upLarge === 2) {
      level += 2;
      upgrades.push('Very large effect (+2)');
    }
    if (upDose) {
      level += 1;
      upgrades.push('Dose-response gradient (+1)');
    }
    if (upConfound) {
      level += 1;
      upgrades.push('All plausible confounders would reduce effect (+1)');
    }
  } else if (upLarge > 0 || upDose || upConfound) {
    upgrades.push('Rate-up criteria selected but not applied (RCT evidence starts HIGH)');
  }

  level = Math.max(1, Math.min(4, level));

  const levels = {
    4: { name: 'HIGH', symbol: '4/4', meaning: 'Very confident in the effect estimate' },
    3: { name: 'MODERATE', symbol: '3/4', meaning: 'Moderately confident; true effect likely close' },
    2: { name: 'LOW', symbol: '2/4', meaning: 'Limited confidence; true effect may differ substantially' },
    1: { name: 'VERY LOW', symbol: '1/4', meaning: 'Very little confidence; true effect likely very different' }
  };

  const result = levels[level];

  const output = document.getElementById('grade-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>GRADE Certainty Assessment</strong>

Outcome: ${outcome}
Starting level: ${design === 'rct' ? 'HIGH (RCTs)' : 'LOW (Observational)'}

<strong>Downgrades applied:</strong>
${downgrades.length > 0 ? downgrades.map(d => '- ' + d).join('\n') : '- None'}

<strong>Upgrades applied:</strong>
${upgrades.length > 0 ? upgrades.map(u => '- ' + u).join('\n') : '- None'}

----------------------------------------
FINAL CERTAINTY: ${result.symbol} ${result.name}
----------------------------------------

<strong>What this means:</strong>
${result.meaning}

<strong>For clinical practice:</strong>
${level === 4 ? 'Strong confidence in the estimate. Guidelines can make strong recommendations.' :
  level === 3 ? 'Moderate confidence. Recommendations possible but may change with future evidence.' :
  level === 2 ? 'Low confidence. Recommendations should be weak/conditional. More research needed.' :
  'Very low confidence. Any estimate is very uncertain. Decisions should consider patient values and context heavily.'}
  `;

  awardPoints(25, 'GRADE assessment completed');
  trackToolUse('grade-builder');
}

function calculatePRISMA() {
  const items = document.querySelectorAll('.prisma-item:checked').length;
  const total = document.querySelectorAll('.prisma-item').length;
  const pct = Math.round((items / total) * 100);

  const output = document.getElementById('prisma-checklist-output');
  output.style.display = 'block';
  output.innerHTML = `
<strong>PRISMA 2020 Essentials (15-item training subset)</strong>

Items completed: ${items}/${total}
Completeness (training subset): ${pct}%

${'‚ñà'.repeat(Math.round(pct/5))}${'‚ñë'.repeat(20 - Math.round(pct/5))} ${pct}%

<strong>Assessment:</strong>
${pct >= 90 ? 'Strong coverage of core PRISMA essentials in this training subset.' :
  pct >= 70 ? 'Good coverage with some missing essentials.' :
  pct >= 50 ? 'Moderate coverage. Several important essentials are missing.' :
  'Low coverage. Review PRISMA essentials before reporting results.'}

<strong>Critical items for reproducibility:</strong>
‚Ä¢ Full search strategy (at least one database)
‚Ä¢ PRISMA flow diagram
‚Ä¢ Risk of bias assessments
‚Ä¢ Effect measures and synthesis methods

Missing these items severely limits the ability of others to verify or replicate your review.

<strong>Important:</strong> This tool does not replace full PRISMA 2020 27-item reporting.
  `;

  awardPoints(20, 'PRISMA checklist evaluated');
  trackToolUse('prisma-checklist');
}

// ============================================================
// SCENARIOS
// ============================================================

function renderScenario(scenario) {
  const completed = gameState.scenariosCompleted[scenario.id];

  return `
    <div class="scenario-panel" id="scenario-${scenario.id}">
      <div class="scenario-header">
        <span class="scenario-icon">üîÄ</span>
        <span class="scenario-title">${scenario.title}</span>
      </div>
      <div class="scenario-situation">${scenario.situation}</div>
      <div class="scenario-question">${scenario.question}</div>
      <div class="scenario-choices">
        ${scenario.choices.map(c => `
          <div class="scenario-choice ${completed === c.id ? (c.id === scenario.correct ? 'correct' : 'incorrect') : ''} ${completed && c.id === scenario.correct ? 'correct' : ''}"
               onclick="${completed ? '' : `selectScenario('${scenario.id}', '${c.id}')`}"
               style="${completed ? 'pointer-events: none;' : ''}">
            <span class="choice-letter">${c.id.toUpperCase()}</span>
            <span>${c.text}</span>
          </div>
        `).join('')}
      </div>
      <div class="scenario-consequence ${completed ? 'visible' : ''} ${completed ? scenario.choices.find(c => c.id === completed)?.consequence : ''}" id="consequence-${scenario.id}">
        ${completed ? scenario.choices.find(c => c.id === completed)?.result : ''}
      </div>
    </div>
  `;
}

function selectScenario(scenarioId, choiceId) {
  // Find the scenario
  let scenario;
  modules.forEach(m => {
    m.slides.forEach(s => {
      if (s.type === 'scenario' && s.content.id === scenarioId) {
        scenario = s.content;
      }
    });
  });

  if (!scenario || gameState.scenariosCompleted[scenarioId]) return;

  gameState.scenariosCompleted[scenarioId] = choiceId;

  const choice = scenario.choices.find(c => c.id === choiceId);
  const isCorrect = choiceId === scenario.correct;

  // Update UI
  const choices = document.querySelectorAll(`#scenario-${scenarioId} .scenario-choice`);
  choices.forEach(el => {
    el.style.pointerEvents = 'none';
    const letter = el.querySelector('.choice-letter').textContent.toLowerCase();
    if (letter === scenario.correct) {
      el.classList.add('correct');
    } else if (letter === choiceId) {
      el.classList.add('incorrect');
    }
  });

  const consequence = document.getElementById(`consequence-${scenarioId}`);
  consequence.textContent = choice.result;
  consequence.className = `scenario-consequence visible ${choice.consequence}`;

  // Award points
  if (isCorrect) {
    awardPoints(30, 'Correct scenario decision');
  } else {
    awardPoints(10, 'Scenario attempted');
  }

  saveProgress();
}

// ============================================================
// DECISION TREES (Interactive Branching Narratives)
// ============================================================

function renderDecisionTree(tree) {
  const treeState = gameState.decisionTrees || {};
  const currentPath = treeState[tree.id] || { currentNode: 'start', history: [] };

  // Build path history display
  const pathHistory = currentPath.history.length > 0 ? `
    <div class="path-history" id="path-history-${tree.id}">
      <span class="path-step">Start</span>
      ${currentPath.history.map((step, i) => {
        const node = tree.nodes[step.node] || tree.nodes.find(n => n.id === step.node);
        const branchText = node && node.branches ?
          (node.branches.find(b => b.id === step.branch) || {}).text || step.branch :
          step.branch;
        return `<span class="path-step" title="${branchText}">${branchText.substring(0, 25)}${branchText.length > 25 ? '...' : ''}</span>`;
      }).join('')}
    </div>
  ` : '';

  // Tree controls (undo and restart)
  const treeControls = currentPath.history.length > 0 ? `
    <div class="tree-controls" id="tree-controls-${tree.id}">
      <button class="undo-btn" onclick="undoDecisionBranch('${tree.id}')" aria-label="Undo last choice">
        ‚Ü∂ Undo Last Choice
      </button>
      <button class="restart-btn" onclick="resetDecisionTree('${tree.id}')" aria-label="Start over">
        ‚Ü©Ô∏è Start Over
      </button>
    </div>
  ` : '';

  return `
    <div class="decision-tree" id="tree-${tree.id}" role="region" aria-label="Decision scenario: ${tree.title}">
      <div class="scenario-header">
        <span class="scenario-icon" aria-hidden="true">üå≥</span>
        <span class="scenario-title">${tree.title}</span>
      </div>
      ${tree.realCase ? `
        <div style="margin-bottom: 1rem; padding: 0.75rem; background: rgba(197,48,48,0.1); border-left: 3px solid var(--red); border-radius: 0 8px 8px 0;">
          <strong style="color: var(--red);">üìö Real Case:</strong>
          <span style="color: rgba(255,255,255,0.9);">${tree.realCase}</span>
        </div>
      ` : ''}
      <div class="scenario-situation" style="margin-bottom: 1rem;">${tree.scenario || tree.situation}</div>

      ${pathHistory}

      <div id="tree-nodes-${tree.id}">
        ${renderDecisionNode(tree, currentPath.currentNode, tree.id)}
      </div>

      ${treeControls}
    </div>
  `;
}

function renderDecisionNode(tree, nodeId, treeId) {
  // Handle both array-style and object-style node storage
  let node;
  if (Array.isArray(tree.nodes)) {
    node = tree.nodes.find(n => n.id === nodeId);
  } else {
    node = tree.nodes[nodeId];
  }

  if (!node) return '<p style="color: var(--red);">Node not found: ' + nodeId + '</p>';

  // Check if this is an ending node (has isEnding flag or type === 'outcome')
  const isEnding = node.isEnding || node.type === 'outcome';
  const outcome = node.outcome || node.consequence;

  if (isEnding) {
    return `
      <div class="decision-node ${outcome === 'good' ? 'completed' : outcome === 'bad' ? 'wrong' : 'active'}">
        <div class="decision-question" style="color: ${outcome === 'good' ? 'var(--green)' : outcome === 'bad' ? 'var(--red)' : 'var(--gold)'};">
          ${outcome === 'good' ? '‚úì Good Outcome' : outcome === 'bad' ? '‚úó Poor Outcome' : '‚óã Neutral Outcome'}
        </div>
        ${node.situation ? `<p style="color: rgba(255,255,255,0.9); line-height: 1.7; margin-bottom: 1rem;">${node.situation}</p>` : ''}
        ${node.text ? `<p style="color: rgba(255,255,255,0.9); line-height: 1.7; margin-bottom: 1rem;">${node.text}</p>` : ''}
        ${node.lesson ? `
          <div style="margin-top: 1rem; padding: 1rem; background: rgba(212,175,55,0.1); border-left: 3px solid var(--gold); border-radius: 0 8px 8px 0;">
            <strong style="color: var(--gold);">üí° Lesson:</strong>
            <p style="color: rgba(255,255,255,0.9); margin-top: 0.5rem; line-height: 1.6;">${node.lesson}</p>
          </div>
        ` : ''}
        ${node.realCase ? `
          <div style="margin-top: 1rem; padding: 0.75rem; background: rgba(255,255,255,0.05); border-radius: 8px; font-size: 0.9rem;">
            <strong style="color: var(--gold);">üìö Real Case:</strong>
            <span style="color: rgba(255,255,255,0.8);">${node.realCase}</span>
          </div>
        ` : ''}
      </div>
    `;
  }

  // Regular decision node with branches
  return `
    <div class="decision-node active" role="group" aria-label="Decision point">
      ${node.situation ? `<p style="color: rgba(255,255,255,0.85); margin-bottom: 1rem; line-height: 1.6;">${node.situation}</p>` : ''}
      <div class="decision-question">${node.question}</div>
      <div class="decision-branches" role="list">
        ${(node.branches || []).map((branch, idx) => `
          <button class="decision-branch" role="listitem"
                  onclick="selectDecisionBranch('${treeId}', '${nodeId}', '${branch.id}', '${branch.nextNode}')"
                  aria-label="Option ${idx + 1}: ${branch.text}">
            <span class="branch-arrow" aria-hidden="true">${String.fromCharCode(65 + idx)}</span>
            <span>${branch.text}</span>
          </button>
        `).join('')}
      </div>
    </div>
  `;
}

function selectDecisionBranch(treeId, currentNodeId, branchId, nextNodeId) {
  // Find the tree
  let tree;
  modules.forEach(m => {
    m.slides.forEach(s => {
      if (s.type === 'decision-tree' && s.content.id === treeId) {
        tree = s.content;
      }
    });
  });

  if (!tree) return;

  // Update state
  if (!gameState.decisionTrees) gameState.decisionTrees = {};
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }

  const treeState = gameState.decisionTrees[treeId];
  treeState.history.push({ node: currentNodeId, branch: branchId });
  treeState.currentNode = nextNodeId;

  // Check if outcome (handle both array and object node storage)
  let nextNode;
  if (Array.isArray(tree.nodes)) {
    nextNode = tree.nodes.find(n => n.id === nextNodeId);
  } else {
    nextNode = tree.nodes[nextNodeId];
  }

  const isEnding = nextNode && (nextNode.isEnding || nextNode.type === 'outcome');
  const outcome = nextNode ? (nextNode.outcome || nextNode.consequence) : null;

  if (isEnding) {
    if (outcome === 'good') {
      awardPoints(40, 'Optimal decision path');
    } else if (outcome === 'neutral') {
      awardPoints(20, 'Acceptable decision path');
    } else {
      awardPoints(10, 'Decision tree completed');
    }
  }

  // Re-render the node area
  const nodesContainer = document.getElementById(`tree-nodes-${treeId}`);
  if (nodesContainer) {
    nodesContainer.innerHTML = renderDecisionNode(tree, nextNodeId, treeId);
  }

  // Update or add path history
  const treeContainer = document.getElementById(`tree-${treeId}`);
  let pathHistory = document.getElementById(`path-history-${treeId}`);

  if (!pathHistory && treeContainer) {
    pathHistory = document.createElement('div');
    pathHistory.className = 'path-history';
    pathHistory.id = `path-history-${treeId}`;
    const scenarioSituation = treeContainer.querySelector('.scenario-situation');
    if (scenarioSituation) {
      scenarioSituation.after(pathHistory);
    }
  }

  if (pathHistory) {
    let pathHtml = '<span class="path-step">Start</span>';
    treeState.history.forEach(step => {
      let node;
      if (Array.isArray(tree.nodes)) {
        node = tree.nodes.find(n => n.id === step.node);
      } else {
        node = tree.nodes[step.node];
      }
      const branchText = node && node.branches ?
        (node.branches.find(b => b.id === step.branch) || {}).text || step.branch :
        step.branch;
      pathHtml += `<span class="path-step" title="${branchText}">${branchText.substring(0, 25)}${branchText.length > 25 ? '...' : ''}</span>`;
    });
    pathHistory.innerHTML = pathHtml;
  }

  // Update or add tree controls
  let treeControls = document.getElementById(`tree-controls-${treeId}`);
  if (!treeControls && treeContainer) {
    treeControls = document.createElement('div');
    treeControls.className = 'tree-controls';
    treeControls.id = `tree-controls-${treeId}`;
    treeControls.innerHTML = `
      <button class="undo-btn" onclick="undoDecisionBranch('${treeId}')" aria-label="Undo last choice">
        ‚Ü∂ Undo Last Choice
      </button>
      <button class="restart-btn" onclick="resetDecisionTree('${treeId}')" aria-label="Start over">
        ‚Ü©Ô∏è Start Over
      </button>
    `;
    treeContainer.appendChild(treeControls);
  }

  saveProgress();
}

function resetDecisionTree(treeId) {
  if (gameState.decisionTrees && gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }

  // Find and re-render the tree
  let tree;
  modules.forEach(m => {
    m.slides.forEach(s => {
      if (s.type === 'decision-tree' && s.content.id === treeId) {
        tree = s.content;
      }
    });
  });

  if (tree) {
    const nodesContainer = document.getElementById(`tree-nodes-${treeId}`);
    if (nodesContainer) {
      nodesContainer.innerHTML = renderDecisionNode(tree, 'start', treeId);
    }

    // Remove path history
    const pathHistory = document.getElementById(`path-history-${treeId}`);
    if (pathHistory) pathHistory.remove();

    // Remove tree controls
    const treeControls = document.getElementById(`tree-controls-${treeId}`);
    if (treeControls) treeControls.remove();

    // Remove any standalone restart button
    const restartBtn = document.querySelector(`#tree-${treeId} .restart-btn`);
    if (restartBtn) restartBtn.remove();
  }

  saveProgress();
}

function undoDecisionBranch(treeId) {
  if (!gameState.decisionTrees || !gameState.decisionTrees[treeId]) return;

  const treeState = gameState.decisionTrees[treeId];
  if (treeState.history.length === 0) return;

  // Pop the last decision
  const lastStep = treeState.history.pop();
  treeState.currentNode = lastStep.node;

  // Find and re-render the tree
  let tree;
  modules.forEach(m => {
    m.slides.forEach(s => {
      if (s.type === 'decision-tree' && s.content.id === treeId) {
        tree = s.content;
      }
    });
  });

  if (tree) {
    const nodesContainer = document.getElementById(`tree-nodes-${treeId}`);
    if (nodesContainer) {
      nodesContainer.innerHTML = renderDecisionNode(tree, treeState.currentNode, treeId);
    }

    // Update path history
    const pathHistory = document.getElementById(`path-history-${treeId}`);
    if (pathHistory) {
      if (treeState.history.length === 0) {
        pathHistory.remove();
        // Also remove tree controls
        const treeControls = document.getElementById(`tree-controls-${treeId}`);
        if (treeControls) treeControls.remove();
      } else {
        // Rebuild path history
        let pathHtml = '<span class="path-step">Start</span>';
        treeState.history.forEach(step => {
          let node;
          if (Array.isArray(tree.nodes)) {
            node = tree.nodes.find(n => n.id === step.node);
          } else {
            node = tree.nodes[step.node];
          }
          const branchText = node && node.branches ?
            (node.branches.find(b => b.id === step.branch) || {}).text || step.branch :
            step.branch;
          pathHtml += `<span class="path-step" title="${branchText}">${branchText.substring(0, 25)}${branchText.length > 25 ? '...' : ''}</span>`;
        });
        pathHistory.innerHTML = pathHtml;
      }
    }
  }

  saveProgress();
}

// ============================================================
// QUIZZES
// ============================================================

function renderQuiz(quiz, slideIdx) {
  const quizId = `quiz-${currentModule}-${slideIdx}`;

  return `
    <div class="quiz-container" id="${quizId}" role="group" aria-labelledby="${quizId}-question">
      <div class="quiz-question" id="${quizId}-question">${quiz.question}</div>
      <div class="quiz-options" role="radiogroup" aria-label="Answer choices">
        ${quiz.options.map((opt, idx) => `
          <button class="quiz-option" role="radio" aria-checked="false"
                  onclick="selectQuizOption('${quizId}', '${opt.id}', ${opt.correct})"
                  data-option-id="${opt.id}">
            <span class="option-letter" aria-hidden="true">${String.fromCharCode(65 + idx)}.</span>
            ${opt.text}
          </button>
        `).join('')}
      </div>
      <div class="quiz-feedback" id="${quizId}-feedback" role="alert" aria-live="polite" style="display: none; margin-top: 1rem; padding: 1rem; border-radius: 8px;"></div>
    </div>
  `;
}

function selectQuizOption(quizId, optionId, isCorrect) {
  const container = document.getElementById(quizId);
  const options = container.querySelectorAll('.quiz-option');
  const feedback = document.getElementById(`${quizId}-feedback`);

  // Track the quiz answer
  gameState.quizAnswers[quizId] = {
    selected: optionId,
    correct: isCorrect,
    timestamp: Date.now()
  };

  // Disable all options and update ARIA
  options.forEach(opt => {
    opt.disabled = true;
    opt.setAttribute('aria-disabled', 'true');
  });

  // Find the quiz data
  let module = modules[currentModule];
  let quiz;
  module.slides.forEach(s => {
    if (s.type === 'quiz') quiz = s.content;
  });

  if (quiz) {
    // Mark options using data-option-id attribute matching
    options.forEach((opt, index) => {
      const thisOptData = quiz.options[index];
      const thisOptId = opt.getAttribute('data-option-id') || ['a', 'b', 'c', 'd'][index];

      if (thisOptId === optionId) {
        // This is the selected option
        opt.classList.add(isCorrect ? 'correct' : 'incorrect');
        opt.setAttribute('aria-checked', 'true');
      }

      // Always show the correct answer
      if (thisOptData && thisOptData.correct) {
        opt.classList.add('correct');
      }
    });

    feedback.innerHTML = `
      <strong>${isCorrect ? '‚úì Correct!' : '‚úó Not quite.'}</strong><br><br>
      ${quiz.explanation}
    `;
    feedback.style.display = 'block';
    feedback.style.background = isCorrect ? 'rgba(34,197,94,0.15)' : 'rgba(239,68,68,0.1)';
    feedback.style.border = `1px solid ${isCorrect ? 'var(--green)' : 'var(--red)'}`;
  }

  if (isCorrect) {
    awardPoints(20, 'Quiz correct');
  }

  checkBadges();
  saveProgress();
}

// ============================================================
// NAVIGATION
// ============================================================

function goToModule(moduleId) {
  currentModule = moduleId;
  currentSlide = 0;
  renderSlides();
  updateModuleList();
  updateSlideNav();
  document.getElementById('moduleIndicator').textContent = `Module ${moduleId}: ${modules[moduleId].title}`;
}

function goToNextModule() {
  if (currentModule < modules.length - 1) {
    markModuleComplete(currentModule);
    goToModule(currentModule + 1);
  }
}

function nextSlide() {
  const module = modules[currentModule];
  if (currentSlide < module.slides.length - 1) {
    currentSlide++;
    updateSlideDisplay();
  } else if (currentModule < modules.length - 1) {
    markModuleComplete(currentModule);
    goToModule(currentModule + 1);
  }
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
    updateSlideDisplay();
  } else if (currentModule > 0) {
    goToModule(currentModule - 1);
    currentSlide = modules[currentModule].slides.length - 1;
    updateSlideDisplay();
  }
}

function updateSlideDisplay() {
  const slides = document.querySelectorAll('.slide');
  slides.forEach((s, i) => {
    s.classList.toggle('active', i === currentSlide);
  });
  updateSlideNav();
}

function updateSlideNav() {
  const module = modules[currentModule];
  document.getElementById('slideCounter').textContent = `${currentSlide + 1} / ${module.slides.length}`;
  document.getElementById('prevBtn').disabled = currentModule === 0 && currentSlide === 0;
  document.getElementById('nextBtn').textContent =
    currentSlide === module.slides.length - 1 && currentModule < modules.length - 1 ? 'Next Module ‚Üí' : 'Next ‚Üí';
}

function updateModuleList() {
  document.querySelectorAll('.module-item').forEach(el => {
    const isActive = parseInt(el.dataset.module) === currentModule;
    el.classList.toggle('active', isActive);
    if (isActive) {
      el.setAttribute('aria-current', 'true');
    } else {
      el.removeAttribute('aria-current');
    }
  });
}

// ============================================================
// GAMIFICATION
// ============================================================

function awardPoints(points, reason) {
  const oldPoints = gameState.points;
  gameState.points += points;
  updateSidebarPoints();
  showToast(`+${points} pts`, reason);
  checkLevelUp(oldPoints, gameState.points);
  checkBadges();
  saveProgress();
}

function trackToolUse(toolId) {
  if (!gameState.toolsUsed.includes(toolId)) {
    gameState.toolsUsed.push(toolId);
    checkBadges();
  }
  saveProgress();
}

function markModuleComplete(moduleId) {
  if (!gameState.modulesCompleted.includes(moduleId)) {
    gameState.modulesCompleted.push(moduleId);
    awardPoints(100, 'Module completed');
    renderModuleList();
    checkBadges();
    checkCourseCompletion();
  }
  saveProgress();
  updateProgress();
}

function updateSidebarPoints() {
  document.getElementById('sidebarPoints').textContent = gameState.points + ' pts';
}

function updateProgress() {
  const pct = Math.round((gameState.modulesCompleted.length / modules.length) * 100);
  document.getElementById('progressPercent').textContent = pct + '%';
  document.getElementById('progressFill').style.width = pct + '%';
}

// ============================================================
// TOAST NOTIFICATIONS
// ============================================================

function showToast(title, message, type = 'points') {
  const container = document.getElementById('toastContainer');
  const toast = document.createElement('div');
  toast.className = `toast ${type}-toast`;
  toast.innerHTML = `<span>${title}</span><span style="opacity:0.8;font-weight:400;"> ${message}</span>`;
  container.appendChild(toast);
  setTimeout(() => toast.remove(), 3000);
}

// ============================================================
// NOTIFICATION MODAL
// ============================================================

function showNotification(title, message) {
  document.getElementById('notificationTitle').textContent = title;
  document.getElementById('notificationMessage').textContent = message;
  document.getElementById('notificationModal').classList.add('active');
}

function closeNotification() {
  document.getElementById('notificationModal').classList.remove('active');
}

// ============================================================
// BADGE SYSTEM
// ============================================================

function checkBadges() {
  let newBadgesEarned = false;
  badges.forEach(badge => {
    if (!gameState.earnedBadges.includes(badge.id) && badge.condition()) {
      gameState.earnedBadges.push(badge.id);
      showToast(`${badge.icon} ${badge.name}`, 'Badge earned!', 'badge');
      newBadgesEarned = true;
    }
  });
  if (newBadgesEarned) {
    saveProgress();
  }
}

function renderBadges() {
  const grid = document.getElementById('badgeGrid');
  grid.innerHTML = badges.map(badge => {
    const earned = gameState.earnedBadges.includes(badge.id);
    return `
      <div class="badge ${earned ? 'earned' : ''}" title="${badge.description}">
        <span>${badge.icon}</span> ${badge.name}
      </div>
    `;
  }).join('');
}

// ============================================================
// LEVEL SYSTEM
// ============================================================

function getCurrentLevel() {
  let currentLevel = levels[0];
  for (const level of levels) {
    if (gameState.points >= level.minPoints) {
      currentLevel = level;
    }
  }
  return currentLevel;
}

function checkLevelUp(oldPoints, newPoints) {
  const oldLevel = levels.filter(l => oldPoints >= l.minPoints).pop();
  const newLevel = levels.filter(l => newPoints >= l.minPoints).pop();
  if (newLevel && oldLevel && newLevel.name !== oldLevel.name) {
    showToast(`‚¨ÜÔ∏è Level Up!`, `You are now ${newLevel.name}`, 'level');
    updateLevelBadge();
  }
}

function updateLevelBadge() {
  const level = getCurrentLevel();
  document.getElementById('levelBadge').textContent = `Level: ${level.name}`;
}

// ============================================================
// DASHBOARD
// ============================================================

function openDashboard() {
  document.getElementById('totalPoints').textContent = gameState.points;
  document.getElementById('modulesCompleted').textContent = `${gameState.modulesCompleted.length}/${modules.length}`;
  document.getElementById('toolsUsed').textContent = gameState.toolsUsed.length;
  updateLevelBadge();
  renderBadges();
  const dashboard = document.getElementById('progressDashboard');
  dashboard.classList.add('open');
  // Focus trap
  const closeBtn = dashboard.querySelector('.close-btn');
  if (closeBtn) closeBtn.focus();
}

function closeDashboard() {
  document.getElementById('progressDashboard').classList.remove('open');
}

function startDailyReview() {
  // Simple spaced repetition - show random quiz from completed modules
  if (gameState.modulesCompleted.length < 2) {
    showNotification('Daily Review Locked', 'Complete at least 2 modules to unlock Daily Review!');
    return;
  }
  const completedWithQuiz = gameState.modulesCompleted.filter(id => {
    return modules[id] && modules[id].slides.some(s => s.type === 'quiz');
  });
  if (completedWithQuiz.length === 0) {
    showNotification('No Quizzes Yet', 'No quizzes available for review yet. Keep learning!');
    return;
  }
  const randomModuleId = completedWithQuiz[Math.floor(Math.random() * completedWithQuiz.length)];
  goToModule(randomModuleId);
  // Navigate to quiz slide
  const quizIndex = modules[randomModuleId].slides.findIndex(s => s.type === 'quiz');
  if (quizIndex >= 0) {
    currentSlide = quizIndex;
    renderSlides();
  }
}

// ============================================================
// SIDEBAR TOGGLE (Mobile)
// ============================================================

function toggleSidebar() {
  const sidebar = document.getElementById('sidebar');
  const hamburger = document.querySelector('.hamburger');
  const overlay = document.querySelector('.sidebar-overlay');

  sidebar.classList.toggle('open');
  hamburger.classList.toggle('active');
  overlay.classList.toggle('active');

  const isOpen = sidebar.classList.contains('open');
  hamburger.setAttribute('aria-expanded', isOpen);
}

// ============================================================
// TOOL LIBRARY
// ============================================================

const toolLibraryItems = [
  { id: 'pico-builder', name: 'PICO Builder', description: 'Structure your research question with Population, Intervention, Comparator, Outcome', module: 1 },
  { id: 'search-builder', name: 'Search Strategy Builder', description: 'Create database search strings with Boolean operators', module: 3 },
  { id: 'prisma-flow', name: 'PRISMA Flow Generator', description: 'Create PRISMA 2020 flow diagrams for your review', module: 4 },
  { id: 'extraction-form', name: 'Data Extraction Form', description: 'Standardized forms for extracting study data', module: 5 },
  { id: 'rob2-tool', name: 'RoB 2 Assessment', description: 'Evaluate risk of bias using Cochrane RoB 2 tool', module: 6 },
  { id: 'effect-calculator', name: 'Effect Size Calculator', description: 'Calculate RR, OR, SMD, and other effect sizes', module: 7 },
  { id: 'forest-plot', name: 'Forest Plot Builder', description: 'Interactive forest plots with fixed/random effects', module: 8 },
  { id: 'heterogeneity-explorer', name: 'Heterogeneity Explorer', description: 'Visualize I¬≤, œÑ¬≤, and prediction intervals', module: 9 },
  { id: 'funnel-plot', name: 'Funnel Plot Builder', description: 'Funnel plots with Egger\'s test for publication bias', module: 10 },
  { id: 'grade-builder', name: 'GRADE Assessment', description: 'Build Summary of Findings tables with GRADE ratings', module: 11 },
  { id: 'prisma-checklist', name: 'PRISMA Checklist', description: 'Complete PRISMA 2020 reporting checklist', module: 12 }
];

function openToolLibrary() {
  const modal = document.getElementById('toolLibraryModal');
  const grid = document.getElementById('toolLibraryGrid');

  grid.innerHTML = toolLibraryItems.map(tool => `
    <div class="tool-library-item" onclick="goToTool('${tool.id}', ${tool.module})" role="button" tabindex="0" aria-label="Open ${tool.name}">
      <h4>${tool.name}</h4>
      <p>${tool.description}</p>
      <small style="color: var(--gold); margin-top: 0.5rem; display: block;">Module ${tool.module}</small>
    </div>
  `).join('');

  modal.classList.add('active');
  document.body.style.overflow = 'hidden';

  // Focus trap
  modal.querySelector('.close-btn').focus();
}

function closeToolLibrary() {
  const modal = document.getElementById('toolLibraryModal');
  modal.classList.remove('active');
  document.body.style.overflow = '';
}

function goToTool(toolId, moduleId) {
  closeToolLibrary();
  goToModule(moduleId);
  // Find the tool slide
  const toolIndex = modules[moduleId].slides.findIndex(s => s.type === 'tool' && s.content.id === toolId);
  if (toolIndex >= 0) {
    currentSlide = toolIndex;
    renderSlides();
  }
}

// ============================================================
// GLOSSARY
// ============================================================

const glossaryTerms = {
  'I¬≤': 'Percentage of variability in effect estimates due to heterogeneity rather than sampling error. 0% = no heterogeneity, 75%+ = high heterogeneity.',
  'œÑ¬≤ (tau-squared)': 'Between-study variance in random effects meta-analysis. Measures absolute heterogeneity in same units as effect size squared.',
  'Prediction Interval': 'Range where 95% of true effects in future studies would fall. Unlike CI (average effect), PI shows variability across settings.',
  'Risk Ratio (RR)': 'Ratio of risk in treatment vs control: RR = (a/n‚ÇÅ) / (c/n‚ÇÇ). RR < 1 indicates treatment reduces risk.',
  'Odds Ratio (OR)': 'Ratio of odds: OR = (a√ód) / (b√óc). Used when outcome is common or for case-control studies.',
  'SMD': 'Standardized Mean Difference (Cohen\'s d). Effect size for continuous outcomes on different scales: SMD = (M‚ÇÅ-M‚ÇÇ) / SD_pooled.',
  'PICO': 'Population, Intervention, Comparator, Outcome. Framework for structuring systematic review questions.',
  'RoB 2': 'Cochrane Risk of Bias 2 tool. Assesses bias across 5 domains: randomization, deviations, missing data, measurement, selection.',
  'GRADE': 'Grading of Recommendations, Assessment, Development and Evaluations. Framework for rating certainty in evidence.',
  'Egger\'s Test': 'Statistical test for funnel plot asymmetry. Significant p-value (<0.1) suggests possible publication bias.',
  'Publication Bias': 'Tendency for positive/significant results to be published more than negative/null results, distorting evidence synthesis.',
  'Fixed Effect': 'Model assuming one true effect size. All variability is sampling error. Weights by inverse variance only.',
  'Random Effects': 'Model assuming distribution of true effects. Adds between-study variance (œÑ¬≤) to weights. More conservative CIs.',
  'NNT': 'Number Needed to Treat. Number of patients to treat for one additional good outcome: NNT = 1/ARR.',
  'Forest Plot': 'Graphical display of meta-analysis results showing individual study effects, CIs, weights, and pooled estimate.'
};

function openGlossary() {
  const terms = Object.entries(glossaryTerms).map(([term, def]) =>
    `<div style="margin-bottom: 1rem; padding: 1rem; background: rgba(255,255,255,0.05); border-radius: 8px;">
      <strong style="color: var(--gold);">${term}</strong>
      <p style="margin-top: 0.5rem; color: rgba(255,255,255,0.8); font-size: 0.9rem;">${def}</p>
    </div>`
  ).join('');

  const modal = document.createElement('div');
  modal.className = 'tool-library-modal active';
  modal.id = 'glossaryModal';
  modal.innerHTML = `
    <div class="tool-library-content" style="max-height: 80vh; overflow-y: auto;">
      <div class="tool-library-header">
        <h2>üìñ Glossary of Terms</h2>
        <button class="close-btn" onclick="this.closest('.tool-library-modal').remove(); document.body.style.overflow='';">&times;</button>
      </div>
      <div>${terms}</div>
    </div>
  `;
  document.body.appendChild(modal);
  document.body.style.overflow = 'hidden';
}

// ============================================================
// CERTIFICATE
// ============================================================

function checkCourseCompletion() {
  // Check if all modules are completed
  if (gameState.modulesCompleted.length >= modules.length - 1) { // -1 for module 0
    showCertificate();
  }
}

function showCertificate() {
  const modal = document.getElementById('certificateModal');
  const dateEl = document.getElementById('certificateDate');
  const nameEl = document.getElementById('certificateName');

  // Get stored name or prompt
  let userName = localStorage.getItem('metaMethodsUserName');
  if (!userName) {
    userName = prompt('Congratulations on completing the course! Enter your name for the certificate:') || 'Course Participant';
    localStorage.setItem('metaMethodsUserName', userName);
  }

  nameEl.textContent = userName;
  dateEl.textContent = `Completed on ${new Date().toLocaleDateString('en-US', { year: 'numeric', month: 'long', day: 'numeric' })}`;

  modal.classList.add('active');
  document.body.style.overflow = 'hidden';
}

function closeCertificate() {
  const modal = document.getElementById('certificateModal');
  modal.classList.remove('active');
  document.body.style.overflow = '';
}

function downloadCertificate() {
  // Create printable version
  const cert = document.querySelector('.certificate');
  const printWindow = window.open('', '_blank');
  printWindow.document.write(`
    <html>
    <head>
      <title>Meta-Analysis Methods Course Certificate</title>
      <link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&display=swap" rel="stylesheet">
      <style>
        body { font-family: 'Source Sans Pro', sans-serif; display: flex; justify-content: center; align-items: center; min-height: 100vh; margin: 0; background: #f5f5f5; }
        .certificate { background: linear-gradient(135deg, #FAF8F5, #F5F0E8); border: 8px solid #D4AF37; border-radius: 8px; padding: 3rem; max-width: 700px; text-align: center; position: relative; box-shadow: 0 10px 40px rgba(0,0,0,0.1); }
        .certificate::before { content: ''; position: absolute; inset: 8px; border: 2px solid #D4AF37; border-radius: 4px; pointer-events: none; }
        .certificate-title { font-family: 'Cormorant Garamond', Georgia, serif; font-size: 2.5rem; color: #1E2761; margin-bottom: 0.5rem; }
        .certificate-subtitle { color: #718096; margin-bottom: 2rem; }
        .certificate-name { font-family: 'Cormorant Garamond', Georgia, serif; font-size: 2rem; color: #1E2761; margin: 1.5rem 0; padding: 0.5rem; border-bottom: 2px solid #D4AF37; display: inline-block; }
        .certificate-body { color: #2D3748; line-height: 1.6; margin-bottom: 1rem; }
        .certificate-date { color: #718096; margin-top: 2rem; }
        @media print { body { background: white; } .certificate { box-shadow: none; } }
      </style>
    </head>
    <body>
      ${cert.outerHTML.replace(/<div class="certificate-actions">[\s\S]*?<\/div>/, '')}
      ${'<'}script>window.onload = function() { window.print(); }${'<'}/script>
    </body>
    </html>
  `);
  printWindow.document.close();
}

// ============================================================
// PERSISTENCE
// ============================================================

function saveProgress() {
  try {
    localStorage.setItem(STORAGE_KEY, JSON.stringify({
      currentModule,
      currentSlide,
      gameState
    }));
  } catch (e) {
    console.log('Impossibile salvare i progressi');
  }
}

function loadProgress() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) {
      const data = JSON.parse(saved);
      // Restore game state with schema validation
      if (data.gameState) {
        gameState = {
          points: data.gameState.points || 0,
          earnedBadges: data.gameState.earnedBadges || [],
          toolsUsed: data.gameState.toolsUsed || [],
          modulesCompleted: data.gameState.modulesCompleted || [],
          scenariosCompleted: data.gameState.scenariosCompleted || {},
          decisionTrees: data.gameState.decisionTrees || {},
          quizAnswers: data.gameState.quizAnswers || {}
        };
      }
      // Restore position with bounds checking
      if (typeof data.currentModule === 'number' && data.currentModule >= 0 && data.currentModule < modules.length) {
        currentModule = data.currentModule;
      }
      if (typeof data.currentSlide === 'number' && data.currentSlide >= 0) {
        currentSlide = Math.min(data.currentSlide, modules[currentModule].slides.length - 1);
      }
      updateSidebarPoints();
      updateProgress();
    }
  } catch (e) {
    console.log('Could not load progress:', e);
  }
}

// ============================================================
// KEYBOARD NAVIGATION
// ============================================================

document.addEventListener('keydown', (e) => {
  // Handle Escape key to close modals
  if (e.key === 'Escape') {
    if (document.getElementById('progressDashboard').classList.contains('open')) {
      closeDashboard();
    }
    if (document.getElementById('notificationModal').classList.contains('active')) {
      closeNotification();
    }
    if (document.getElementById('toolLibraryModal').classList.contains('active')) {
      closeToolLibrary();
    }
    if (document.getElementById('certificateModal').classList.contains('active')) {
      closeCertificate();
    }
    return;
  }

  // Handle Enter/Space on module items
  if ((e.key === 'Enter' || e.key === ' ') && e.target.classList.contains('module-item')) {
    e.preventDefault();
    const moduleId = parseInt(e.target.dataset.module);
    if (!isNaN(moduleId)) {
      goToModule(moduleId);
    }
    return;
  }

  if (e.target.tagName === 'INPUT' || e.target.tagName === 'TEXTAREA' || e.target.tagName === 'SELECT') return;

  if (e.key === 'ArrowRight') {
    nextSlide();
  } else if (e.key === 'ArrowLeft') {
    prevSlide();
  }
});
</script>
</body>
</html>
